Modules
Needs Validation
322 rows, unmerged
| Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Validation Reason | Assigned Rep | Customer | Customer ID | Site | State | Opportunity Type | Confidence | Priority Score | Revenue Base | GP Base | Analyzer Platform | SKU Product Quote | Deterministic Signal | CRM Context | Counter Evidence | Recommended Contact | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c3cd7902e0a91f417be562f5e3deee0b83eb40dd61a230452a3486e3749c6925 | OPP-b0571bcf4c3f09ad5d08968276375f21a1289713ddadac99bedadd9a318aa828 | SER-3258c41daf53d73bf34790dd1bb83e141a2686529d54bf91ce1318790df399af | Not selected for publication; targeted context validation is still required. | **** | Riverside Health Alliance, Inc. | 46808 | Vendor | NM | Cross-Sell | Medium | 54.26 | 385.37 | 108.13 | Medica EasyLyte | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | Verified by Description for Medica EasyLyte; item purchased by 7 of 17 comparable active sites (41.2%); peer median annual revenue $385.37. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-c3cd7902e0a91f417be562f5e3deee0b83eb40dd61a230452a3486e3749c6925 | Customer 46808 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-293cf4183db447f87a031cf41938b45457ec461e810d6693ed77ab1f86b1dd9d | OPP-a587ac393c3e7c6e0d6cd449920535233e561bfd8c585381cc21e9b3d63d86c1 | SER-2c1a2e6c89cf555352ca8ed95544ba5d656a6aa9967752912cb3105a64df8bd2 | Not selected for publication; targeted context validation is still required. | **** | Riverside Health Alliance, Inc. | 46808 | Vendor | NM | Cross-Sell | Medium | 54.09 | 385.37 | 108.13 | Medica EasyLyte | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | Verified by Description for Medica EasyLyte; item purchased by 7 of 17 comparable active sites (41.2%); peer median annual revenue $385.37. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-293cf4183db447f87a031cf41938b45457ec461e810d6693ed77ab1f86b1dd9d | Customer 46808 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-efb3a32015897c21554f8d3a9abafd21ab4d5b4ff0c6a933fe0947d162f235d8 | OPP-695aadcab0725b6a5daa7b317409b7ad51fc584ad7d1f7378952642a7c202263 | SER-e21de936bba1d9c546f3735113461576d7c73ca053bb37330af4f6aa4085bef8 | Not selected for publication; targeted context validation is still required. | **** | Lakeside Laboratory Partners, LLC | 6566 | HQ | NJ | Cross-Sell | Medium | 59.84 | 592.54 | 351.45 | Olympus / Beckman AU | OSR6178 — Olympus OSR6178 CREATININE Reagent (4x990 tests) Customer request at least 4 month expiration date. | Verified by Description for Olympus / Beckman AU; item purchased by 15 of 38 comparable active sites (39.5%); peer median annual revenue $592.54. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-efb3a32015897c21554f8d3a9abafd21ab4d5b4ff0c6a933fe0947d162f235d8 | Customer 6566 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a0cb7155800696ca898f734e8f7ee918edbe7180ff1aee4f5821ff42f1202a5b | OPP-d2cb35d2efc8a61a717975aa1168636c7cc42ee75c0d72d4d169ee625a04f4d0 | SER-a8eda73322def831261a565707cfa4e5b10da0e22d994dd3d514ce9aab70474b | Not selected for publication; targeted context validation is still required. | **** | Copperfield Diagnostics, Inc. | 43112 | Vendor | MA | Cross-Sell | Medium | 54.72 | 385.37 | 108.13 | Medica EasyLyte | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | Verified by Description for Medica EasyLyte; item purchased by 7 of 17 comparable active sites (41.2%); peer median annual revenue $385.37. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-a0cb7155800696ca898f734e8f7ee918edbe7180ff1aee4f5821ff42f1202a5b | Customer 43112 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e99f8e9a9892f809cf6c7372c35d7d886e76e5cd8b172d118bc416886065c617 | OPP-e7d76483dd0c743b2fb23c8d428b9cfa5c78adc3e272a4e4694700594a0798ca | SER-52c241c55b3812070fec5bf451164c316954121d1a7f3e7628e272b0f571d39b | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Physician Group, PLLC | 8457 | HQ | TN | Lost Purchasing / Account Risk | Needs Validation | 94.14 | 18193.52 | 7104.1 | Olympus / Beckman AU | OSR6137 — OSR6137 Olympus CO2 Reagent (4x580 tests) | 386167 — Beckman 386167 Reaction Vessels, UniCel DxI 800, 1000/bag, 10 bags/box | ODR3021 — ODR3021 Olympus Serum Protein Multi Calibrator | Analyzer Platform Purchasing Loss; 8 independent signals; trailing 90-day revenue $0.00 versus $2987.28; trailing 180-day revenue $2987.28 versus $39374.32; 112 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jenna Zellner | CONFIRM_ACCOUNT | Candidate CAND-e99f8e9a9892f809cf6c7372c35d7d886e76e5cd8b172d118bc416886065c617 | Customer 8457 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-68f83bc82c64d5912d7149cc39836c0ef2e66cbff9baa64098acf5d0645de4e6 | OPP-d5a332380b6a1afe29d2c8bf564637de43d7a938ea6c614680a8099e87445031 | SER-4d4d0c63063e2f3718db164ba95ebd63f63bf6e75668c587fbb6bbc938cd7f9b | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Clinical Labs, LLC | 7021 | HQ | NC | Lost Purchasing / Account Risk | Needs Validation | 91.07 | 23707 | 5058.11 | — | Account / Site Risk — Revenue and Gross-Profit Decline | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $21152.00; trailing 180-day revenue $21152.00 versus $68566.00; 67 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Laura Brennock | CONFIRM_ACCOUNT | Candidate CAND-68f83bc82c64d5912d7149cc39836c0ef2e66cbff9baa64098acf5d0645de4e6 | Customer 7021 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | OPP-2925f4da431f0012264f720dc32f1988a9608d416aa44525ad4d041d13877c76 | SER-922694b967080f34b28991f892661eb90308520023057a913d1c2bb1fa16f03f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | HQ | VA | Lost Purchasing / Account Risk | Needs Validation | 90.87 | 14396.01 | 4246.75 | Parts Group | 308UR-0100 — 308UR-0100 Alere Immunalysis Phencyclidine HEIA All same lot if possible | Analyzer Platform Purchasing Loss; 8 independent signals; trailing 90-day revenue $750.00 versus $8742.06; trailing 180-day revenue $9492.06 versus $38284.08; 50 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-253f4e44f7bef4f6e54a3a68633fd728f706ef2d0d438a9e226b091d472562dd | Customer 47700 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-259c4d5931ac8a051783900f88c76d7a7e52fc9352be9c7a537a5be6dbaffc7d | OPP-fdfacddb4d38aa403f7abfc57bb68402fe1cadfa448c74c8d02bd0e4de65c10d | SER-e51f8d72206ed567817c6978662f83c904b15cfb67d50344b715008290371182 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Health System, LLC | 7777 | HQ | ON | Lost Purchasing / Account Risk | Needs Validation | 89.55 | 35699.75 | 11157.85 | — | 10736512 — 10736512 Siemens Healthineers Epoc Eurotrol Gas-ISE/BUN Ctrl -CON - Lvl 3 | 10736510 — 10736510 Siemens Healthineers Epoc Eurotrol Gas-ISE/BUN Ctrl -CON - Lvl 1 | 10736511 — 10736511 Siemens Healthineers Epoc Eurotrol Gas-ISE/BUN Ctrl -CON - Lvl 2 | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $12688.25 versus $48388.00; trailing 180-day revenue $61076.25 versus $97637.90; 30 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Aaron Quezada | CONFIRM_ACCOUNT | Candidate CAND-259c4d5931ac8a051783900f88c76d7a7e52fc9352be9c7a537a5be6dbaffc7d | Customer 7777 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a1265a3a6be5560365f222f5a643b49445ae6209af09e3bda896dbbdc5778b72 | OPP-5b8db4ac45d81d75bb9f54c9db2c52541a5dadad94396c5ef650b91e26ce605e | SER-f28e3231e3fb8b4b73f9fecd3e114f6945ab081d7ce5015663e81dec279c8f05 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Brightwater Health Partners, LLC | 9317 | Vendor | MD | Lost Purchasing / Account Risk | Needs Validation | 71.15 | 3203.33 | 913.64 | — | 1220001636 — PC400 HDL, Direct CP Reagent - PC400 | 1220001638 — LDL, Direct CP Reagent - PC400 | 1220001891 — PC400 Cuvette Segments - PC400 | Revenue Decline; 3 independent signals; trailing 90-day revenue $394.16 versus $343.95; trailing 180-day revenue $738.11 versus $2731.25; 30 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Zoe Bishop | CONFIRM_ACCOUNT | Candidate CAND-a1265a3a6be5560365f222f5a643b49445ae6209af09e3bda896dbbdc5778b72 | Customer 9317 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-eb6806ec02c752146530870aae2f350bff4092deff04e1f60b701e83123b8bbf | OPP-3ffe620a2eb7626fb58e1b6f078bd7c8fe4bb772bfdea4f85f0ccbb81edfc97c | SER-ff2084fc78fbc5692872c5077970fc8a323db64c3d1144fb332cf131ca3777cf | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Crestview Health System, PLLC | 6873 | HQ | KY | Lost Purchasing / Account Risk | Needs Validation | 69.21 | 3937.52 | 1369.51 | — | 4G109 — Olympus 4G109 Emit 2000 Valproic Acid Calibrator For AU Series Analyzer 1x5mL/5x2mL Liquid Volume, Each | Revenue Decline; 2 independent signals; trailing 90-day revenue $3510.00 versus $685.00; trailing 180-day revenue $4195.00 versus $3936.01; -3 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-eb6806ec02c752146530870aae2f350bff4092deff04e1f60b701e83123b8bbf | Customer 6873 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | OPP-834043c0a0432707e591ec1ea7b469b7ae4773e587cab1d4b8c5ec6409a3ea38 | SER-f0add73e3249c6e8d41ad12fa20ab4ec37e0394a913d2fdede0d8b5ffb89a969 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | Vendor | VA | Lost Purchasing / Account Risk | Needs Validation | 65.42 | 3057.34 | 681.59 | — | Account / Site Risk — Materially Delayed Purchasing | Materially Delayed Purchasing; 3 independent signals; trailing 90-day revenue $3208.59 versus $5682.83; trailing 180-day revenue $8891.42 versus $12229.35; 33 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-ebeb7778871401f0ba57d9bc40ade40d00714f0092d1e1c77168183d5981b61e | Customer 47700 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f9c6a7be64ebf23208af4cf3d6c52c83f69c6a84f70cef52c2a7d9219e9d570a | OPP-e10ede33c98dac9da0cb877dc10d5a46c49ba19160b8f01784694789a2bd6aa2 | SER-e8b7716325fb0c3ad9033895d5c333bac5c3c7daab87c0407b2dd235ce33e549 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Whitmore Care Partners, Corp. | 8254 | HQ | — | Lost Purchasing / Account Risk | Needs Validation | 62.14 | 6300.72 | 1398.4 | — | IST-03P9325 — IST-03P9325 Abbott I-Stat BNP CARTRIDGE 25/BX | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $26864.80 versus $17076.08; trailing 180-day revenue $43940.88 versus $56542.32; -38 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Noah Draycott | CONFIRM_ACCOUNT | Candidate CAND-f9c6a7be64ebf23208af4cf3d6c52c83f69c6a84f70cef52c2a7d9219e9d570a | Customer 8254 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-18554a5e59070bbb6f4801cb308960cba369dd86fb0bce75666be35ca93f347e | OPP-2fda8c6f137e7a73ccfd707193cffbab42163f3747e3d9bf2c131fcde14d106e | SER-5bd0ffccedf2f0b1ca3132f53c9f4f816441c3b0b787befd586e1bfd7ceb3666 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Pathology Labs, Corp. | 9458 | Vendor | NC | Lost Purchasing / Account Risk | Needs Validation | 62 | 2051.98 | 629.73 | — | 986000 — 986000 Thermo Scientific INDIKO CUVETTES 10800/PK | T-100248 — Thermo Kit Oxycodone 70mL | T-0037 — Thermo Kit Alcohol 100mL | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 420 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ezra Calder | CONFIRM_ACCOUNT | Candidate CAND-18554a5e59070bbb6f4801cb308960cba369dd86fb0bce75666be35ca93f347e | Customer 9458 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-89eec33fb5d7a301c53656bbbc95ebe33ed65fe5f38aeb8e29f5bb2e1702b2ff | OPP-fc1cda4f88871ec27514e7eeed83ee727f97aeeb82178e2392c2f35c24ef8bb1 | SER-fd9e1cec2c48b2bddf68faa102045163714dc297b23c0848aafefb3a15188db4 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Health Partners, LLC | 8950 | HQ | NC | Lost Purchasing / Account Risk | Needs Validation | 60.89 | 1444.81 | 710.97 | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $1444.81; trailing 180-day revenue $1444.81 versus $0.00; -181 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Zoe Rowntree | CONFIRM_ACCOUNT | Candidate CAND-89eec33fb5d7a301c53656bbbc95ebe33ed65fe5f38aeb8e29f5bb2e1702b2ff | Customer 8950 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8d786a14a6441c75695172e7061303220afa59c910e9dfff4f5d309a2d60d19a | OPP-22eb9dd857c227bb86f744220b8189211052af00d4f7187cbe2da2a35058ca8b | SER-7ff7a9c1f24043adfce8b587ec19230568158faf0b147eaae9376d59aeca2116 | Not selected for publication; targeted context validation is still required. | **** | Meridian Diagnostic Group, Inc. | 4313 | Vendor | TN | Lost Purchasing / Account Risk | Low | 54.64 | 503.85 | 143.72 | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $427.09; trailing 180-day revenue $427.09 versus $1434.79; 21 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-8d786a14a6441c75695172e7061303220afa59c910e9dfff4f5d309a2d60d19a | Customer 4313 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d84a75a100b83dff245a6f8a38b6c7e2bba460c13a0bde0c0f03a4298e4f96ed | OPP-d7e0a8782fd88a5aa5767fa906d776c532704eaa069c3e14bc45c8bf6fa35923 | SER-a018dcea39df79f795e5ba7023d8ca3bd83dc81c377713fa4030f5cf5244de3b | Not selected for publication; targeted context validation is still required. | **** | Summit Clinical Partners, LLC | 44635 | HQ | KY | Lost Purchasing / Account Risk | Low | 54.52 | 720.21 | 222.55 | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $1256.41 versus $1976.62; trailing 180-day revenue $3233.03 versus $3261.43; -25 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-d84a75a100b83dff245a6f8a38b6c7e2bba460c13a0bde0c0f03a4298e4f96ed | Customer 44635 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b6dd9df5fc4241c4f8aacc73de9b5a2578f40c1b178c111908f7d9694071746a | OPP-f6c08d860d77c25ba3ae89e8835f136ffdc5e8b27c911e251a210783ce61d406 | SER-14b7f629afbe2828293435105719974b7988a80ae228951719efee124938942f | Not selected for publication; targeted context validation is still required. | **** | Summit Clinical Partners, LLC | 44635 | Vendor | KY | Lost Purchasing / Account Risk | Low | 51.94 | 709.47 | 171.5 | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $1370.20 versus $2079.67; trailing 180-day revenue $3449.87 versus $2407.15; -4 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b6dd9df5fc4241c4f8aacc73de9b5a2578f40c1b178c111908f7d9694071746a | Customer 44635 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7362ad38b607082c64cf50186a05bf744c34091508de0e87734262f13a539b5a | OPP-921b47ce72e4db1c9179092f7716b3c6888205ae91cb834f984c77ec8274dea8 | SER-0572341be0bd6aab0ee20896409eb380cb0567966059b75ec7c78eeaec35478a | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bridgeport Lab Services, Inc. | 41316 | HQ | IL | Lost Purchasing / Account Risk | Needs Validation | 95.74 | 27462.5 | 12168.29 | Olympus / Beckman AU | OSR6132 — OSR6132 Olympus TP Reagent (4x750 tests) | 33005 — 33005 BECKMAN ACCESS B12 CAL | 33885 — 33885 Beckman Access FREE T4 CAL | Analyzer Platform Purchasing Loss; 5 independent signals; trailing 90-day revenue $10526.20 versus $33381.98; trailing 180-day revenue $43908.18 versus $98833.18; 0 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Hana Halbrook | CONFIRM_ACCOUNT | Candidate CAND-7362ad38b607082c64cf50186a05bf744c34091508de0e87734262f13a539b5a | Customer 41316 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | OPP-3bc6d1e73aa671af7ebda7383a507aaab2ddd67fa3e64c2f96c975f87e12624a | SER-8f16eea370409d747c558fc4312ee190c164529876a3954c44a5d55cc0109ed3 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | OH | Lost Purchasing / Account Risk | Needs Validation | 93.69 | 14969.99 | 4144.81 | — | T-10015654 — Thermo Kit pH Detect Rgt DRI | 10017331 — 10017331 Thermo Fisher 1mL nesting cups, 1000/pk | 984030 — 984030 Thermo Scientific INDIKO WASH SOLN 4X20ML/PK | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $11844.24; trailing 180-day revenue $11844.24 versus $41784.22; 130 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Talia Brennock | CONFIRM_ACCOUNT | Candidate CAND-ef5131a2d3bf7cc4d9985a5b73e69a73e697fa3303ae10b99f8b04f89ddb616b | Customer 7918 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4014df547638c87590915d88b5e2865fcebd24945039cce74c47455614da35a5 | OPP-2b1b46bd8de8c6109676cf1384dd181b1b855cb68906b7013ec37ff88c9d48ac | SER-9df3f762f8829ccaa90f470647b1ed3331f6e11933047f13ab370fe57e5a399e | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Health Alliance, LLC | 7676 | HQ | IL | Lost Purchasing / Account Risk | Needs Validation | 83.4 | 6970.1 | 5034.69 | — | B63284 — B63284 Beckman Access TSH (3rd IS) 2x100 Det | A48619 — A48619 Beckman Access SHBG QC | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $4493.42 versus $11463.52; trailing 180-day revenue $15956.94 versus $22416.28; 5 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Rowntree ("Key-You") Li (Primary, Lab Director) | CONFIRM_ACCOUNT | Candidate CAND-4014df547638c87590915d88b5e2865fcebd24945039cce74c47455614da35a5 | Customer 7676 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fae275c9c9824dfb5b03299f7ad3d087fbcc42867c3b308db42f1a06fb3f544e | OPP-25baea2f24c39e1bd8e3f686e340aa4edb396a59b9e9153e4ebe65adda940806 | SER-836de20841585e07c296448e284e07355eef90f3b58d1cdfdd7325ff84bbe99d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Health Alliance, PLLC | 42712 | HQ | IL | Lost Purchasing / Account Risk | Needs Validation | 75.18 | 4756.27 | 2533.85 | — | 98200 — 98200 Quidel Triage BNP Reagents for Access 2 | B24838 — B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests | 33000 — 33000 Beckman Access B12 Reagent 100/BX | Revenue Decline; 2 independent signals; trailing 90-day revenue $676.00 versus $0.00; trailing 180-day revenue $676.00 versus $2258.45; -13 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Quinn Garrow | CONFIRM_ACCOUNT | Candidate CAND-fae275c9c9824dfb5b03299f7ad3d087fbcc42867c3b308db42f1a06fb3f544e | Customer 42712 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dc22ebceaf1cbc63b420f962eaf787a5d4f17fe2387432957f7c920f3447b761 | OPP-beb9c4975f8099e3a93af2cdcf92f42c80d81bfc17263bd1b1d43d41038b3431 | SER-b837249f6981926ed27b738c311db36cca74dc9a223812127471a4c9cd2a7b81 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Health Partners, LLC | 8950 | HQ | MN | Lost Purchasing / Account Risk | Needs Validation | 71.57 | 1157.46 | 461.39 | Olympus / Beckman AU | ODC0004 — ODC0004 Olympus Control Serum Level 2, 1 x 5 mL | ODC0003 — ODC0003 Olympus Control Serum Level 1, 1 x 5 mL | OSR60118 — OSR60118 Triglycerides reagent 4x20/4x5mL 4/Kt | Analyzer Platform Purchasing Loss; 4 independent signals; trailing 90-day revenue $0.00 versus $819.44; trailing 180-day revenue $819.44 versus $3134.36; 21 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Zoe Rowntree | CONFIRM_ACCOUNT | Candidate CAND-dc22ebceaf1cbc63b420f962eaf787a5d4f17fe2387432957f7c920f3447b761 | Customer 8950 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-251f51991c750d3e2f9f450531beaedd0f0ac043e46731494f0b06f93f1cd62a | OPP-ea76a31643f1721044723e6c6769d80f74ddb323176346bda56343ae6380f7de | SER-0f5dea2380749cef12081f18e850951e9673f0aeed0c184cafb1af8d6dffa0db | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Pathology Associates, Inc. | 9369 | Vendor | MN | Lost Purchasing / Account Risk | Needs Validation | 71.19 | 4936.07 | 1541.12 | — | T-10014665 — [T-10014665] Thermo Kit THC Rgt DRI Thermo Kit THC Rgt DRI | T-10014601 — [T-10014601] Thermo Kit Opiate Rgt DRI Thermo Kit Opiate Rgt DRI | T-10014593 — [T-10014593] Thermo Kit Cocaine Rgt DRI Thermo Kit Cocaine Rgt DRI | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 438 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Hana Xiong | CONFIRM_ACCOUNT | Candidate CAND-251f51991c750d3e2f9f450531beaedd0f0ac043e46731494f0b06f93f1cd62a | Customer 9369 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5fdef91a9b8881160ca49ca4a9b438c6821e891e3d4a8672cbff433b684d582e | OPP-ba40782c95763917031c673c2c24951a90d6ebe1a16ef3e6a357ec14e0e7175c | SER-2926dbdb77d22230952997ace7194d9bcde8fcb24620cdd2e16750a85f045e31 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Pathology Associates, Inc. | 9369 | Vendor | MN | Lost Purchasing / Account Risk | Needs Validation | 61.74 | 2789.62 | 670.13 | — | Account / Site Risk — Reduced Order Frequency | Reduced Order Frequency; 1 independent signal; trailing 90-day revenue $3359.29 versus $6148.91; trailing 180-day revenue $9508.20 versus $14330.91; 5 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Hana Xiong | CONFIRM_ACCOUNT | Candidate CAND-5fdef91a9b8881160ca49ca4a9b438c6821e891e3d4a8672cbff433b684d582e | Customer 9369 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8249e003c0738aae4b7d37a43b0c5a91c79a528a8a6f87516222096c755419b2 | OPP-11210c5c4d28439bc8f90e14ae40fb0bc78ecddcded070eabab2c0184c31f077 | SER-562fde078d4008363ef49401ebb9e200ce1abdc365c4b52058db2ad59e7dedca | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Copperfield Medical Center, Inc. | 8959 | Vendor | OH | Lost Purchasing / Account Risk | Needs Validation | 57.79 | 925.76 | 349.84 | — | D2011HK — D2011HK DiatroLyse Diff for Abacus 3, 1L | Revenue Decline; 2 independent signals; trailing 90-day revenue $838.24 versus $790.54; trailing 180-day revenue $1628.78 versus $3480.30; -32 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Oscar Merriweather | CONFIRM_ACCOUNT | Candidate CAND-8249e003c0738aae4b7d37a43b0c5a91c79a528a8a6f87516222096c755419b2 | Customer 8959 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2cb3ab3cd006af6e38490bb73a0d4a7c9ba85261410911ea696d5934725be3da | OPP-3061380af20c7f23daf81d2725ab42058220a19151f2428805839e34431fccb3 | SER-6f0661a21a2cee5934be4ed30f6e97316bbbed668e04fef72c4bb8017f74cf86 | Not selected for publication; targeted context validation is still required. | **** | Elmhurst Medical Associates, Inc. | 4488 | Vendor | MI | Lost Purchasing / Account Risk | Low | 53.39 | 703.69 | 202.28 | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $63.45 versus $646.04; trailing 180-day revenue $709.49 versus $2116.87; -173 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-2cb3ab3cd006af6e38490bb73a0d4a7c9ba85261410911ea696d5934725be3da | Customer 4488 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-98bb95b629b29ea8b8d5d97da811da571382af60f83320c0a8c6fd5fbb95a0ba | OPP-a7ebc9325a7b58c09336227ca29b637df80731c072b6ec6cdf86c808b754caed | SER-4feb5d6dcfb26f140c99c1a2895cb0a28588daa3443aa2c339c16aebef080d61 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Physician Group, LLC | 8228 | HQ | OH | Lost Purchasing / Account Risk | Needs Validation | 50.59 | 1896 | 398.68 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 1 independent signal; trailing 90-day revenue $1896.00 versus $3792.00; trailing 180-day revenue $5688.00 versus $3696.00; -38 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-98bb95b629b29ea8b8d5d97da811da571382af60f83320c0a8c6fd5fbb95a0ba | Customer 8228 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e93cbbfc1d217adaa104b454407b50b763551867fb45096a07ddefa41e8a50e5 | OPP-d75ebe2c7f62f54b4eab3bc1cec7a92f4c39953135c2a3b29586990c05cc5eb8 | SER-aabea4e0be2e6424fb752eba0553124525a8bc5ffe8dfb576c91b08be4efb11d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Wrenfield Diagnostic Group, Corp. | 9912 | HQ | TX | Lost Purchasing / Account Risk | Needs Validation | 87.48 | 10740.53 | 4042.77 | — | OSR6195 — OSR6195 Olympus HDL-C (HDL Cholesterol) Reagent, 4 x 30 mL & 4 x 10 mL | B00389 — B00389 Olympus HbA1c (AU Systems Hemoglobin A1c) Reagent, incl. Calibrators | OSR60118 — OSR60118 Triglycerides reagent 4x20/4x5mL 4/Kt | Complete Purchasing Cessation; 7 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $4343.14; 278 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Umar Marrow | CONFIRM_ACCOUNT | Candidate CAND-e93cbbfc1d217adaa104b454407b50b763551867fb45096a07ddefa41e8a50e5 | Customer 9912 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58ea338d72d11f4228eef1939f5d75af28ffafaf83d48c6b6ea20620773e3a00 | OPP-e8f9bd4862e93a07c52d5544449d81c27847c6eb1ad67d7145458dcd62f58c6b | SER-941d15c9a8cb6315c27c3bceb4bb853517d9af4aeebf74cfba264da2155c95bd | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Medical Partners, LLC | 9652 | HQ | TX | Lost Purchasing / Account Risk | Needs Validation | 76.98 | 2226.03 | 823.47 | — | B00389 — B00389 Olympus HbA1c (AU Systems Hemoglobin A1c) Reagent, incl. Calibrators | Complete Purchasing Cessation; 8 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $4452.06; 173 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Dana Delgado | CONFIRM_ACCOUNT | Candidate CAND-58ea338d72d11f4228eef1939f5d75af28ffafaf83d48c6b6ea20620773e3a00 | Customer 9652 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-77908a4ebf80eb9b37d8f715fd9ac7f0255ca346c6637e0454c57ea5407697a3 | OPP-e1ff62615b9237873209a3f4d26e9d83e422f66ff8def3b3a6bd5c42288d7f92 | SER-dc1ba64a792b8e43c1b354cbcd8167eef158db0852a7345916c78cd652077ac1 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Alderbrook Clinical Partners, Inc. | 9452 | Vendor | CA | Lost Purchasing / Account Risk | Needs Validation | 76.69 | 2134.44 | 677.35 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 3 independent signals; trailing 90-day revenue $0.00 versus $2134.44; trailing 180-day revenue $2134.44 versus $0.00; 86 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ivy Garrow | CONFIRM_ACCOUNT | Candidate CAND-77908a4ebf80eb9b37d8f715fd9ac7f0255ca346c6637e0454c57ea5407697a3 | Customer 9452 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5705aabd14f45287b301619b55e092d55d0f428fad81301a64c7d81442afdb03 | OPP-f208049b7b4eafd44f063b2a8ffce8e5c5d7d8a9f2440209767ccbb36a107da0 | SER-e40a7a89f9dc6bc07ee4e8035ad58e9dd1906c585f81bdaae87baebbf69b737a | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Brightwater Health Collective, PLLC | 9236 | Vendor | CA | Lost Purchasing / Account Risk | Needs Validation | 76.53 | 1879.98 | 529.27 | — | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | 2108 — [2108] Medica EasyLyte Solutions Valve | 2102 — [2102] Medica EasyLyte Sodium Electrode | Complete Purchasing Cessation; 6 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $3759.95; 153 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Laura Quezada | CONFIRM_ACCOUNT | Candidate CAND-5705aabd14f45287b301619b55e092d55d0f428fad81301a64c7d81442afdb03 | Customer 9236 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2352ab42d340af5d5f7d70005b6bcc12a90bad14176257b0f5e35642b380ebc9 | OPP-82391ddcd7ec31bafad958c409ad611946a1ef936bd60651d5ea9f7e44c94138 | SER-9dc5f13cfd82ec31b777eba70d7cab1fede59f57a4c5597e6a2960b4cb677c56 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Lakeside Pathology Associates, Inc. | 42928 | HQ | CA | Lost Purchasing / Account Risk | Needs Validation | 74.27 | 6048.72 | 3927.48 | — | B24838 — B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests | 37200 — 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | B63284 — B63284 Beckman Access TSH (3rd IS) 2x100 Det | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 364 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Bishop | CONFIRM_ACCOUNT | Candidate CAND-2352ab42d340af5d5f7d70005b6bcc12a90bad14176257b0f5e35642b380ebc9 | Customer 42928 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-87cb49bb51e73b334a779f4eac4f65f9498b14fe238dc1719527f084c38bdce2 | OPP-2edd90d7bc1273edfe5c9f6c873389e3a4295765ead2fc8dc6ffd620d4d9ca47 | SER-2bb0bce5658ac7aea4ad287608af060dd6ee592fbb62b1492eb03f103e81e20d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Crestview Clinical Labs, PLLC | 10096 | Vendor | TX | Lost Purchasing / Account Risk | Needs Validation | 70.56 | 1514.31 | 428.17 | — | 2102 — [2102] Medica EasyLyte Sodium Electrode | 2101 — [2101] Medica EasyLyte Potassium Electrode | 2113 — [2113] Medica EasyLyte Chloride Electrode | Revenue Decline; 4 independent signals; trailing 90-day revenue $435.87 versus $1307.61; trailing 180-day revenue $1743.48 versus $4772.10; 58 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Umar Ulster | CONFIRM_ACCOUNT | Candidate CAND-87cb49bb51e73b334a779f4eac4f65f9498b14fe238dc1719527f084c38bdce2 | Customer 10096 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-be5d5fbacf6c3be4da35759370dd5158cf00e8d7da53b47088a6623724f380dd | OPP-f04e14f57eaaf545fd2db5b48ef79c632c3ef113d6a6b08d182c8c637f614a1c | SER-232b1e9b210236038c2407aa27fb285725461df52ed4e7c26ae5662cbdbd3718 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Wrenfield Diagnostic Group, Corp. | 9912 | Vendor | TX | Lost Purchasing / Account Risk | Needs Validation | 68.14 | 3505.05 | 701.69 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 3 independent signals; trailing 90-day revenue $768.00 versus $4273.05; trailing 180-day revenue $5041.05 versus $963.00; 28 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Umar Marrow | CONFIRM_ACCOUNT | Candidate CAND-be5d5fbacf6c3be4da35759370dd5158cf00e8d7da53b47088a6623724f380dd | Customer 9912 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cf1c4b80902159f14ce2cb77a2b40e80028b2f01ae33e455c39ffb36b46e0bbe | OPP-ad9c21e24aa2cb25f1765cadde91796907ee642b6a66cc4668cf0307e87bcd9d | SER-27937a4bd45429cabf900e923b8becaf2b39585495d887a75d025063612dd929 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Care Partners, Inc. | 9422 | HQ | CA | Lost Purchasing / Account Risk | Needs Validation | 66.36 | 3382.92 | 939.2 | — | 10736515 — 10736515 Siemens EPOC BGEM BUN Test Cards (Detectable Analytes - pH, pO2, pCO2, Na+, K+, Ca++, Cl-, Glucose, Lactate, Creatinine, Hct, TCO2, BUN), PKG/25 Tests | IST-09P31-26 — 09P31-26 Abbott I-Stat CHEM8+ Cartridge 25/BX | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 428 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jasper Zellner | CONFIRM_ACCOUNT | Candidate CAND-cf1c4b80902159f14ce2cb77a2b40e80028b2f01ae33e455c39ffb36b46e0bbe | Customer 9422 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7a41fa6fede67ae37ac2afeba399a05cec87e980635b14966472041d8242d456 | OPP-d5d4aae3fa2b520916458f74edc5254ba8ba7eb620db6f1deba2b82537b79f35 | SER-e3f61c42b570f6d21fa53f90109e728581d9ad68930f66f40010ba3c1c59664f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bellwood Laboratory Partners, Corp. | 10006 | HQ | CA | Lost Purchasing / Account Risk | Needs Validation | 65.78 | 2039.63 | 850.59 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 1 independent signal; trailing 90-day revenue $421.64 versus $409.94; trailing 180-day revenue $831.58 versus $1229.82; -50 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Aaron Ibsen (Primary) | CONFIRM_ACCOUNT | Candidate CAND-7a41fa6fede67ae37ac2afeba399a05cec87e980635b14966472041d8242d456 | Customer 10006 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-446dc0f0a8ab865fabb229529ec192618b4748bf67071edcd1b8b766d36433f9 | OPP-ef0d119f77d907d07c0382f7fb18beffbacda01e9d4720ef01e4ee06898c1992 | SER-ffb067669683170d5c58e7f02322cbeb3ba986d7d150679d2ac93f6bdde8ff20 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Analytical Labs, LLC | 9023 | HQ | TX | Lost Purchasing / Account Risk | Needs Validation | 64.8 | 1664.8 | — | — | T-0017 — Thermo Kit Amph 100mL | T-0039 — Thermo Kit Benz 100mL | T-0055 — Thermo Kit Cocaine 100mL | Complete Purchasing Cessation; 5 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $3329.59; 193 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Oscar Emberton | CONFIRM_ACCOUNT | Candidate CAND-446dc0f0a8ab865fabb229529ec192618b4748bf67071edcd1b8b766d36433f9 | Customer 9023 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fc3c3e894161a9c2766775a34023986a5653d17a7047e216d1fd7f09883f3ce4 | OPP-7552ec82393682a836fa00e7d15f0fa8b2c18efc67492741e3eb2ef9b7cb804f | SER-7f32a0abb1c349e3ca3ef368b962548084a3df748bb9f8778450c959bd25e54e | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Diagnostics, Corp. | 7257 | HQ | CA | Lost Purchasing / Account Risk | Needs Validation | 64.46 | 1203.13 | 296.87 | Parts Group | 2300 — 2300 Siemens Multistix 10 SG Reagent Strips (pkg/100) | Analyzer Platform Purchasing Loss; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1925.00; 168 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Carly Sutcliffe | CONFIRM_ACCOUNT | Candidate CAND-fc3c3e894161a9c2766775a34023986a5653d17a7047e216d1fd7f09883f3ce4 | Customer 7257 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7f4c71a7ca6ef6c695077d5336efd2d9cf527134c19bdb36b786e262fc563e71 | OPP-bee8d875326c4b02290c151b2bd7fda5c64c3d626b420dfef464c18455e7a3e3 | SER-580d1cb2c5484f0bea729d215f2db8277135f2afe5a482c7a793b1f507e00a80 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Medical Partners, LLC | 9652 | Vendor | TX | Lost Purchasing / Account Risk | Needs Validation | 58.53 | 944.25 | 185.42 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 2 independent signals; trailing 90-day revenue $775.05 versus $1321.44; trailing 180-day revenue $2096.49 versus $3984.99; 9 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Dana Delgado | CONFIRM_ACCOUNT | Candidate CAND-7f4c71a7ca6ef6c695077d5336efd2d9cf527134c19bdb36b786e262fc563e71 | Customer 9652 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58babf6d55a7496d8d89450be9ed558587ccf781d68e66066dba5839c728f9c6 | OPP-f896364439ead96dd23a6935fd4afdcdb0a5857cd1c2ec1b05d52bec480337fd | SER-89feaa0af8bfb427308a0af3a32f1e96bfb6f050a0cd80928ca6496335277895 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Medical Group, Corp. | 157 | HQ | TX | Lost Purchasing / Account Risk | Needs Validation | 57.77 | 732.5 | 417.94 | Parts Group | 2300 — 2300 Siemens Multistix 10 SG Reagent Strips (pkg/100) | Analyzer Platform Purchasing Loss; 2 independent signals; trailing 90-day revenue $4945.00 versus $0.00; trailing 180-day revenue $4945.00 versus $6410.00; -37 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-58babf6d55a7496d8d89450be9ed558587ccf781d68e66066dba5839c728f9c6 | Customer 157 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-aa7860e2e294c90acc58d7f4ec34204bae8e2dc4766826203f47009dfc5112c9 | OPP-16b483c37d30cd962cda436e95b2bab96e54621c3186147be0a4a875e734a915 | SER-c8dc4bde98403ac2aceebc9f15d2884b78a1e5f3ba6b8cc02789309d4d1119d3 | Not selected for publication; targeted context validation is still required. | **** | Bellwood Care Partners, Inc. | 39506 | HQ | CA | Lost Purchasing / Account Risk | Low | 56.07 | 790 | 468.79 | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $790.00; trailing 180-day revenue $790.00 versus $2212.22; 105 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-aa7860e2e294c90acc58d7f4ec34204bae8e2dc4766826203f47009dfc5112c9 | Customer 39506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-601e080aaa03443255a9b056640e10954b9207874ed3f52c85ab312fee8351fe | OPP-594e740861ad6284f35c8732e1b776bc4f10bf7c57b9b1f00d639442a1769995 | SER-d6ed8828c2d2aba741d277162f56aef77c77feeb5e7a0a6b870e1c7365d02b5d | Not selected for publication; targeted context validation is still required. | **** | Maple Health Collective, PLLC | 43173 | HQ | CA | Lost Purchasing / Account Risk | Low | 50.05 | 814 | 552.14 | — | Account / Site Risk — Reduced Order Frequency | Reduced Order Frequency; 1 independent signal; trailing 90-day revenue $1920.00 versus $2734.00; trailing 180-day revenue $4654.00 versus $2432.00; 16 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-601e080aaa03443255a9b056640e10954b9207874ed3f52c85ab312fee8351fe | Customer 43173 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-065ffc1c7cd358550724c262c5f64a00d626057d2f60f25bd8601ba75f7f9e82 | OPP-7b76e78886927f2309f8e6a2eff7a61308e69121871259a14cf2145f53eca62b | SER-5a0fe6dfa8f192620812e4a2b748d9ece39cce0aa081fd8c5f8bcf298cc9e4fc | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Clinical Partners, LLC | 41977 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 84.14 | 5346.75 | 2748.45 | Bio-Rad | B24838 — B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests | OSR6137 — OSR6137 Olympus CO2 Reagent (4x580 tests) | B36846 — Beckman Coulter B36846 Reagent Hematology Lyse For DxH 500 Series Analyzers, 500 mL | Analyzer Platform Purchasing Loss; 7 independent signals; trailing 90-day revenue $0.00 versus $1669.50; trailing 180-day revenue $1669.50 versus $12363.00; 66 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ezra Marrow | CONFIRM_ACCOUNT | Candidate CAND-065ffc1c7cd358550724c262c5f64a00d626057d2f60f25bd8601ba75f7f9e82 | Customer 41977 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-10b13cf548d302262c2954375fcb4b5132517bb1e6e0de508d0152e01288e31f | OPP-87c8154c6286c9ebe072be1f1fcd9f851033f360024955d231f33ae1e3dba7f8 | SER-f8d5f2a2a0db55aea9d178bf758b5779423a7efe37861bef0160ceda58756247 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Whitmore Diagnostic Labs, LLC | 10321 | HQ | NV | Lost Purchasing / Account Risk | Needs Validation | 82.49 | 8095.3 | 2698.47 | — | Account / Site Risk — Revenue and Gross-Profit Decline | Revenue and Gross-Profit Decline; 3 independent signals; trailing 90-day revenue $620.64 versus $8715.94; trailing 180-day revenue $9336.58 versus $5340.08; -30 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Wade Grissom | CONFIRM_ACCOUNT | Candidate CAND-10b13cf548d302262c2954375fcb4b5132517bb1e6e0de508d0152e01288e31f | Customer 10321 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9b6a5f30e81ca9fa8589c3bfcce7ca833b64c525b9395149a72cf34ed3b4ccd3 | OPP-cb0483b5c8e2b27d98b8ca36925b26c174f494bdfbd5ff7dcfaa65c242af5ce3 | SER-1351d31304a49bc57cee8ccb3bf16a0e4bedba535ff7669f45cb157f1c9902dd | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Clinical Partners, LLC | 41977 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 79.78 | 3697.38 | 2031.94 | — | A98032 — A98032 Beckman Access Folate Reagent | 33880 — 33880 BECKMAN ACCESS FREE T4 RGT 100/BX | Revenue and Gross-Profit Decline; 6 independent signals; trailing 90-day revenue $0.00 versus $3697.38; trailing 180-day revenue $3697.38 versus $2032.11; 103 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ezra Marrow | CONFIRM_ACCOUNT | Candidate CAND-9b6a5f30e81ca9fa8589c3bfcce7ca833b64c525b9395149a72cf34ed3b4ccd3 | Customer 41977 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33e | OPP-00fd7f07efeb44ad644865feabb88a6d4a86a5f263841b752f106ec908b3c327 | SER-5bac9f71d31fd3bd2c2eda5505ba8c67a094ed11888d590c07b3f174ca68ae6c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Laboratory Partners, Inc. | 6935 | HQ | AZ | Lost Purchasing / Account Risk | Needs Validation | 77.01 | 4586.25 | 1310.4 | — | Account / Site Risk — Revenue and Gross-Profit Decline | Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $4586.25; trailing 180-day revenue $4586.25 versus $2476.92; 82 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33e | Customer 6935 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9f980691a528d70ea58fd234640baac8bd36a6d0623cf363a0b4307c4acfd048 | OPP-e58d561ac927eccb68c8d1931924606eae9690aa3ebccb24bf08164bdbce0a3a | SER-da5f2895db6c532118fd920cb1cdf90061ac2758f04a124231d16d776912cf0e | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Diagnostics, Corp. | 9053 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 70.41 | 1300 | 218.6 | — | 10736515 — 10736515 Siemens EPOC BGEM BUN Test Cards (Detectable Analytes - pH, pO2, pCO2, Na+, K+, Ca++, Cl-, Glucose, Lactate, Creatinine, Hct, TCO2, BUN), PKG/25 Tests | Complete Purchasing Cessation; 3 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $2600.00; 225 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Kessler | CONFIRM_ACCOUNT | Candidate CAND-9f980691a528d70ea58fd234640baac8bd36a6d0623cf363a0b4307c4acfd048 | Customer 9053 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-944a1d4b4254f399f7e05fb439e44c57c757067ae88a121828c9c270834f2e27 | OPP-b278114fd91d564d0a726b2dcbab796dec84dd8b6e40deda8175981945317aa1 | SER-3d735697b0aa2a50f76a58f0485d0b70fcb05e382e9d835af21ef08eda6eb691 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cascade Medical Center, Inc. | 41477 | Vendor | AZ | Lost Purchasing / Account Risk | Needs Validation | 68.62 | 2182.73 | 572.72 | — | T-10015893 — Thermo Kit EtG Rgt 500mL CJF | T-100240 — Thermo Kit Buprenorphine MCC, 65ml | T-0186 — Thermo Kit THC 500mL | Revenue Decline; 2 independent signals; trailing 90-day revenue $1174.54 versus $0.00; trailing 180-day revenue $1174.54 versus $4846.75; -4 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jasper Holcomb | CONFIRM_ACCOUNT | Candidate CAND-944a1d4b4254f399f7e05fb439e44c57c757067ae88a121828c9c270834f2e27 | Customer 41477 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78b6d4268f28a1ac8dc09358801c3297bf0da4730b9fd52db51886c81843479c | OPP-f7c9a64024e61dcfdf67221e1735843a9dd78441638bcb10eec60fa7c84ad6ac | SER-22e7a611d17b2845004f031716129b90f62ccdfac1a040365f33e321575b84f9 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ironwood Medical Center, Inc. | 9329 | Vendor | AZ | Lost Purchasing / Account Risk | Needs Validation | 67.02 | 1279.53 | 340.31 | MicroGenics | T-10014601 — Thermo Kit Opiate Rgt DRI | 986000 — 986000 Thermo Scientific INDIKO CUVETTES 10800/PK | T-10015638 — Thermo Kit Creatinine Rgt DRI | Analyzer Platform Purchasing Loss; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1689.45; 248 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Kara Isakov | CONFIRM_ACCOUNT | Candidate CAND-78b6d4268f28a1ac8dc09358801c3297bf0da4730b9fd52db51886c81843479c | Customer 9329 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5f99aa6dd7843b9d55a38dddec87f52c40948d3f770540874d134ca5adce1684 | OPP-10fc50982d40ca16572875d6e6275d828ea65e392213cb2f196d8897197e66c2 | SER-1b97245ff6230039e265760760f441ea10c7b816f9d19f22b50cf18601fc5558 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cascade Medical Center, Inc. | 41477 | HQ | AZ | Lost Purchasing / Account Risk | Needs Validation | 65.4 | 2481.54 | — | — | Account / Site Risk — Revenue Decline | Revenue Decline; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $138.35; 271 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jasper Holcomb | CONFIRM_ACCOUNT | Candidate CAND-5f99aa6dd7843b9d55a38dddec87f52c40948d3f770540874d134ca5adce1684 | Customer 41477 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4b42c74c13c49d85e53a2d4cd4f00900d91b7506a63f3d056cd12c74603d784c | OPP-edec11a1b0a84207ff281877c4a9ebd38183dfc8860a3c27fb0dac64fe077273 | SER-a2c6a9cc2406df9926cae28c1f555b49d7e6170988243db2253df7994ec492c1 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ironwood Medical Center, Corp. | 9695 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 63.43 | 1487.64 | 726.36 | — | 37200 — 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | B24838 — B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests | Product Family Purchasing Loss; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $530.00; 325 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Elena Ulster | CONFIRM_ACCOUNT | Candidate CAND-4b42c74c13c49d85e53a2d4cd4f00900d91b7506a63f3d056cd12c74603d784c | Customer 9695 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ed65670f60e4bc72945a4ecaf182bfa951ffab26ff9ce56ef08d9f17ff14f4d9 | OPP-9f97d19a9f37ff6f242044f17a60cbe4e971cf21ef553b13c5a7eaf62fa34748 | SER-1cd0c51a03bc53984651c265a907869aa48b52ab33b287eade6bd55dab13e0c5 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Analytical Labs, PLLC | 3669 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 61.55 | 2201.4 | 872 | — | DF105B — DF105B Siemens Dimension Hemoglobin A1c Reagent, 120 Tests | DF84 — DF84 Siemens Dimension IBCT - Iron Binding Capacity (autom.), 240 tests | DF48B — DF48B Siemens AHDL - HDL-Cholesterol, 240 Tests | Revenue Decline; 1 independent signal; trailing 90-day revenue $1917.60 versus $4119.00; trailing 180-day revenue $6036.60 versus $3285.00; -8 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Talia Torbin | CONFIRM_ACCOUNT | Candidate CAND-ed65670f60e4bc72945a4ecaf182bfa951ffab26ff9ce56ef08d9f17ff14f4d9 | Customer 3669 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-db834e1034b7407206687ee64e55b7d206554d23b314e06e33e5309e8857301e | OPP-f844ec195e898e489eaa8e20d74e604fa59bf276a8dbc66532a08c7c0f8b9eb7 | SER-4488913a4c4d6054ffd87e56017d8418c8f68d52748333c834baa07a932de354 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Lab Services, Corp. | 9385 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 60.47 | 2150.4 | 644.05 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $2150.40; trailing 180-day revenue $2150.40 versus $1519.76; 20 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Elena Kilbride | CONFIRM_ACCOUNT | Candidate CAND-db834e1034b7407206687ee64e55b7d206554d23b314e06e33e5309e8857301e | Customer 9385 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8eaa9b711fbf3e92ada013c68eabf8a8b7b65828e34a3a13dec060c5b9027ccd | OPP-b013cd9741a699064f510dceb9dafa6359b09ac5f79269ff785fd72aea3619c0 | SER-a892d8224cd3a8e06b897975c860b712848f7164025875b6637b775b3a31b2c5 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ironwood Medical Center, Inc. | 9329 | HQ | AZ | Lost Purchasing / Account Risk | Needs Validation | 60.41 | 1748.29 | 455.3 | — | Disappearing group: Greiner Bio-One | Product Family Purchasing Loss; 3 independent signals; trailing 90-day revenue $2364.33 versus $1802.43; trailing 180-day revenue $4166.76 versus $7663.33; -6 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Kara Isakov | CONFIRM_ACCOUNT | Candidate CAND-8eaa9b711fbf3e92ada013c68eabf8a8b7b65828e34a3a13dec060c5b9027ccd | Customer 9329 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f9b59d4821538633d8c1b4744ba879d9428917b06daf48dc8183260bb0b7780e | OPP-9dddb32fc36787a125630f4f52dd13ff5ae782807606d42c52e1315ad36748cf | SER-f89fb09a9544496c3eaf4318e23e0df01ca13c73d90f43d451e9dc5e801e4545 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Medical Associates, Corp. | 8880 | HQ | AZ | Lost Purchasing / Account Risk | Needs Validation | 59.13 | 2392.66 | 683.63 | — | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | 2124 — [2124] Medica EasyLyte Expand Na/K/Cl/Ca/Li Solutions pack, 800mL | 2118 — [2118] Medica EasyLyte Daily Cleaning Solution Kit | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 419 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-f9b59d4821538633d8c1b4744ba879d9428917b06daf48dc8183260bb0b7780e | Customer 8880 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-610bb4bcacbd83872f739f249cd8c7e434098921ad48a71f459741ac38775494 | OPP-c33b53f1f29aecf587cd9a2e0e58001cacee8297d631fdf9890f788c8bacf37d | SER-878445b26adba8fe6912c0be3846b6071846db5937eeb62adef257ac26d8f215 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Diagnostics, Corp. | 9053 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 58.61 | 2600 | 363.54 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 1 independent signal; trailing 90-day revenue $1300.00 versus $3900.00; trailing 180-day revenue $5200.00 versus $4550.00; -7 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Kessler | CONFIRM_ACCOUNT | Candidate CAND-610bb4bcacbd83872f739f249cd8c7e434098921ad48a71f459741ac38775494 | Customer 9053 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a851bc2d7bc2d104cd2109c86f064ab43299bb40675af0038efceb31b245bc8d | OPP-1576f4ed9434c2da5eec6e862128b82a95fc80cdf14952cfda79315cc7687dbc | SER-63550abf625af7c8f4484615ebc1c14b489b38289993ad0435f86091454f7617 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Medical Partners, Inc. | 9241 | HQ | GA | Lost Purchasing / Account Risk | Needs Validation | 57 | 2459.64 | 795.25 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $2459.64; trailing 180-day revenue $2459.64 versus $2459.64; 1 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-a851bc2d7bc2d104cd2109c86f064ab43299bb40675af0038efceb31b245bc8d | Customer 9241 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | OPP-cc5f7d563542da0d509157ae870789bcb9e5e026ffadc7ab0dd9e285848a9553 | SER-d1d41c1aa5f24257974431a9a474b2eb76a8ebf525c9c8f1834172b91419d745 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Diagnostic Group, Inc. | 9880 | HQ | NV | Lost Purchasing / Account Risk | Needs Validation | 56.35 | 1283.62 | — | — | Account / Site Risk — Revenue Decline | Revenue Decline; 2 independent signals; trailing 90-day revenue $1038.22 versus $2321.84; trailing 180-day revenue $3360.06 versus $4993.53; 7 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Leo Delgado | CONFIRM_ACCOUNT | Candidate CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | Customer 9880 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | OPP-e352db033ac82525589dca9a4534f296794f231b94219711e86da965b5ec6822 | SER-1c8630707d43926be2757a2b8c57ba7df96248fbf52c7bc463f55e5ee7670b81 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Diagnostic Group, Inc. | 9880 | Vendor | NV | Lost Purchasing / Account Risk | Needs Validation | 55.43 | 1550.99 | 311.59 | — | 10017331 — 10017331 Thermo Fisher 1mL nesting cups, 1000/pk | T-10015632 — Thermo Kit Oxycodone Rgt DRI | T-10014593 — Thermo Kit Cocaine Rgt DRI | Revenue Decline; 1 independent signal; trailing 90-day revenue $951.03 versus $1862.23; trailing 180-day revenue $2813.26 versus $2847.74; 23 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Leo Delgado | CONFIRM_ACCOUNT | Candidate CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | Customer 9880 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-581ff99de969a0646093040b5c6680d6c5a7aefde2343de98fb0d7759c4b8de2 | OPP-0b8889dcda962328d3bb57d5a6795f4a18054b14d54d32eb3b9cbf96dcdb3f60 | SER-bf294c8f1b8fdbd2b96b5dd905c217bf11aa006ab58351267278de70e9ed2583 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Brightwater Clinical Labs, LLC | 8624 | HQ | FL | Lost Purchasing / Account Risk | Needs Validation | 49.31 | 1020 | 319.46 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 1 independent signal; trailing 90-day revenue $3480.00 versus $0.00; trailing 180-day revenue $3480.00 versus $0.00; -165 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-581ff99de969a0646093040b5c6680d6c5a7aefde2343de98fb0d7759c4b8de2 | Customer 8624 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a53bf0a3528f350a040b4a0806d951d1ba449d7d341046673cd12f3b3ce6536f | OPP-01acde0ac3ceb28aa82be004c1c1811c2ef7fdb8f51c7e3e6108b293a8ef48cf | SER-92c3eb961900f42eb4652cc5ad9ad68125838c85654b76bbac7fa581224ca065 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Whitmore Laboratory Partners, Inc. | 7879 | HQ | NY | Lost Purchasing / Account Risk | Needs Validation | 94.17 | 19699.38 | 13653.99 | Bio-Rad | A98856 — A98856 Beckman 25(OH) Vitamin D Reagent (for use on UniCel DxI Immunoassay Systems), 100 Determinations, 2 x 50 Tests | 386371 — 386371 Access CK-MB Reagent, 100 Determinations, 2 x 50 tests | A16793 — A16793 Beckman Wash Buffer II, UniCel DxI, 1 x 10L - Lot 331260F | Analyzer Platform Purchasing Loss; 7 independent signals; trailing 90-day revenue $5826.48 versus $13597.34; trailing 180-day revenue $19423.82 versus $5642.66; 55 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Oscar Nakamura | CONFIRM_ACCOUNT | Candidate CAND-a53bf0a3528f350a040b4a0806d951d1ba449d7d341046673cd12f3b3ce6536f | Customer 7879 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7a3376188eeda2c8288be87307674d6ccb3c0844f437b27890a30861ce2e8c67 | OPP-a3ae05db50f4dfb16529584a3f0e5413a50530415a42449b845a28e6aa6b8ab2 | SER-499de8edab9aadedca3162e090e04f91dcc39a110062efb2ce9a19c0428a23af | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Reference Labs, Inc. | 8324 | HQ | NJ | Lost Purchasing / Account Risk | Needs Validation | 83.36 | 4692.78 | 2102.41 | Bio-Rad | 591 — Bio-Rad 591 Immunology 1 Liq 6 x 1mL | 593 — Bio-Rad 593 Immunology 3 Liq 6 x 1mL | 592 — Bio-Rad 592 Immunology 2 Liq 6 x 1mL | Analyzer Platform Purchasing Loss; 5 independent signals; trailing 90-day revenue $6131.14 versus $0.00; trailing 180-day revenue $6131.14 versus $15516.70; 27 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Nadia Lofgren | CONFIRM_ACCOUNT | Candidate CAND-7a3376188eeda2c8288be87307674d6ccb3c0844f437b27890a30861ce2e8c67 | Customer 8324 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78ecb2d2569dad09476f575202c1e99386f3561afb08929313a3dd58dfd762b4 | OPP-5422b5772e493bdb7e7de3a09f12cf69462180937766ec74ee8703f88e8e8d88 | SER-d6c5036545239c0fa68517b4d15edad2173fe7024e80c932a82cc31fee4c9d78 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Health System, Corp. | 7771 | HQ | NY | Lost Purchasing / Account Risk | Needs Validation | 81.84 | 27165.79 | 18425.59 | — | A98856 — A98856 Beckman 25(OH) Vitamin D Reagent (for use on UniCel DxI Immunoassay Systems), 100 Determinations, 2 x 50 Tests | 37210 — 37210 BECKMAN ACCESS PSA HYBRTCH FREE 100S | OSR6199 — OSR6199 C-Reactive Protein - Latex (Normal CRP) - Latex (High Sensitivity CRP) 4 x 30 mL R1 4 x 30 mL R2 | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 384 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Rosa Bishop (Practice Admin, Usman says she is a good resource if Usman not available) | CONFIRM_ACCOUNT | Candidate CAND-78ecb2d2569dad09476f575202c1e99386f3561afb08929313a3dd58dfd762b4 | Customer 7771 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-99ff3259cc2055a588be8b724b1cd35b8edd977144dd97906f31ec030d6a9301 | OPP-7fb482d7c29c6700183ad7bde30ba4a7aff9808aae3629eec4406f84da17d59b | SER-018d98cfd22e89b5cbe5a4ce09df84b71711682d8769e36b6247a101ebee2e43 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Analytical Labs, PLLC | 8970 | HQ | NY | Lost Purchasing / Account Risk | Needs Validation | 79.52 | 12590.48 | 8045.89 | — | 33550 — 33550 Beckman Access PROG RGT | 33880 — 33880 BECKMAN ACCESS FREE T4 RGT 100/BX | A16793 — A16793 Beckman Wash Buffer II, UniCel DxI, 1 x 10L Short Datinig Expire 7-19-2024 discount | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 657 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Sam Sutcliffe | CONFIRM_ACCOUNT | Candidate CAND-99ff3259cc2055a588be8b724b1cd35b8edd977144dd97906f31ec030d6a9301 | Customer 8970 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ab4f1d3b83a5f1be455bb4819ea86f320bb88e41c9dae7ec679a35436d3201c4 | OPP-d751f0e8db204853bc303b9a9cc5902cfd1f2e379968822c70f2d1386a8c0896 | SER-7fb4928a09cab62b71b80e7783e8ae89a762ef1fb0ee8a19b86870906c629fc4 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bridgeport Diagnostics, Corp. | 5592 | HQ | NY | Lost Purchasing / Account Risk | Needs Validation | 74.18 | 6948.14 | 5550.49 | — | 81901 — 81901 Beckman Access Cuvette Reaction Vessels | B84494 — B84494 - Access Sensitive Estradiol Calibrators (S0-S5), S0 - 4.0 mL; S1-S5 - 2.0 | Revenue Decline; 1 independent signal; trailing 90-day revenue $5397.15 versus $4146.58; trailing 180-day revenue $9543.73 versus $10219.05; -30 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Aaron Garrow | CONFIRM_ACCOUNT | Candidate CAND-ab4f1d3b83a5f1be455bb4819ea86f320bb88e41c9dae7ec679a35436d3201c4 | Customer 5592 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a7f7be298793cc4479ebb7642d25b881b6bd8152cf47b6ee1110ddbbc57b37e4 | OPP-18b22fbe5c8bb7459503398c4a57e875c6722647f0fd0779796a1a8ceee0daa4 | SER-24dec4158ad0b0df19fadf8af715aea93c099a794d89076654bf2c8a789be930 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Physician Group, Inc. | 9102 | HQ | PA | Lost Purchasing / Account Risk | Needs Validation | 69.82 | 4394.51 | 1397.49 | — | 10491448 — [10491448] Siemens RP500 MCART LAC 400 TEST | 10329097 — [10329097] Siemens Wash / Waste kit 4 Cartridges | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 370 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Vera Draycott | CONFIRM_ACCOUNT | Candidate CAND-a7f7be298793cc4479ebb7642d25b881b6bd8152cf47b6ee1110ddbbc57b37e4 | Customer 9102 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ccb891daa7ded4cd6f54e28afec9c3d5156b635e7d9c579778d44fc3fbe50a71 | OPP-625d97027c977afa3f6548fd7bba17057f813631930e74b4b4ea9b76d7d6c621 | SER-538233def0009743a276428324f049baeede57a32ce77abd6544f2ea47cdf41c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Whitmore Lab Services, Inc. | 6421 | Vendor | MA | Lost Purchasing / Account Risk | Needs Validation | 67.59 | 1729.2 | 458.58 | — | T-100246 — Thermo Kit Bup Control | Revenue Decline; 2 independent signals; trailing 90-day revenue $0.00 versus $1186.05; trailing 180-day revenue $1186.05 versus $4644.45; -53 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Piper Feldstein | CONFIRM_ACCOUNT | Candidate CAND-ccb891daa7ded4cd6f54e28afec9c3d5156b635e7d9c579778d44fc3fbe50a71 | Customer 6421 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | OPP-50cedd9a3e3f93e3517182b814a35224adeec1c0cdd938886c898a875c531157 | SER-fc3b62d3d430662f48d3cd5ac8b6e63a72685cd4482b93bd6e9315b8cf9f57a6 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Whitmore Pathology Associates, Inc. | 5440 | HQ | NY | Lost Purchasing / Account Risk | Needs Validation | 66.14 | 754.63 | 560.38 | Beckman Access / DxI | 37200 — 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | B63284 — B63284 Beckman Access TSH (3rd IS) 2x100 Det | Analyzer Platform Purchasing Loss; 3 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $1481.60; 318 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-964bd35b5109d23a86894df4c8e915f2f2ae0dc073436a93cec51d86901ccf68 | Customer 5440 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cbcb9c27432db82eb871efdace2faaabcdfb557c414e13f68ee8e3250ca498e9 | OPP-74c9f7e5cf07e833bc8c894de00a8232dc596f7eb0a90442516c54854c523498 | SER-4cc6f0aa3e04b5556071d2280bb709ed7bd2acb8123c9cc5655c0654eb1be6c8 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Diagnostics, Corp. | 9178 | Vendor | NJ | Lost Purchasing / Account Risk | Needs Validation | 65.75 | 3804.42 | 1316.31 | — | T-1128 — Thermo Kit Tricyclic Serum Tox | Revenue Decline; 1 independent signal; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $0.00; 406 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Grace Whitfield | CONFIRM_ACCOUNT | Candidate CAND-cbcb9c27432db82eb871efdace2faaabcdfb557c414e13f68ee8e3250ca498e9 | Customer 9178 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9cc6089cc1cf33e045c24724cd4c3ba1dd60eeea019d29d200233e02c3e83a8c | OPP-7d4ffa153599fc7836f2c53f08814b96ae8ab3cc8ff8634fa399f80073d807d7 | SER-f3211059db97572d3e479ef25de5988213bc9028546b582b1b33d1575851af98 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Medical Center, Corp. | 605 | HQ | NY | Lost Purchasing / Account Risk | Needs Validation | 64.96 | 2437.61 | 1198.82 | — | OSR6279 — OSR6279 Olympus CK-NAC Reagent 4 x 490 Tests | OSR6119 — OSR6119 Olympus GGT Reagent (4x310 tests), R1 4x18ml, R2 4x18ml | MU919600 — MU919600 Beckman CL Electrode | Reduced Order Frequency; 2 independent signals; trailing 90-day revenue $4580.83 versus $5067.28; trailing 180-day revenue $9648.11 versus $14523.33; -17 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ezra Kilbride | CONFIRM_ACCOUNT | Candidate CAND-9cc6089cc1cf33e045c24724cd4c3ba1dd60eeea019d29d200233e02c3e83a8c | Customer 605 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b9d02a84e634f25c0496223e7a2f13899374f0cfdf60267afd1eb944f1bdfb7d | OPP-7b6334f81ec590ea5aed212c4710a8c12a099dce14ba6174715b42a542d09b5b | SER-3859ee5eb301d0375ae25f7b08a96ba5f6d85621b18e75f6d86be25e5ebeced7 | Not selected for publication; targeted context validation is still required. | **** | Ironwood Diagnostic Group, Corp. | 10240 | Vendor | NJ | Lost Purchasing / Account Risk | Medium | 61.42 | 1414.53 | 386.95 | — | Account / Site Risk — Revenue Decline | Revenue Decline; 2 independent signals; trailing 90-day revenue $0.00 versus $823.39; trailing 180-day revenue $823.39 versus $3652.45; 70 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b9d02a84e634f25c0496223e7a2f13899374f0cfdf60267afd1eb944f1bdfb7d | Customer 10240 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-81d0008fe8f1d75f4eee383ee838d7ad84d173b603592bb05e147c625e74c6f3 | OPP-f80cfcd83d86313909ffed0ed0b59c73d2c174e6071cc32322ea871dbe444007 | SER-15069a64aa5bd2bc0b6825d7b626c1a8c5c485b4c5eeed510c1f0951504e1a1c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Clinical Partners, LLC | 5261 | HQ | NY | Lost Purchasing / Account Risk | Needs Validation | 61.24 | 725.66 | 488.25 | — | Disappearing group: Beckman Access | Product Family Purchasing Loss; 2 independent signals; trailing 90-day revenue $0.00 versus $0.00; trailing 180-day revenue $0.00 versus $942.30; 318 days beyond expected account order date. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ian Yarborough | CONFIRM_ACCOUNT | Candidate CAND-81d0008fe8f1d75f4eee383ee838d7ad84d173b603592bb05e147c625e74c6f3 | Customer 5261 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | OPP-dede2f1d8cd9e203b014fcaa926ed5854997e34ae629e8798dddebaeec1ef576 | SER-a966b3fa27cea4d9f0bb3e2bf1409fba3d9504eee8507b2e36a2b3f1f22e172d | Not selected for publication; targeted context validation is still required. | **** | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | WA | Lost Purchasing / Account Risk | Medium | 56.42 | 1059.9 | 258.3 | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $885.73; trailing 180-day revenue $885.73 versus $1435.58; 62 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | Customer 44961 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8784a0b79f79ca246007f58644b836a159b6ceee0fee3a4f18e1adf68cd87e06 | OPP-09c1c324cf75a2c0f72d734f0e4ccf7fd6ec0778aa4e4c3c3a52197a7abc5e79 | SER-e09a6d4c47fdc2e3d07d228004260fb7b518e6f6276c4c691dc09b8a58abf937 | Not selected for publication; targeted context validation is still required. | **** | Stonebridge Health System, PLLC | 44486 | HQ | WA | Lost Purchasing / Account Risk | Medium | 55.3 | 3220.81 | — | — | Account / Site Risk — Revenue Decline | Revenue Decline; 1 independent signal; trailing 90-day revenue $4597.76 versus $3899.85; trailing 180-day revenue $8497.61 versus $14939.22; 26 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-8784a0b79f79ca246007f58644b836a159b6ceee0fee3a4f18e1adf68cd87e06 | Customer 44486 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | OPP-e1066fe70160427f60bb9294097792fbef9313eace35690f4cdff655b10df898 | SER-c3b907c33a8cbef2256f877f1cf45adc889807748f1d4cb7c0d0f772ed242aba | Not selected for publication; targeted context validation is still required. | **** | Bellwood Medical Group, Inc. | 7389 | HQ | NY | Lost Purchasing / Account Risk | Medium | 52.55 | 1234.98 | 591.53 | — | OSR6106 — OSR6106 Olympus AMY (Amylase) Reagent, 4 x 40 mL | OSR6137 — OSR6137 Olympus CO2 Reagent (4x580 tests) | MU988800 — MU988800 Olympus OEM Beckman Lamp for AU400, AU480, AU600, AU640, AU680 | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $4069.59 versus $3422.73; trailing 180-day revenue $7492.32 versus $9881.05; -19 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-25582fff669b843b4319a0004c47820b7dd445784dc546945386163f7bb3c55a | Customer 7389 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d82dbe8f82092324328feb79a967cc66faa6c22ef8836efe7bb245b57ffe0989 | OPP-551f59826e52bef94bb01aa95e54b0693e732c3c9ae2610bf778350a6b5a8e74 | SER-524ef9a3d21d1b6e4598ea82032ea8114121f950f1cf8227ff0703385cdc0127 | Not selected for publication; targeted context validation is still required. | **** | Silverline Clinical Group, Corp. | 42652 | Vendor | MA | Lost Purchasing / Account Risk | Low | 48.72 | 682.95 | — | — | Account / Site Risk — Reduced SKU Breadth | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $682.95; trailing 180-day revenue $682.95 versus $741.64; 23 days beyond expected account order date. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-d82dbe8f82092324328feb79a967cc66faa6c22ef8836efe7bb245b57ffe0989 | Customer 42652 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-61a3a152eb89ec74740645d0eee78bf47ce76bb4e8b637aa2388b0badc10006c | OPP-6132929afc2e2faa1d772e6ec612f790bfaccd531daeea55a3b8995decab8504 | SER-ca58c0ad6b3298523c843b3f66cff378c43f7ad2574725b721f1f346a864725c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Clinical Labs, LLC | 7021 | HQ | NC | Overdue Reorder | Needs Validation | 94.42 | 19830 | 3180.45 | Siemens Centaur | 10699533 — 10699533 Centaur Vitamin D Total incl. Calibrators, 500 Tests $250 Credit Applied for Defective Kit | 16 completed purchases over 937 days; median interval 58.0 days; expected reorder 2026-05-31; High Risk by 71 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Laura Brennock | CONFIRM_ACCOUNT | Candidate CAND-61a3a152eb89ec74740645d0eee78bf47ce76bb4e8b637aa2388b0badc10006c | Customer 7021 | Order 51352 | Item 13155 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9dc0819b08ce02d634076319f538e44ec3e3e6cbda75dbaec228cf0be054d7be | OPP-8cac18b2b34ea85a4ba45544e1b0a50bc8cb0764bd21e7db94f6c9f05563e21b | SER-0453019570496b819c92ffa05aaa52b45d398be5d84ba5e1da3124f949053eb9 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Fairmont Health Alliance, PLLC | 8367 | HQ | NC | Overdue Reorder | Needs Validation | 72.88 | 231.67 | 212 | Beckman Access / DxI | 33880 — 33880 BECKMAN ACCESS FREE T4 RGT 100/BX | 11 completed purchases over 876 days; median interval 90.5 days; expected reorder 2026-04-29; High Risk by 103 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Item appears inactive; validate replacement or supersession before quoting. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ivy Quezada | CONFIRM_ACCOUNT | Candidate CAND-9dc0819b08ce02d634076319f538e44ec3e3e6cbda75dbaec228cf0be054d7be | Customer 8367 | Order 50392 | Item 4253 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b5ebadffc85946af72c6f44f73bdd7ad8850e5edb4296522c582b2bf677b60b0 | OPP-88dd80fda1c83815a4809e591c26618df429a363a4451f07bf130c3c9c751a01 | SER-000afc4230a7284cd7bc5d0122f32fa7b5145ab5c876e6c78144664972cc9144 | Not selected for publication; targeted context validation is still required. | **** | Lakeside Diagnostic Labs, Corp. | 15496 | HQ | KY | Overdue Reorder | Low | 69.22 | 2985.8 | 851.38 | MicroGenics | T-10028872 — Thermo DRI Fentanyl II 115mL | 3 completed purchases over 211 days; median interval 105.5 days; expected reorder 2026-03-26; High Risk by 137 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b5ebadffc85946af72c6f44f73bdd7ad8850e5edb4296522c582b2bf677b60b0 | Customer 15496 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-54e4d7b0d098cfd3d6b9dddf0e6ac128ffe3d17856ea08b8a47edba9d36c6cbe | OPP-b3933573d5dd48c97343f467b69e7d9246fa63e2731acac7ec89eda691b74b2d | SER-f2ccb0567517dd6aeb968bba4df5aea8c480a01dddb77af0941dfe9f8e89c996 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Medical Partners, PLLC | 53594 | Vendor | KY | Overdue Reorder | Needs Validation | 64.74 | 1533.9 | 460.17 | MicroGenics | T-100248 — Thermo Kit Oxycodone 70mL | 5 completed purchases over 151 days; median interval 42.0 days; expected reorder 2026-08-12; Due Soon in 2 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Quinn Ibsen | CONFIRM_ACCOUNT | Candidate CAND-54e4d7b0d098cfd3d6b9dddf0e6ac128ffe3d17856ea08b8a47edba9d36c6cbe | Customer 53594 | Order 52688 | Item 11585 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-57e88d0c32a04b6e63816584effab5b6198faedf1f1bafe3935775e522b42c1e | OPP-e426bdd66865d54f3a7ead807744ad2fc8d6485ea431351c490065907698f808 | SER-fd1c2da8c74445901fe8e01c058ae7341e05cd7bcc0f841a4806e8ee42aab9b7 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Medical Partners, PLLC | 53594 | Vendor | KY | Overdue Reorder | Needs Validation | 62.73 | 1371.52 | 257.16 | MicroGenics | 986000 — 986000 Thermo Scientific INDIKO CUVETTES 10800/PK | 5 completed purchases over 151 days; median interval 42.0 days; expected reorder 2026-08-12; Due Soon in 2 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Quinn Ibsen | CONFIRM_ACCOUNT | Candidate CAND-57e88d0c32a04b6e63816584effab5b6198faedf1f1bafe3935775e522b42c1e | Customer 53594 | Order 52688 | Item 13160 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3703564b662afd0ad8393905fcc127aec8efe432b6ef6884aa562d50aa448827 | OPP-fe569707ef1a2f833e350f5691e4944f06d76adba45f01c1be631f8be6cf4b5b | SER-a8b44d7c6664e39bb67008cd36a61eb3aeaf743b8663402d1e4f2442a208cacc | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | HQ | VA | Overdue Reorder | Needs Validation | 61.74 | 1633.33 | 352.85 | Immunalysis | 307UR-0100 — 307UR-0100 Alere Immunalysis Opiates Reagent, 100mL | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-3703564b662afd0ad8393905fcc127aec8efe432b6ef6884aa562d50aa448827 | Customer 47700 | Order 50556 | Item 13063 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bc192d499178169af8c5be646af826ed1efe4ac3c8919d956bd912c82a6b6e2d | OPP-8f111b6a98ed601335b12471ed4ade6b5d748978269c1387d38f288e0b68d152 | SER-b45471449d58db78900501db082f9d53623f5d185fd2418122c1a1427766d842 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | HQ | VA | Overdue Reorder | Needs Validation | 61.74 | 1633.33 | 352.85 | Immunalysis | 302UR-0100 — 302UR-0100 Alere Immunalysis Oxycodone Reagent, 100mL | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-bc192d499178169af8c5be646af826ed1efe4ac3c8919d956bd912c82a6b6e2d | Customer 47700 | Order 50556 | Item 13064 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d486d1d3927ee94ffcd96c428697c3ca9345930e01c66b843a9bc7235f7e7c4b | OPP-efe1898f04d2d71e2c1d42317b38ca0449bafbe787b40e0a18fec2cd2b6417d5 | SER-9d4eb6f19aa47e49045fe2ba1033485b2b1f9deaedbd4540c1d86034bd2bde6b | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | HQ | VA | Overdue Reorder | Needs Validation | 61.74 | 1633.33 | 352.85 | Immunalysis | 309UR-0100 — 309UR-0100 Alere Immunalysis Amphetamine Reagent, 100mL | 3 completed purchases over 201 days; median interval 100.5 days; expected reorder 2026-05-29; High Risk by 73 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-d486d1d3927ee94ffcd96c428697c3ca9345930e01c66b843a9bc7235f7e7c4b | Customer 47700 | Order 50556 | Item 13054 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-91cbb77e1beb64d88695103f6c37ef7eead59c02a5db36802ec1fa1a71758736 | OPP-4687fd04d664e700c236698f3f68295da5bf8a5a7478bb45841616e9ee266d43 | SER-1cf1d94b0d908988198a716a45135a6d8dc9979d9c3f54aec199f22b1ad5f411 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Fairmont Health Alliance, PLLC | 8367 | HQ | NC | Overdue Reorder | Needs Validation | 60.8 | 284.8 | 144.98 | Beckman Access / DxI | 33800 — 33800 BECKMAN ACCESS TOTAL T4 RGT 100/BX | 11 completed purchases over 971 days; median interval 93.0 days; expected reorder 2026-08-10; Due Soon by 0 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ivy Quezada | CONFIRM_ACCOUNT | Candidate CAND-91cbb77e1beb64d88695103f6c37ef7eead59c02a5db36802ec1fa1a71758736 | Customer 8367 | Order 51909 | Item 4252 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2de93c82fbbd4d1d1429407848201e3d5ba5c4a6ea0813b16e54346c6362744f | OPP-ce2a466bcee4ab2b13cd029316997f87057e43ddff335a0fb09e46899821a4e4 | SER-08f05bcc5c5b2d12744d8db2a53eb64de6c9580b71784051103e40934a24dc5d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ironwood Medical Center, PLLC | 7394 | Vendor | MD | Overdue Reorder | Needs Validation | 60.74 | 447.4 | 89.49 | MicroGenics | T-100248 — Thermo Kit Oxycodone 70mL | 27 completed purchases over 1073 days; median interval 40.0 days; expected reorder 2026-09-07; Due Soon in 28 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Hana Kilbride (new email) | CONFIRM_ACCOUNT | Candidate CAND-2de93c82fbbd4d1d1429407848201e3d5ba5c4a6ea0813b16e54346c6362744f | Customer 7394 | Order 53217 | Item 11585 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9476d1f2258b377c97e85e391a64be7691f4efd2667f883dc2c1ce206ffafbac | OPP-fa2f0250abc260147a53a1fded35d2fd098227c2d9f876de94321704b46d4967 | SER-c4c3f3fe387e263119a4ab9356362a1f15569fbcf7b6f9ab9e11af75eb115fc7 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | HQ | VA | Overdue Reorder | Needs Validation | 60.06 | 1211.29 | 370.8 | Immunalysis | 306UR-0100 — 306UR-0100 Alere Immunalysis Benzoylecgonine Reagent, 100mL | 3 completed purchases over 190 days; median interval 95.0 days; expected reorder 2026-06-05; High Risk by 66 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-9476d1f2258b377c97e85e391a64be7691f4efd2667f883dc2c1ce206ffafbac | Customer 47700 | Order 50786 | Item 13057 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-98ee785fd27f5638bb2038ecbc6de482648e77cb076943794652e97cc0570d24 | OPP-0fc4e2709011ec823c192409f96a72cfbe6f1ffd51039f6a8e2e995424b36274 | SER-77456e6b5e9e9f130cc2af5fb089661ea12a4b4aa0a97848e32bebab908fabfb | Not selected for publication; targeted context validation is still required. | **** | Summit Clinical Partners, LLC | 44635 | Vendor | KY | Overdue Reorder | Low | 55.92 | 205.88 | 30.88 | MicroGenics | T-0135 — Thermo Kit Opiate 100mL | 3 completed purchases over 142 days; median interval 71.0 days; expected reorder 2026-07-10; Overdue by 31 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-98ee785fd27f5638bb2038ecbc6de482648e77cb076943794652e97cc0570d24 | Customer 44635 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-944bee39fd0c207cf46b7e1ab8d8fbee22c3e01884e3148a57e4c5904f0a1af5 | OPP-2645140e80030ce3e798f317e8f4e4747dba880772ad96bfb8ac7ffb5f6bb720 | SER-60e86cb106114193e74ac9980eeb97f9b401c5205ecdd87b05a37a9cb7f17d45 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | Vendor | VA | Overdue Reorder | Needs Validation | 55.01 | 1442.57 | 183.93 | MicroGenics | T-100249 — Thermo Kit Oxycodone 500mL | 3 completed purchases over 139 days; median interval 69.5 days; expected reorder 2026-08-10; Due Soon by 0 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-944bee39fd0c207cf46b7e1ab8d8fbee22c3e01884e3148a57e4c5904f0a1af5 | Customer 47700 | Order 52243 | Item 11586 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-41a416d51b288c9785b8cfc2865994c0c1219b7ae04ed5ec686496560bb43386 | OPP-07ea5fa38e6ebf3efc9e1ef97d965b7055cb1eac8006c95165634038a3ccf45c | SER-b45b7ea9f9330d591a911e5fdbdb402ae6878bab0898c593f86f676f0d5a12a2 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 52.79 | 697.04 | 174.26 | Horiba | 5300000974 — Apolipoprotein A1 Open Channel Reagent | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-41a416d51b288c9785b8cfc2865994c0c1219b7ae04ed5ec686496560bb43386 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d737c8d65fda1cae41d4527d99251d87dc5450d6f9d513a22207e12597d1b3f6 | OPP-d6b8c1796ac7cfb4b24701648c115e7fe95bd361e328b7824271ed10b6257e01 | SER-c810c699c46f6b573b004e4b1489b0b63491173671b03558a759a847187f4314 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 52.24 | 627.06 | 156.76 | Horiba | 5300000975 — Apolipoprotein B Open Channel Reagent | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-d737c8d65fda1cae41d4527d99251d87dc5450d6f9d513a22207e12597d1b3f6 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-831d3e14e105c91e50370f8c4ce0a8b6cc5958c8beff9bb3e67056190be2e8a1 | OPP-752e9e4dea8026a86dcdb7345dd1df2e82b468cb21465e17004ea404bb1f266f | SER-d4c6ac8c8d46267b316837de536ef3372f248fc7c1cf2741b074c96a0dec32e5 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 51.14 | 498.16 | 124.54 | Horiba | 5390013029 — Direct TIBC Reagent, 150mL | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-831d3e14e105c91e50370f8c4ce0a8b6cc5958c8beff9bb3e67056190be2e8a1 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c47f3b939e38a5c9a326abee279f7083b0229b8a564331f43cd5e226617e0ce8 | OPP-c49024579d247ac8252a97c9985f0097f0882662ddbeec5d54bb724cde53b29c | SER-ec51821e1cbb00a1ca3d2f25641a5bc5074cb1d76174c15523d5f660dd6b6cf2 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 49.8 | 358.52 | 89.63 | Horiba | 5390012528 — CRP Standard Set, 5 x 2mL | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-c47f3b939e38a5c9a326abee279f7083b0229b8a564331f43cd5e226617e0ce8 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-16ec025fa569bc20a46c4cfe53545e36406c35301f19fdee1622aab480229371 | OPP-130b47ef8d5694e48ee2068f1be3164eba8d819f1e5a1a177f375d42aa69ec45 | SER-91ff0f86aced20318169cd6a04a5964a97122e6ca604b95efd3c76d53ee7ad9f | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 49.61 | 340 | 85 | Horiba | 5300000963 — D-Dimer Reagent KAI-090 - Open Channel | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-16ec025fa569bc20a46c4cfe53545e36406c35301f19fdee1622aab480229371 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-950a174bb93e0a59383740d8d3650fc3eb7cc995a4484221294abce56e900be8 | OPP-6dac314d3ca594b333102d2372ec67fab129176f7ab6f2a921b8052d02371361 | SER-71d76194a00787331a87055918a860895e16cb7849245d4f5c92cbd5e35d1631 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 49.55 | 335.07 | 83.77 | Horiba | 5300000597 — RF Control K55C-2M | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-950a174bb93e0a59383740d8d3650fc3eb7cc995a4484221294abce56e900be8 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-18fed4ddc3cc5c6e0ae722578d0d8a00a7df6871cea66cbb82a7266e993a2f89 | OPP-382da927531793b0f17e8679a4871d46a917e05533ff9b69dbb2ab0b9fd99294 | SER-b9ed89e4b87e05e5cbe0298038bd3f77d3ec28d7523d7288fea2c05dfc9d6afc | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 48.93 | 278.28 | 69.57 | Horiba | 5390013106 — Direct Hemoglobin A1c Reagent - AU | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-18fed4ddc3cc5c6e0ae722578d0d8a00a7df6871cea66cbb82a7266e993a2f89 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e400a417f44a37e67658b1451ff536bf575aa6def75f687a743c7c4231e7bb2a | OPP-12365d01c282183cce02981fe9b27ab2a47077749c500f0b981b03e8f04269f7 | SER-7b64efa73ae2ca52110a05dd5b92201dd678d7b35639dc02147a74ca60fb9cdc | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 48.42 | 233.33 | 58.33 | Horiba | 5390013030 — Direct TIBC Cal Set, 2 x 1mL | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e400a417f44a37e67658b1451ff536bf575aa6def75f687a743c7c4231e7bb2a | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f0a97b8ff8b8468583bf0413b8eddf9fef64f5c6397391db9f8e3561b658defe | OPP-1b63026d6ed7af0df44cd8b940588e20826dba737e848190dec191e10109bcb9 | SER-13ad06cb4f184247c20a9585d8f1a287a1cee0ffa4bfeb4f54a86abc11ec5e11 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 48.01 | 200 | 50 | Horiba | 5300000945 — Multi-Analyte Calibrators, 6x1mL - Open Channel | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-f0a97b8ff8b8468583bf0413b8eddf9fef64f5c6397391db9f8e3561b658defe | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e12292904513e11912b83a2cd92200a2f56a4264dc97f271812600e6a1ab0575 | OPP-9532f9e2fd0bc8f772f79fd363d7cc54c5ea41b7cde26a25bc11911c5928e027 | SER-0b5211277d894209b45c6527f3c42a93764c055d861483a5de9f32f6fdffad51 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 47.9 | 190.37 | 47.59 | Horiba | 5300000989 — Apo A1/B Calibrator | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e12292904513e11912b83a2cd92200a2f56a4264dc97f271812600e6a1ab0575 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3cf06775b936305a329a2791711b91fc35bbc77e95a678fc3362212cdd5de428 | OPP-ffe393f61cb57fca9742bca1082023336b3b0103531068f43a4be4403d855eee | SER-e09ff6f32c43386c5d9dd09dc07d8650b1b82b25c4352ebf48d9b69186326642 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 47.85 | 186.67 | 46.67 | Horiba | 5300000583 — RFCAL2 KAI-231C | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-3cf06775b936305a329a2791711b91fc35bbc77e95a678fc3362212cdd5de428 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-132d7622774d8076aa87cce3a41a8b13c1df4ed507a56215d65cf924966268c8 | OPP-2a7fbb7b9f2d2a874b3c39eeed12c72b2db28cca4ff7407f861dce85bc1ae98b | SER-17e24816b6a5eb1b726456fd6dad37803e59f0d904976d87536278efacb2f9c3 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 47.79 | 205.08 | 32.82 | Horiba | 5300000946 — Liquid ITA Control, L1, L2; 2x2mL ea, liquid - Open Channel | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-132d7622774d8076aa87cce3a41a8b13c1df4ed507a56215d65cf924966268c8 | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-10a2a60eebd76bf157163b5bf6612c496a44c9c0810253b8d56b33d07528626f | OPP-159d7146d0149afdafd324024726d93bf2bae19602585b4feafcb3a4010167a1 | SER-86e6e62f14a4c0f8bbc675d3f99d9903cd40b9ecdebc17a399fc53fe992ba586 | Not selected for publication; targeted context validation is still required. | **** | Ashcroft Laboratory Partners, PLLC | 53298 | Vendor | TN | Overdue Reorder | Low | 47.32 | 187.91 | 12.91 | Horiba | 5300000964 — D-Dimer Controls K92C-4M - Open Channel | 3 completed purchases over 106 days; median interval 53.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-10a2a60eebd76bf157163b5bf6612c496a44c9c0810253b8d56b33d07528626f | Customer 53298 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2255f151874ae8071862184788122b1feb327b5562f1d440a746c6b32ee3268e | OPP-a5dd4e9c91e454765198b43421c862eae7e88ad7b8c4d877b198c0c2b12f048d | SER-dcd2ff329c36c7538602f6931d2022571ef107f364c7e667544e016529da4848 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | OH | Overdue Reorder | Needs Validation | 83.79 | 1996.67 | 853.04 | MicroGenics | 986000 — 986000 Thermo Scientific INDIKO CUVETTES 10800/PK | 11 completed purchases over 924 days; median interval 90.0 days; expected reorder 2026-06-12; High Risk by 59 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Talia Brennock | CONFIRM_ACCOUNT | Candidate CAND-2255f151874ae8071862184788122b1feb327b5562f1d440a746c6b32ee3268e | Customer 7918 | Order 51015 | Item 13160 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f1309b48eae4ab86ea5b2ddd3328703ed1916cb5a6ba6c532bb1febce0e76a06 | OPP-3c0a7612e1335e66621b0b5cd43104983e7e518e141197cdb06536d1757233da | SER-ca4bd222d3f81613787ad4928c5124cad76fb9db5745532454e1ec1554d7c48c | Not selected for publication; targeted context validation is still required. | **** | Crestview Pathology Labs, PLLC | 24572 | HQ | WI | Overdue Reorder | Low | 83.07 | 10500 | 2625 | bioMerieux VIDAS | 30409 — 30409 VIDAS PROGESTERONE, 60 Tests | 6 completed purchases over 743 days; median interval 45.0 days; expected reorder 2026-07-23; Overdue by 18 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-f1309b48eae4ab86ea5b2ddd3328703ed1916cb5a6ba6c532bb1febce0e76a06 | Customer 24572 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6e7fb75692d436eb13e03348a6e8b07247fb9dba2a19ac82fff77a52ea377115 | OPP-88857b4c02d5b6717aa4133a92d3af2dfd9bb863ae8b2f09ca00473a43786081 | SER-481ec3e6267055b901e340e5351d3a3ba3f51c02d2e941305125ef294a93178a | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | OH | Overdue Reorder | Needs Validation | 80.25 | 1606.31 | 275.37 | MicroGenics | T-10020849 — Thermo Buprenorphine II Rgt CEDIA | 23 completed purchases over 910 days; median interval 31.5 days; expected reorder 2026-04-15; High Risk by 117 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Talia Brennock | CONFIRM_ACCOUNT | Candidate CAND-6e7fb75692d436eb13e03348a6e8b07247fb9dba2a19ac82fff77a52ea377115 | Customer 7918 | Order 50830 | Item 12744 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ebf4d804eeb5f0dbe971f815fd441c2817dd4b2625a6493f4ae2e4a4f82e75de | OPP-7e381c6d3ce50ddca546e75b50cf2db2bbdb6128e123024b6fb0275c43af2db4 | SER-2fe3232a015dc47466cd987ac898d85001b42eac9645daef64b4ac45d47dcee9 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Health Alliance, LLC | 7676 | HQ | IL | Overdue Reorder | Needs Validation | 78.58 | 573.1 | 507.1 | Beckman Access / DxI | 33550 — 33550 Beckman Access PROG RGT - Lot 337989 | 18 completed purchases over 967 days; median interval 60.0 days; expected reorder 2026-07-02; High Risk by 39 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Rowntree ("Key-You") Li (Primary, Lab Director) | CONFIRM_ACCOUNT | Candidate CAND-ebf4d804eeb5f0dbe971f815fd441c2817dd4b2625a6493f4ae2e4a4f82e75de | Customer 7676 | Order 51341 | Item 5121 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-76f4e65d8dff2c23e18d6b37d7259ac1f26901b887a7659cd58e40928c7878f9 | OPP-00a1a8b5afc83a2f058ae5793c5a9ba7d630fb4f11ff9944177fdab49bc5ac98 | SER-8b21167261f8b12dec0feee9456ea55449805832d8227e5c347f82aac1a985d3 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Health Alliance, LLC | 7676 | HQ | IL | Overdue Reorder | Needs Validation | 74.22 | 963.54 | 843.94 | Beckman Access / DxI | 33410 — 33410 Beckman Access Ultrasensitive Insulin Reagent Pack, 100 /box - Lot# 338271 | 23 completed purchases over 1027 days; median interval 39.0 days; expected reorder 2026-08-17; Due Soon in 7 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Rowntree ("Key-You") Li (Primary, Lab Director) | CONFIRM_ACCOUNT | Candidate CAND-76f4e65d8dff2c23e18d6b37d7259ac1f26901b887a7659cd58e40928c7878f9 | Customer 7676 | Order 52600 | Item 5239 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1ac7ff3a528f4c19445ed23603816f189ee8c63ef39b07b623240c2291537041 | OPP-e606f660fdc0a14435f639d9793843ee534d06e080582a0a5a98d1482e7c83ff | SER-644dc52621e65c4c224d341a3dee6666a5e6cbb6dc22f6f892030fd890cacb7d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | OH | Overdue Reorder | Needs Validation | 72.89 | 303.83 | 67.13 | MicroGenics | T-10014593 — Thermo Kit Cocaine Rgt DRI | 31 completed purchases over 922 days; median interval 27.0 days; expected reorder 2026-04-07; High Risk by 125 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Talia Brennock | CONFIRM_ACCOUNT | Candidate CAND-1ac7ff3a528f4c19445ed23603816f189ee8c63ef39b07b623240c2291537041 | Customer 7918 | Order 50985 | Item 11509 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1a95e723f94014e5df11b07cb765c5590abfef0e4ab0830e78b8b421f41d3b8b | OPP-db77922290355a28edd1234c416c15451834335d3c1b3ea6c227b12dd860ab83 | SER-1ac8d7ff1e4943110b2d3e58ba9ba948127bced402029f40ba77662788e15a87 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bellwood Clinical Group, Corp. | 7918 | Vendor | OH | Overdue Reorder | Needs Validation | 72.41 | 249.61 | 65.81 | MicroGenics | T-10016403 — Thermo Kit Methadone Rgt DRI | 33 completed purchases over 922 days; median interval 26.0 days; expected reorder 2026-04-06; High Risk by 126 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Talia Brennock | CONFIRM_ACCOUNT | Candidate CAND-1a95e723f94014e5df11b07cb765c5590abfef0e4ab0830e78b8b421f41d3b8b | Customer 7918 | Order 50985 | Item 11555 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b3764a5a416c135bfd87048a236d25a5d76d48ffbb22dfa0b38c05007e54ff2d | OPP-9071b47ae445ecb1eb90fabad158d04ad4c2e23eb3eee5fb6d8ab84ea1b9cd7e | SER-caafaa340c0356fa4c4488ab7edba0741c72511d42456f37d8a22dc8e550736a | Not selected for publication; targeted context validation is still required. | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | IL | Overdue Reorder | Low | 66.83 | 315 | 208.57 | Beckman Access / DxI | 33880 — 33880 BECKMAN ACCESS FREE T4 RGT 100/BX | 10 completed purchases over 272 days; median interval 19.0 days; expected reorder 2026-05-19; High Risk by 83 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b3764a5a416c135bfd87048a236d25a5d76d48ffbb22dfa0b38c05007e54ff2d | Customer 41770 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-93fbe5546db0612245d044ad2eebcb29eaea6dfd745eacd435a2792a00ff9c83 | OPP-1e5a0c090f3a844a0f3c4b1c8c6c44542f5ba9ae6bdb4bf75ec79a96df0abd82 | SER-4d02df50c76484f1548c21edd52f8b1b7ab50b29bf404efe4f3ca631ec3d70a3 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Health Alliance, LLC | 7676 | HQ | IL | Overdue Reorder | Needs Validation | 66.37 | 503.33 | 537.3 | Beckman Access / DxI | B84493 — B84493 - Access Sensitive Estradiol Reagent, 100 Determinations, 2 x 50 tests | 21 completed purchases over 1005 days; median interval 52.5 days; expected reorder 2026-09-08; Due Soon in 29 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Rowntree ("Key-You") Li (Primary, Lab Director) | CONFIRM_ACCOUNT | Candidate CAND-93fbe5546db0612245d044ad2eebcb29eaea6dfd745eacd435a2792a00ff9c83 | Customer 7676 | Order 52906 | Item 13143 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8f367974ee98c07943ae720a185bac2476c8beee0dff7534f16ac8f59ac1ec7c | OPP-ac564e8410d49ae01cdb73553dd48478e7096ff269e82cb990cf7fe2f9b99460 | SER-ea9766bedfce2946505f52bc0d65b1216af8d46b22738c84d2b6ae8dcbb1e7fe | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Health Alliance, LLC | 7676 | HQ | IL | Overdue Reorder | Needs Validation | 65.75 | 351.35 | 418.92 | Beckman Access / DxI | A10826 — A10826 Beckman Access DHEA-S RGT | 21 completed purchases over 1055 days; median interval 56.5 days; expected reorder 2026-08-29; Due Soon in 19 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Rowntree ("Key-You") Li (Primary, Lab Director) | CONFIRM_ACCOUNT | Candidate CAND-8f367974ee98c07943ae720a185bac2476c8beee0dff7534f16ac8f59ac1ec7c | Customer 7676 | Order 52906 | Item 5120 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-26247a4850ad09085a0495117885387666de65c1f6d3ffc1f08f51ce699c8e7a | OPP-cf21cbcdb2e3309720d0fdca73af7a00c92f3255c61baae14cf6182c76e2c96b | SER-5a2df63237e61ce1da6bf16abee6eba52dc8a0dab784fbd3a400f73b3486bad2 | Not selected for publication; targeted context validation is still required. | **** | Fairmont Health System, Corp. | 18519 | Vendor | MI | Overdue Reorder | Low | 62.42 | 862.73 | 588.5 | Thermo | 100357 — Pacific Hemostasis Thromboplastin D, 10 x 10 mL | 3 completed purchases over 135 days; median interval 67.5 days; expected reorder 2026-08-03; Overdue by 7 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-26247a4850ad09085a0495117885387666de65c1f6d3ffc1f08f51ce699c8e7a | Customer 18519 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c54b46ae744b8096edea6a3b34a59d0359091fb4877ed158101da700f98258d6 | OPP-586861ef91dc4b9570b69514a383548fd5655929ba3286f312769c77bac58e91 | SER-ea429bfef0b0588a893bb2e34a0c2faed85b5dd8d04cb69a3e9f114288099d0f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Health Alliance, LLC | 7676 | HQ | IL | Overdue Reorder | Needs Validation | 61.91 | 216 | 152.2 | Beckman Access / DxI | 33600 — 33600 BECKMAN ACCESS CORTISOL RGT 100/BX ***Replacement | 23 completed purchases over 1055 days; median interval 43.5 days; expected reorder 2026-09-06; Due Soon in 27 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Rowntree ("Key-You") Li (Primary, Lab Director) | CONFIRM_ACCOUNT | Candidate CAND-c54b46ae744b8096edea6a3b34a59d0359091fb4877ed158101da700f98258d6 | Customer 7676 | Order 52906 | Item 4257 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f1f4d30393636eb0e46ee27f837eadc5152c638ec5f089c6c88304b6a5b30268 | OPP-96b052dd166de7e22380f1543b87d44c653677e7ac5ed7490b664c78a6e81567 | SER-934c8706bcf4eec3e4c75e51252491435a73f92df69c6474d605b59c4e86f550 | Not selected for publication; targeted context validation is still required. | **** | Copperfield Diagnostics, PLLC | 9363 | Vendor | OH | Overdue Reorder | Low | 57.34 | 406.17 | 144.9 | MicroGenics | T-10028874 — Thermo DRI Fentanyl II Neg Cal | 3 completed purchases over 515 days; median interval 257.5 days; expected reorder 2025-12-17; High Risk by 236 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-f1f4d30393636eb0e46ee27f837eadc5152c638ec5f089c6c88304b6a5b30268 | Customer 9363 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bd1f6a1606481f1023fe8c65931b7e2349d9997bd389299217b46ce254c0925c | OPP-f4e954b27108c7fd81d0838502069f6080281bd318ca631ae6379998f9f0716d | SER-a5db9bfcf6edaf72e575f3903b0043f4d4420993659bc8a59acfe68837dce64b | Not selected for publication; targeted context validation is still required. | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | IL | Overdue Reorder | Low | 53.08 | 220.12 | 174.12 | Olympus / Beckman AU | OSR6006 — OSR6006 Olympus Amylase Reagent (4x10ml) | 3 completed purchases over 121 days; median interval 60.5 days; expected reorder 2026-07-27; Overdue by 14 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-bd1f6a1606481f1023fe8c65931b7e2349d9997bd389299217b46ce254c0925c | Customer 41770 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-edff6659be091a23808a1f640713f120fd033fea40caf196dca5216c5af12ed7 | OPP-01e79a78c330f340e8db472b97e452e99c0aa9b7dfad364f072f7934b55b2766 | SER-a86fb6c4775e7f1ab75cd60bc162c054ee5b93e6a58e654029e9dde1e22da5a6 | Not selected for publication; targeted context validation is still required. | **** | Maple Health Collective, LLC | 9818 | HQ | NE | Overdue Reorder | Low | 52.21 | 150.37 | 128.05 | Beckman Access / DxI | 33025 — 33025 BECKMAN ACCESS FERRITIN CAL | 3 completed purchases over 427 days; median interval 213.5 days; expected reorder 2026-02-12; High Risk by 179 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-edff6659be091a23808a1f640713f120fd033fea40caf196dca5216c5af12ed7 | Customer 9818 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-25baac8fb56a243c4cf82df0c83ddbe769df6456717617d5868c1d139933db0c | OPP-b8020557bbd68708ca0feafbfe8fd86cdc1f62019af71ec797bd24f4513a8893 | SER-0d2c325c11f61ad3772a0aad176b959c31911e8cc5d536be0bccbee163d67937 | Not selected for publication; targeted context validation is still required. | **** | Bellwood Laboratory Partners, LLC | 41633 | HQ | IL | Overdue Reorder | Low | 51.39 | 341.67 | 216.8 | Olympus / Beckman AU | OSR60117 — OSR60117 Olympus Calcium Reagent (4x700 tests) | 3 completed purchases over 88 days; median interval 44.0 days; expected reorder 2026-08-22; Due Soon in 12 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-25baac8fb56a243c4cf82df0c83ddbe769df6456717617d5868c1d139933db0c | Customer 41633 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-0f197a61cdc4fe91d332468eeacaa8cb7c362d150b308f0de8aab90d406f3f81 | OPP-2ca0bf2a37f67575d21911779cdfcb7782cad7071d9dcfa5271309e199ff754c | SER-cc86259696421b55cc1ef4bf55c12318ef2aeaf943efd8468f24b653f7efb1e1 | Not selected for publication; targeted context validation is still required. | **** | Meridian Medical Center, Corp. | 10031 | HQ | OH | Overdue Reorder | Low | 50.05 | 1077.67 | -438 | MicroGenics | T-100249 — Thermo Kit Oxycodone 500mL | 3 completed purchases over 271 days; median interval 135.5 days; expected reorder 2026-08-28; Due Soon in 18 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-0f197a61cdc4fe91d332468eeacaa8cb7c362d150b308f0de8aab90d406f3f81 | Customer 10031 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-635c8048726a039616d2193f6624aa8f8a2a3ff0115fa76dcb8bfef4041ea45a | OPP-f10490c290aed4f041fb886d129b825b5f25de817ade6ec56160272bb9c7d71e | SER-d46c3659d9b9501b0d80889799c3e11a1fe23d9cbccf02a28e142d419e0c1672 | Not selected for publication; targeted context validation is still required. | **** | Lakeside Clinical Group, Inc. | 41770 | HQ | IL | Overdue Reorder | Low | 48.21 | 150 | 93.65 | Olympus / Beckman AU | OSR6132 — OSR6132 Olympus TP Reagent (4x750 tests) | 3 completed purchases over 209 days; median interval 104.5 days; expected reorder 2026-07-26; Overdue by 15 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-635c8048726a039616d2193f6624aa8f8a2a3ff0115fa76dcb8bfef4041ea45a | Customer 41770 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4047d7c1f2c4bc97720674fa961d3e27bcd2dec9a586372c455436831aa1e2b9 | OPP-5775e2ca72b096ffa99bdd5a6f950de01a813a51f74de9957b736db4d2f32a15 | SER-22b13b80923192dfcab1c807659fcd58956aeeb916674c9f62ba91777f8ea0e3 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Brightwater Analytical Labs, LLC | 19 | HQ | CA | Overdue Reorder | Needs Validation | 73.79 | 1843.33 | 768 | Siemens | 2083 — Siemens 2083 Clinitek Microalbumin 2 Reagent Strips for Urinalysis 25/btl | 26 completed purchases over 1067 days; median interval 31.0 days; expected reorder 2026-08-24; Due Soon in 14 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Miles Ulster | CONFIRM_ACCOUNT | Candidate CAND-4047d7c1f2c4bc97720674fa961d3e27bcd2dec9a586372c455436831aa1e2b9 | Customer 19 | Order 53106 | Item 506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d13b6c7564509e427ddf370667d157e9be04ae941f4f44801e9b218319c713f7 | OPP-70b343da73b5fc198e5b4d2cee50d4551021976c49cd7011a7d64418858d08d1 | SER-d6d0cbfab10b3e157070e33523ef5a43f6e1a66cb404425df863f6401c9b9dd3 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Diagnostics, Corp. | 7257 | HQ | CA | Overdue Reorder | Needs Validation | 72.95 | 1604.17 | 475 | Parts Group | 2300 — 2300 Siemens Multistix 10 SG Reagent Strips (pkg/100) | 7 completed purchases over 645 days; median interval 108.5 days; expected reorder 2026-02-25; High Risk by 166 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Carly Sutcliffe | CONFIRM_ACCOUNT | Candidate CAND-d13b6c7564509e427ddf370667d157e9be04ae941f4f44801e9b218319c713f7 | Customer 7257 | Order 48984 | Item 10667 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-471ca0511967f65f9c823a0864d68d6ee126e7f9063afd6298c90c39c1644ac4 | OPP-31f4067a0ee6978b66abc79b9537398948b247074882ead3d5b1b82afa34c388 | SER-38be9d04b6c7845ab6a384ee1597b299bd35b91106144e98b6f3267b557c0e3d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Lakeside Pathology Associates, Inc. | 42928 | HQ | CA | Overdue Reorder | Needs Validation | 72.13 | 1185 | 480 | Beckman Access / DxI | B24838 — B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests - MUST BE NEW LOT | 17 completed purchases over 602 days; median interval 36.0 days; expected reorder 2026-08-13; Due Soon in 3 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Bishop | CONFIRM_ACCOUNT | Candidate CAND-471ca0511967f65f9c823a0864d68d6ee126e7f9063afd6298c90c39c1644ac4 | Customer 42928 | Order 52966 | Item 10920 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-22701863589ed5fbff9faace6701bcbf81ff1e5b4f2dcdc8c46a60b8d58f8216 | OPP-480152c46e800b2ed75c5771e115dd176ef5bee8556e30be6362a895f5ca6189 | SER-8ecd41650028e0d25267e31c06590872c198475d3646c5071fe2d4afeb6dd456 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Brightwater Health Collective, PLLC | 9236 | Vendor | CA | Overdue Reorder | Needs Validation | 71.1 | 375.82 | 105.62 | Medica EasyLyte | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | 14 completed purchases over 857 days; median interval 66.0 days; expected reorder 2026-03-26; High Risk by 137 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Laura Quezada | CONFIRM_ACCOUNT | Candidate CAND-22701863589ed5fbff9faace6701bcbf81ff1e5b4f2dcdc8c46a60b8d58f8216 | Customer 9236 | Order 49938 | Item 525 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4785f427070f7f678a1937fe232b579346431c9adfa5007402a53f68d080e3b6 | OPP-8d9a0b8568f46d155d9164f2fdf6cfebb1595798fbb019383d60dee8ad96d195 | SER-c895d8e88f12c5a05818dc0fcb6fec31c638dff0d3c8dfd59141455821828060 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Medical Group, Corp. | 157 | HQ | TX | Overdue Reorder | Needs Validation | 67.92 | 1376 | 1520 | Siemens | 2083 — Siemens 2083 Clinitek Microalbumin 2 Reagent Strips for Urinalysis 25/btl | 16 completed purchases over 1027 days; median interval 48.5 days; expected reorder 2026-09-07; Due Soon in 28 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-4785f427070f7f678a1937fe232b579346431c9adfa5007402a53f68d080e3b6 | Customer 157 | Order 53351 | Item 506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d729b1a12bf798b8ad093eb29e1de8eee366d6d7596c7bf703ff70eed6d14395 | OPP-40db3fd341b28bef295748d3fd42cdb4c140c1b715c402ef12e145e37dddb202 | SER-13b996e8736ecfcf9f66ec692fc35782b14ebf7a6ebe33842e4133bee3722dd4 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Copperfield Diagnostics, LLC | 44487 | HQ | CA | Overdue Reorder | Needs Validation | 67.63 | 1150 | 174.51 | Parts Group | 10736515 — 10736515 Siemens EPOC BGEM BUN Test Cards (Detectable Analytes - pH, pO2, pCO2, Na+, K+, Ca++, Cl-, Glucose, Lactate, Creatinine, Hct, TCO2, BUN), PKG/25 Tests | 11 completed purchases over 263 days; median interval 27.0 days; expected reorder 2026-08-18; Due Soon in 8 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Umar Calder | CONFIRM_ACCOUNT | Candidate CAND-d729b1a12bf798b8ad093eb29e1de8eee366d6d7596c7bf703ff70eed6d14395 | Customer 44487 | Order 53164 | Item 13498 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-22466bfea45915cf3dde6e0bacd7525f76dbe1e446dad19f5b4a827bfc64f1c6 | OPP-09760a576081ff21592885c59915c5eeea832375d35d960939c445455aa866f4 | SER-4c6dc7ec6f77a064662dcfcfab48cddcb9d67da56c7a46eb868859fdd79c8a0f | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 67.27 | 1156.9 | 330.54 | Roche | 8948844160 — HSV-1 IgG Elecsys Cobas E 100 V2 | 3 completed purchases over 125 days; median interval 62.5 days; expected reorder 2026-05-24; High Risk by 78 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-22466bfea45915cf3dde6e0bacd7525f76dbe1e446dad19f5b4a827bfc64f1c6 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-adba771b26f812380d376c4de97dfaa5c909bf8b73e6072be8203e345ff4f94d | OPP-a1f4d261a284c0acfbf95b1f16ff25f9836d93f49664f04eedd686f32ac6932a | SER-9dce945476232314d1ba588a9a333046326ff4edc53a02c12991c3becb46603c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Wrenfield Diagnostic Group, Corp. | 9912 | HQ | TX | Overdue Reorder | Needs Validation | 63.46 | 1750 | 1158.86 | Olympus / Beckman AU | B00389 — B00389 Olympus HbA1c (AU Systems Hemoglobin A1c) Reagent, incl. Calibrators | 6 completed purchases over 214 days; median interval 52.0 days; expected reorder 2026-09-02; Due Soon in 23 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Umar Marrow | CONFIRM_ACCOUNT | Candidate CAND-adba771b26f812380d376c4de97dfaa5c909bf8b73e6072be8203e345ff4f94d | Customer 9912 | Order 53140 | Item 11374 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7697142161f18b0f5d5d1cfcb53c4a0224168fa218e97606a20812ea11c3cb94 | OPP-cf34c561060fc2df360d487aab211f197440ee1aa01a89d6085b705adc4022a9 | SER-9284a87643b24bf7ae435c28efe124f1f1c814012b32d28afd59e85bc989a191 | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 62.69 | 602.08 | 129.02 | Roche | 11731629160 — 11731629160 CEA Elecsys cobas e 100 | 3 completed purchases over 231 days; median interval 115.5 days; expected reorder 2026-03-13; High Risk by 150 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-7697142161f18b0f5d5d1cfcb53c4a0224168fa218e97606a20812ea11c3cb94 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f0a64e804efdc1f8b3724ff10aeefd9e1e42e3fcef0de1d3240b5169b97dfc42 | OPP-6de108c6cf9ff96b08494c19de7440c70ac0d8bbd183b7f8f288e5575ae0b6f5 | SER-57f5102daefd9c395abd0dbce31cd741dfe9f643df8e657e36e308ca01c53106 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Lakeside Diagnostics, Corp. | 9381 | HQ | AB | Overdue Reorder | Needs Validation | 62.69 | 972.13 | 269.62 | Parts Group | 10736515 — [10736515] Siemens 10736515 EPOC BGEM BUN Test Cards, PKG/25 Tests Siemens EPOC BGEM BUN Test Cards, PKG/25 Tests | 13 completed purchases over 972 days; median interval 76.0 days; expected reorder 2026-08-22; Due Soon in 12 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-f0a64e804efdc1f8b3724ff10aeefd9e1e42e3fcef0de1d3240b5169b97dfc42 | Customer 9381 | Order 52327 | Item 13498 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-487446784e3665438cc9908ef113702cc425e72741f00a22d81530d038513598 | OPP-4b2bd3b4edf64059a507e9932d36f5f3700970d264c4fab834d921cf8921f5fa | SER-61ae0d09d25ac563c72a5e7d287ca99bc553771135337a3cbd922f2c3a685d88 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Lakeside Pathology Associates, Inc. | 42928 | HQ | CA | Overdue Reorder | Needs Validation | 62.13 | 307.49 | 101.72 | Beckman Access / DxI | A16792 — A16792 Beckman Access Wash Buffer, Pkg/4 bottles, 1.9 L/bottle | 15 completed purchases over 561 days; median interval 35.0 days; expected reorder 2026-08-18; Due Soon in 8 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Bishop | CONFIRM_ACCOUNT | Candidate CAND-487446784e3665438cc9908ef113702cc425e72741f00a22d81530d038513598 | Customer 42928 | Order 52966 | Item 4876 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2a688d045df6dd453b80aaea81000ae9b94aebbc065f754c7794412ffe77756b | OPP-999099baad1fea7cd0d3e014ac857a064c62c742d867018e3ec2c737054c4969 | SER-06565889a840e634f6fd5f72a465fc177ea528aa834e62240c8f5abdba50c55d | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 62.07 | 790 | 270.86 | Roche | 08814856160 — Roche HBsAg G2 Elecsys Cobas E 100 V2 | 3 completed purchases over 101 days; median interval 50.5 days; expected reorder 2026-03-20; High Risk by 143 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-2a688d045df6dd453b80aaea81000ae9b94aebbc065f754c7794412ffe77756b | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b1b93650449973d8aec7e10d4952d0c3479e98a77fbb69ad015451bb8e960f71 | OPP-3a1bc78b3fa6313fb9f5f9dcdc7fba08685aaf9782a9a0ea0bbb62842e93a6fb | SER-0cad9202d668e344cab9566972d6816d7421e7f516cfc7d52baacd0504d556c6 | Not selected for publication; targeted context validation is still required. | **** | Brightwater Medical Partners, PLLC | 7409 | Vendor | OK | Overdue Reorder | Low | 61.77 | 988.11 | 355.34 | MicroGenics | 986000 — 986000 Thermo Scientific INDIKO CUVETTES 10800/PK | 3 completed purchases over 184 days; median interval 92.0 days; expected reorder 2026-07-03; Overdue by 38 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b1b93650449973d8aec7e10d4952d0c3479e98a77fbb69ad015451bb8e960f71 | Customer 7409 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ecdab1ae518f4d9fa393035eeb3e9c607b8e0b6dd72ffea5a972b02de9857f0b | OPP-0e5390fd4ba46a7699274677d4e93f42fa7ab7abc7e80df9de763a2f686110a2 | SER-5c2923f6d83022690f4a75f26825362d1999c1c1202d1afa153f579efebec207 | Not selected for publication; targeted context validation is still required. | **** | Crestview Medical Associates, LLC | 8532 | HQ | CA | Overdue Reorder | Low | 61.27 | 361.8 | 219.8 | Olympus / Beckman AU | OSR6106 — OSR6106 Olympus AMY (Amylase) Reagent, 4 x 40 mL | 3 completed purchases over 491 days; median interval 245.5 days; expected reorder 2025-11-06; High Risk by 277 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ecdab1ae518f4d9fa393035eeb3e9c607b8e0b6dd72ffea5a972b02de9857f0b | Customer 8532 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-37f1eea3c07faa9cfd639655283f3ff98798ce4da9e489e219abc8eb8447dad1 | OPP-1c84910a35203f422c9ca60164b6384835d3785d9d7fffbb367714b51bfd5812 | SER-a76a47fffc110df245d156f14fb1cf1e428749658a5f26caed00dc16e26c622d | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 60.25 | 331.53 | 71.04 | Roche | 07092539190 — 07092539190 Progesterone III Gen 100 Test | 3 completed purchases over 231 days; median interval 115.5 days; expected reorder 2026-03-13; High Risk by 150 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-37f1eea3c07faa9cfd639655283f3ff98798ce4da9e489e219abc8eb8447dad1 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-943ce81c11c50234fe9f1c1105d48a55e94ea858cbfa1c17b9c3119cbe151313 | OPP-fb899a4f9fd193a90f21a274ceb07c937ce6608ebc02d5d6691c0055f4d78bde | SER-d39463ae26b20b0c81b059dda0d864cdbe137585643169c92f12f6f70cc2ba05 | Not selected for publication; targeted context validation is still required. | **** | Brightwater Medical Partners, PLLC | 7409 | Vendor | OK | Overdue Reorder | Low | 59.89 | 558.9 | 232.34 | MicroGenics | T-1797 — Thermo Kit Creat-Detect 500mL | 3 completed purchases over 496 days; median interval 248.0 days; expected reorder 2026-04-03; High Risk by 129 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-943ce81c11c50234fe9f1c1105d48a55e94ea858cbfa1c17b9c3119cbe151313 | Customer 7409 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-705e67c5d697af1dac9a3450caed4401d7f50e3c5b52108fa5cc8b37be8c1232 | OPP-bab0c8e7dd38e571e6664380b4ad79e0a4c89a8c26f89e7cc0f3d38979791f1d | SER-5860c2cee687acec483d091c82f2c1126f0877b13637d94de2cc86d8d5734fe1 | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 59.63 | 273.01 | 58.5 | Roche | 09007725190 — 09007725190 T3 Elecsys cobas e 200 V2 | 3 completed purchases over 231 days; median interval 115.5 days; expected reorder 2026-03-13; High Risk by 150 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-705e67c5d697af1dac9a3450caed4401d7f50e3c5b52108fa5cc8b37be8c1232 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-0ac28c747528eb2ac04c7512b103c6699635e2ed8ec8b9bf927bd97c62fc977f | OPP-6c28aa1c8e7374569179830d0c8f3df3a39b85226721490f45e7b2609145e178 | SER-126d1b72b939eb4a4237f18702db5064c23a15ab64dee5c1f4c164c0d072a948 | Not selected for publication; targeted context validation is still required. | **** | Cascade Diagnostic Labs, Inc. | 7758 | Vendor | MO | Overdue Reorder | Low | 58.9 | 416.12 | 138.71 | MicroGenics | T-10015213 — Thermo Kit Heroin Mtb Rgt CEDIA | 3 completed purchases over 105 days; median interval 52.5 days; expected reorder 2026-07-05; High Risk by 36 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-0ac28c747528eb2ac04c7512b103c6699635e2ed8ec8b9bf927bd97c62fc977f | Customer 7758 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d8023e073c89c3e5b4f4f6010563f9622d81c67cb2d436b1dc689b6a7668f9db | OPP-49802943a3f82119a4b744b51c5c8ccb92929598f9e95c8f7aae552a7a1bf702 | SER-09f74040dbcda334d3783e9588f3d38ec660249b5c76d82747cfcf2d52be1359 | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 58.53 | 176.97 | 37.92 | Roche | 08932352190 — 08932352190 FSH Elecsys cobas e 100 V2 | 3 completed purchases over 231 days; median interval 115.5 days; expected reorder 2026-03-13; High Risk by 150 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-d8023e073c89c3e5b4f4f6010563f9622d81c67cb2d436b1dc689b6a7668f9db | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-46b3687ba3de9feb81d8a89dd50eb43835ade5720b9021523ce51d381f3b4e10 | OPP-5fd1f95069e33f43203a1cce1f813c10474191e0bb8bd9617ada1d68da428e4a | SER-d56f0d167cbe0fa9e579739a5f3d74f11f502fffde763aaf9f172cbb4f295ad7 | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 58.49 | 173.45 | 37.17 | Roche | 11732234122 — 11732234122 LH E411 100 T | 3 completed purchases over 231 days; median interval 115.5 days; expected reorder 2026-03-13; High Risk by 150 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-46b3687ba3de9feb81d8a89dd50eb43835ade5720b9021523ce51d381f3b4e10 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-33bbd9fc2352d959055c3fa99c13b7052db144b648ee43887bc0f00d56be77e6 | OPP-f7d6e9d8c1100364c40d6c5ae4b67de1f5c18dddfccb8f0ab0fe8983e1a4eed6 | SER-81900a52230054bcb3a3eccbb9027905d2548bd351060e9a043bf9a060a5fdd4 | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 58.04 | 397.02 | 136.12 | ROCHE-E411 | 08429324160 — 08429324160 Thyroid Stimulating (TSH) 200 Test | 3 completed purchases over 131 days; median interval 65.5 days; expected reorder 2026-05-01; High Risk by 101 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-33bbd9fc2352d959055c3fa99c13b7052db144b648ee43887bc0f00d56be77e6 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a59dbd640cb519bcafed0d15082ce8500dbc69df4fec00944775dfae28f1e99e | OPP-9d16ea50022c5e1e27038befe7a3a2d886c4f90d7c69fef5a1a90b2d553445ff | SER-12d2e08a09637efafd1a418ba82377228a0af50317a303b8fa36aa978f52191d | Not selected for publication; targeted context validation is still required. | **** | Crestview Medical Associates, LLC | 8532 | HQ | CA | Overdue Reorder | Medium | 56.55 | 150 | 37 | Olympus / Beckman AU | OSR61205 — OSR61205 UIBC (Unsaturated Iron Binding Capacity) Reagent, 4 x 240 Tests | 4 completed purchases over 580 days; median interval 211.0 days; expected reorder 2025-12-19; High Risk by 234 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-a59dbd640cb519bcafed0d15082ce8500dbc69df4fec00944775dfae28f1e99e | Customer 8532 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f8344f88c67c585ea71d1c86ebfe94b9b18c869e40a78f2900e9a6549e71bc7f | OPP-a543a09d0d2de2cce97603e7e00a28f6b57e6c4729646f5b14bc564ad808b4bb | SER-ca8890ba5bab53d146dc94f31b5d49841800efed45afbc8f9adaf369df38f215 | Not selected for publication; targeted context validation is still required. | **** | Crestview Medical Associates, LLC | 8532 | HQ | CA | Overdue Reorder | Low | 56.38 | 182.4 | 52.2 | Olympus / Beckman AU | 472137 — 472137 Beckman Synchron and AU Systems Hemolyzing Reagent, 1000 Tests | 3 completed purchases over 384 days; median interval 192.0 days; expected reorder 2025-12-24; High Risk by 229 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-f8344f88c67c585ea71d1c86ebfe94b9b18c869e40a78f2900e9a6549e71bc7f | Customer 8532 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ecdc7ceb8e51a7ba2daf6285f6d91f6b988bf9a094095ecf3fc38db14903f677 | OPP-2cf3dd7123fb7c7b9c3a4d136045eb2810662431da498b6d0b859237f0bcd801 | SER-c6c2c1c5447f5394586afeef61bff1f6a1c0e251a5a3c541c6e2e836e8f4439a | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cascade Laboratory Partners, Inc. | 21701 | Vendor | KS | Overdue Reorder | Needs Validation | 56.35 | 403.33 | 100 | Ditek/Medzah | BDMD05 — Biodegradable Nitrile Power Free Exam Gloves, X-Large 200/BX,10BX/CS (Case of 2,000) | 13 completed purchases over 454 days; median interval 38.0 days; expected reorder 2026-09-05; Due Soon in 26 days. | Classification: Unknown (Low). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Oscar Lofgren | CONFIRM_ACCOUNT | Candidate CAND-ecdc7ceb8e51a7ba2daf6285f6d91f6b988bf9a094095ecf3fc38db14903f677 | Customer 21701 | Order 53185 | Item 15583 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f862e6589cfacdd7c0188a8a54d4f9afb821a8c7244c25382e8faa04befea956 | OPP-6cbb599dd6a39b61078602724e8e50a312e19cac12070cc4d4cff778a7a0b9c3 | SER-ce17b944b7f6cda03f60e7cad86f26c2e268a26cd5f595d61ae3e3b57029851c | Not selected for publication; targeted context validation is still required. | **** | Northgate Clinical Labs, PLLC | 33486 | Vendor | OK | Overdue Reorder | Low | 55.88 | 217.47 | 40.09 | Horiba | 1220001901 — ISE Reference Solution 280mL - PC400 ***Replacement for Shortage*** | 6 completed purchases over 402 days; median interval 29.0 days; expected reorder 2026-08-06; Overdue by 4 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-f862e6589cfacdd7c0188a8a54d4f9afb821a8c7244c25382e8faa04befea956 | Customer 33486 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-275608835bf8d22234bf07e0ce3a953ebe04289a25a0f38c2f3a4ddd47a93e32 | OPP-bfb531d05faef7ede7bfaacd871e14a8c7c0ccc8403636a781ade0547c356220 | SER-2da1596e40613535cfbe7ef3aab66117f41837350c9d25e06b3b54525f20f049 | Not selected for publication; targeted context validation is still required. | **** | Crestview Medical Associates, LLC | 8532 | HQ | CA | Overdue Reorder | Low | 55.87 | 258.33 | 192 | Olympus / Beckman AU | OSR6178 — Olympus OSR6178 CREATININE Reagent (4x990 tests) | 3 completed purchases over 422 days; median interval 211.0 days; expected reorder 2026-02-19; High Risk by 172 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-275608835bf8d22234bf07e0ce3a953ebe04289a25a0f38c2f3a4ddd47a93e32 | Customer 8532 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-30a800db9d90d13b700b9126b8b4bb58ecbb32f838ab236d5409d242973f7b8c | OPP-7a833195b1b9acc34dc6a90aa6352cc5b33c33fabc5179aa9f53064d2b9c43e6 | SER-d83a62dbeb59be264d928d5a2a9931dc98fe2907cde235b83277aadf2fc79372 | Not selected for publication; targeted context validation is still required. | **** | Crestview Medical Associates, LLC | 8532 | HQ | CA | Overdue Reorder | Medium | 55.83 | 202.5 | 115.5 | Olympus / Beckman AU | OSR6109 — OSR6109 Olympus AST Reagent (4x980 tests) | 4 completed purchases over 693 days; median interval 203.0 days; expected reorder 2026-05-01; Overdue by 101 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-30a800db9d90d13b700b9126b8b4bb58ecbb32f838ab236d5409d242973f7b8c | Customer 8532 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d13072f3e6ae47bcc115c12650a27788fa0b4dc447c58289fb329af400b72cfa | OPP-188803d82478c5a2ea1189c4e3381f93ac63ba66df2874c2674b9434a74d23fb | SER-5483a3e7e050c0a09eb5b772ba52ccc1899baf53692609c8affcceb701b30406 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cascade Laboratory Partners, Inc. | 21701 | Vendor | KS | Overdue Reorder | Needs Validation | 54.29 | 220 | 50 | Ditek/Medzah | BDMD04 — Biodegradable Nitrile Power Free Exam Gloves, Large 200/BX,10BX/CS (Case of 2,000) | 13 completed purchases over 454 days; median interval 38.0 days; expected reorder 2026-09-05; Due Soon in 26 days. | Classification: Unknown (Low). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Oscar Lofgren | CONFIRM_ACCOUNT | Candidate CAND-d13072f3e6ae47bcc115c12650a27788fa0b4dc447c58289fb329af400b72cfa | Customer 21701 | Order 53185 | Item 15582 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6f1f64511d6d7574706008d9de1cab33e64c7835e948e5528bfc50b592fcb7f7 | OPP-c0f363d0a6f0aaa0be04058e7f1dac538a5cdf4810467c962aa7ba45f20f0298 | SER-2c9a617b842021240fcd53e3b72775ce9ebcb3b0c244bb009763601ea0c4569a | Not selected for publication; targeted context validation is still required. | **** | Bridgeport Diagnostic Group, Inc. | 10099 | HQ | CA | Overdue Reorder | Low | 53.65 | 448.74 | 166.9 | Abbott i-STAT | IST-03P7725 — IST-03P7725 Abbott I-Stat EG6+ Cartridge 25/BX | 3 completed purchases over 377 days; median interval 188.5 days; expected reorder 2026-06-23; Overdue by 48 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-6f1f64511d6d7574706008d9de1cab33e64c7835e948e5528bfc50b592fcb7f7 | Customer 10099 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cd96ee49ec5ce7e2a01f239848c951bc0374bbc54777cebe841e8a7f6b25f24f | OPP-6d7d970e2cf2db066f9c713975a23524d2cdb438b7b7e6b1a7674d589cd8b077 | SER-edcee4c82fa86296638be767fac468b1f5477fae2e849b2a67c9e6867c4954c6 | Not selected for publication; targeted context validation is still required. | **** | Crestview Medical Associates, LLC | 8532 | HQ | CA | Overdue Reorder | Medium | 52.42 | 160 | 114 | Olympus / Beckman AU | OSR6121 — OSR6121 Olympus Gluc Reagent (4x610 tests) | 4 completed purchases over 585 days; median interval 197.0 days; expected reorder 2026-05-21; Overdue by 81 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-cd96ee49ec5ce7e2a01f239848c951bc0374bbc54777cebe841e8a7f6b25f24f | Customer 8532 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-166392dcd0e362b49123321b0a15e5044767b994b74dd8049b9ef4360583516d | OPP-62c1074a2453e9074b939dd3d5d37911b08291e66429eea714a713335c965142 | SER-1c75492be722ef8188766db40cecce68d93ff41e4edb8fa46542af8601cf9212 | Not selected for publication; targeted context validation is still required. | **** | Northgate Clinical Labs, PLLC | 33486 | Vendor | OK | Overdue Reorder | Low | 51.91 | 622.11 | 155.53 | Horiba | 1220001652 — MultiCalibrator - PC400 | 3 completed purchases over 275 days; median interval 137.5 days; expected reorder 2026-08-25; Due Soon in 15 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-166392dcd0e362b49123321b0a15e5044767b994b74dd8049b9ef4360583516d | Customer 33486 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8851a5ab590147218eb36ff1fc3dd213fecd86dbe2071c926783e7d4f2dde322 | OPP-25eee60d34b6ab5c5ac0f8a729f88699d9593d17a2054c674f3171ecdb50b5d6 | SER-f651f3fa67e45aec761de050572953de614e5e865f465f5803f9877bf7d2d8ff | Not selected for publication; targeted context validation is still required. | **** | Northgate Clinical Labs, PLLC | 33486 | Vendor | OK | Overdue Reorder | Medium | 51.35 | 476.76 | 119.19 | Horiba | 1220001891 — PC400 Cuvette Segments - PC400 | 4 completed purchases over 379 days; median interval 130.0 days; expected reorder 2026-09-02; Due Soon in 23 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-8851a5ab590147218eb36ff1fc3dd213fecd86dbe2071c926783e7d4f2dde322 | Customer 33486 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-bc556be4d45c433bc13452b5cac4efedafeb0619a77b0b4237cf7e47dda4ebbb | OPP-766cbb28e5bf9dc7bf17c07625534405770012eb484ec66b69202efc63e3e9b0 | SER-050a320298402168b350e57a5be778fcc084b5e3770637e68f28022972e41aaa | Not selected for publication; targeted context validation is still required. | **** | Fairmont Medical Partners, PLLC | 56054 | HQ | KS | Overdue Reorder | Low | 50.78 | 755 | 152.82 | Abbott i-STAT | IST-03P85-25 — IST-03P85-25 Abbott I-Stat CG4+ WHITE CARTRIDGE 25/BX | 3 completed purchases over 92 days; median interval 46.0 days; expected reorder 2026-08-08; Overdue by 2 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-bc556be4d45c433bc13452b5cac4efedafeb0619a77b0b4237cf7e47dda4ebbb | Customer 56054 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ebaf25ad8406dc13558abb7cc0a301f44d7eda1a299a406446975ffec0d61366 | OPP-eedd6eba9baac74f472fcce3b5b3e783276f1a7cf6718d577b62cd0573d32d44 | SER-ad715d2e81fab07d550d97c47dabd8a53f2e523e4f4f0fae9b38a08bc4b7178f | Not selected for publication; targeted context validation is still required. | **** | Maple Pathology Labs, LLC | 43803 | HQ | CA | Overdue Reorder | Low | 50.33 | 170.33 | 58.4 | Roche | 04687876160 — 11876309160 HBsAg PC Elecsys | 3 completed purchases over 303 days; median interval 151.5 days; expected reorder 2026-06-29; Overdue by 42 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ebaf25ad8406dc13558abb7cc0a301f44d7eda1a299a406446975ffec0d61366 | Customer 43803 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1da9f563547351aee8cb11ddbbb6c2cc4b684944fa7089084f237da7e89bc54b | OPP-360cf3e0c836dcb4c236ca42318b724e4409ba0619c3a3a73249d313c2e638c5 | SER-1cc43ab06756a05b7f1ee5f982ec1fb3c676a0a6feb2d9968f67dffd48bb4292 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Diagnostics, Corp. | 9053 | HQ | FL | Overdue Reorder | Needs Validation | 70.39 | 1300 | 300.46 | Parts Group | 10736515 — 10736515 Siemens EPOC BGEM BUN Test Cards (Detectable Analytes - pH, pO2, pCO2, Na+, K+, Ca++, Cl-, Glucose, Lactate, Creatinine, Hct, TCO2, BUN), PKG/25 Tests | 18 completed purchases over 832 days; median interval 21.0 days; expected reorder 2026-04-04; High Risk by 128 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Kessler | CONFIRM_ACCOUNT | Candidate CAND-1da9f563547351aee8cb11ddbbb6c2cc4b684944fa7089084f237da7e89bc54b | Customer 9053 | Order 49491 | Item 13498 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e694c3f28cfcf311230b901f7239a352168459e40402a6881864fffed4a10ac2 | OPP-802811f6e5148b9731f0a92e7e1e5110d2df1727f412abdf9810c3abd9b01b72 | SER-6a20c59c5e0f722a3d205849b2de55c34eb4e21ca0c07f16da91b2bcca4e79c0 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cascade Medical Center, Inc. | 41477 | Vendor | AZ | Overdue Reorder | Needs Validation | 67.92 | 1599 | 376.4 | MicroGenics | T-10015893 — Thermo Kit EtG Rgt 500mL CJF | 3 completed purchases over 223 days; median interval 111.5 days; expected reorder 2026-02-22; High Risk by 169 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Jasper Holcomb | CONFIRM_ACCOUNT | Candidate CAND-e694c3f28cfcf311230b901f7239a352168459e40402a6881864fffed4a10ac2 | Customer 41477 | Order 48878 | Item 11537 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d28d2e009948792362bc4a597283e114e5aa737f745c264e9d68fdb5cdfedffd | OPP-c911997d0a1c3b7a9b3b3c28e5b992195deb52584912a425c4a7e577f90db2f3 | SER-249d242f6916a7d208f7003b1fa92aeabd6f572c3552ab197d24b7bf78fe9fce | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Diagnostics, Corp. | 9053 | HQ | FL | Overdue Reorder | Needs Validation | 67.91 | 1733.33 | 186.08 | Parts Group | 10736515 — 10736515 Siemens EPOC BGEM BUN Test Cards (Detectable Analytes - pH, pO2, pCO2, Na+, K+, Ca++, Cl-, Glucose, Lactate, Creatinine, Hct, TCO2, BUN), PKG/25 Tests | 15 completed purchases over 735 days; median interval 49.5 days; expected reorder 2026-08-20; Due Soon in 10 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Kessler | CONFIRM_ACCOUNT | Candidate CAND-d28d2e009948792362bc4a597283e114e5aa737f745c264e9d68fdb5cdfedffd | Customer 9053 | Order 52681 | Item 13498 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e4abec52ebd1e0512e23cfe9ed043169063d10ef5d3d32f5302afbb472bf9841 | OPP-3823a474637fc73f6ecdf09f56a8b61f7654bdfff3df03dd0b382bb2e62a5d3c | SER-97b4b19295e86bfe05a03ee25f81ff0c6590ce95ff3bd3961a4499d9030a2f9d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Laboratory Partners, Inc. | 6935 | HQ | AZ | Overdue Reorder | Needs Validation | 66.74 | 1035.04 | 304.98 | Medica EasyLyte | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | 6 completed purchases over 274 days; median interval 47.0 days; expected reorder 2026-05-31; High Risk by 71 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-e4abec52ebd1e0512e23cfe9ed043169063d10ef5d3d32f5302afbb472bf9841 | Customer 6935 | Order 51615 | Item 525 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-457f0321091404e3ff8473f9ecbd6905e666d58a6b01c576b77b4b79f2c04d8a | OPP-e5666de84de1fe4aa0692156eb0617caba663da64ff3ba59d503f99585cc616d | SER-fb5aa8aa3be644491af3313f960f30ad2a5579578a06378e650746fbe37ac76f | Not selected for publication; targeted context validation is still required. | **** | Elmhurst Clinical Labs, LLC | 9072 | HQ | LA | Overdue Reorder | Low | 65.71 | 155 | 71 | Olympus / Beckman AU | OSR60117 — OSR60117 Olympus Calcium Reagent (4x700 tests) | 12 completed purchases over 728 days; median interval 36.0 days; expected reorder 2026-07-27; Overdue by 14 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-457f0321091404e3ff8473f9ecbd6905e666d58a6b01c576b77b4b79f2c04d8a | Customer 9072 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-76fb90f6e5ad0f30f5e14df24c5f49f34e5f137b5cfeaa547bd157b499011715 | OPP-9241199a20c9a52975c05b6a50b6534d793a9c892f349bc7d23e4b7314831cb8 | SER-1dc6b6c2ab97e5df4df7988305935cdfde3cdbc9b51e5f10f2e9198d4a473941 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Clinical Partners, PLLC | 9113 | HQ | GA | Overdue Reorder | Needs Validation | 62.97 | 402.98 | 134.33 | Abbott i-STAT | IST-09P31-26 — 09P31-26 Abbott I-Stat CHEM8+ Cartridge 25/BX | 11 completed purchases over 834 days; median interval 87.0 days; expected reorder 2026-08-17; Due Soon in 7 days. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Jarrett | CONFIRM_ACCOUNT | Candidate CAND-76fb90f6e5ad0f30f5e14df24c5f49f34e5f137b5cfeaa547bd157b499011715 | Customer 9113 | Order 52126 | Item 2625 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-30e7434f4241bd7a2a284b725a0b7a0d05d83fb609579b79f3a310e18445d6cc | OPP-95fb7904122d94ef28cc05b9352d88a1902610b20b219cab1e90389c85f28837 | SER-356facd8419653aa0d23ef0351c9fdcc62e3eb0029d553ed31ab3cf3ea3a8228 | Not selected for publication; targeted context validation is still required. | **** | Silverline Reference Labs, PLLC | 52763 | HQ | FL | Overdue Reorder | Low | 61.71 | 683.23 | 262.92 | Parts Group | 10736515 — 10736515 Siemens EPOC BGEM BUN Test Cards (Detectable Analytes - pH, pO2, pCO2, Na+, K+, Ca++, Cl-, Glucose, Lactate, Creatinine, Hct, TCO2, BUN), PKG/25 Tests | 3 completed purchases over 105 days; median interval 52.5 days; expected reorder 2026-05-11; High Risk by 91 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-30e7434f4241bd7a2a284b725a0b7a0d05d83fb609579b79f3a310e18445d6cc | Customer 52763 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2e9130946a4d0e833bb7ca8e5838869adf22a66d5d3daba8e70c9b0a1135c955 | OPP-14630d2bbc0893bd0021d49c819a6ad99d9b1e0573dd056465ed53c1d2753558 | SER-dc1f9d65c2426b1b04aca12bafdaa7261b40adf6c40dc70febc2dbd74e2df2a9 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Lab Services, Corp. | 9385 | HQ | FL | Overdue Reorder | Needs Validation | 60.92 | 1003.52 | 241.56 | Abbott Piccolo | 400-0033 — 07P02-09 Abaxis Piccolo Xpress Kidney Check Panel, 10/Box | 4 completed purchases over 187 days; median interval 71.0 days; expected reorder 2026-07-16; Overdue by 25 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Elena Kilbride | CONFIRM_ACCOUNT | Candidate CAND-2e9130946a4d0e833bb7ca8e5838869adf22a66d5d3daba8e70c9b0a1135c955 | Customer 9385 | Order 51931 | Item 5440 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-fd5e87459c15108f5f490d3296bc32f85bde80eeb17b01221ae6beb04eddf445 | OPP-0ba46a3369887c8623e436446d2c6f9ee5895ae5fc25c606d916d32cc20d1d32 | SER-7bccb773052ddc01cbcc7e223eba94bf3806f87d20762b6620ed6a40a4e23500 | Not selected for publication; targeted context validation is still required. | **** | Foothill Care Partners, Inc. | 9091 | Vendor | MS | Overdue Reorder | Low | 59.93 | 341.58 | 137.1 | MicroGenics | 980929 — 980929 Indiko Wash Solution, 4.5% | 3 completed purchases over 502 days; median interval 251.0 days; expected reorder 2025-11-29; High Risk by 254 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-fd5e87459c15108f5f490d3296bc32f85bde80eeb17b01221ae6beb04eddf445 | Customer 9091 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b049401a69c6a72d9f3e0e50b08fbc7775f79b2c2673b155ae50014493b86b2f | OPP-85e6e0f5bf80bf3c2e98db89248cefa5667b6ef20700b38cb0cf2c13a0b02fdd | SER-d43979c8a917bac1efc98fdf081f2b1d758dacbd9b3a1df497387aceb2ff6786 | Not selected for publication; targeted context validation is still required. | **** | Meridian Medical Center, LLC | 9097 | HQ | FL | Overdue Reorder | Low | 58.8 | 151.67 | 137 | Beckman Access / DxI | A13422 — A13422 T3 FREE RGT 100/BX | 7 completed purchases over 623 days; median interval 60.0 days; expected reorder 2026-07-20; Overdue by 21 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b049401a69c6a72d9f3e0e50b08fbc7775f79b2c2673b155ae50014493b86b2f | Customer 9097 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e998be9f2be4d20ce2a52919a1d03552c84c9677d29d64fd8b597c1c5e92d214 | OPP-94917efa3da1c5afa273c5b93375296ccb90e4c4a2f3e5a80a438fbca83c9649 | SER-95437210c8171c7b0b659a218edb4b57ad880ac60e16d5d7a372955830ed7fb9 | Not selected for publication; targeted context validation is still required. | **** | Meridian Medical Center, LLC | 9097 | HQ | FL | Overdue Reorder | Low | 58.19 | 275 | 80 | Olympus / Beckman AU | OSR6130 — Olympus Lipase (4x65 tests) | 6 completed purchases over 448 days; median interval 43.0 days; expected reorder 2026-06-27; High Risk by 44 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e998be9f2be4d20ce2a52919a1d03552c84c9677d29d64fd8b597c1c5e92d214 | Customer 9097 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-48afa974753547267e54b1e0ea97e5b86cafaf97205799f584cbb0ec6184d7db | OPP-dd3ce961be3738a1da3d35af6907b2c93753634c488c16010c1ef1962081183b | SER-66c3aa1e913510ae29bd76dca3c1fa1352ecf14fd4f567b4f4919923d0d54e59 | Not selected for publication; targeted context validation is still required. | **** | Foothill Care Partners, Inc. | 9091 | Vendor | MS | Overdue Reorder | Low | 57.28 | 658.27 | 158.9 | MicroGenics | T-0040 — Thermo Kit Benz 500mL | 3 completed purchases over 297 days; median interval 148.5 days; expected reorder 2026-06-12; Overdue by 59 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-48afa974753547267e54b1e0ea97e5b86cafaf97205799f584cbb0ec6184d7db | Customer 9091 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-899d4d21cb1e27c2ea82d4fe939c8643c0595b2ea82da1e815cede2b68d7e5da | OPP-a4ff04ea5c5247f34b2fca8fe399fdddbd060a24e4fcad73417ac7e3c12cb1bb | SER-49a689129344f4805d3f7b4c167ddcd50f0863457b7f768634921dd4e0b38b3f | Not selected for publication; targeted context validation is still required. | **** | Foothill Care Partners, Inc. | 9091 | Vendor | MS | Overdue Reorder | Low | 57.28 | 658.27 | 158.9 | MicroGenics | T-0056 — Thermo Kit Cocaine 500mL | 3 completed purchases over 297 days; median interval 148.5 days; expected reorder 2026-06-12; Overdue by 59 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-899d4d21cb1e27c2ea82d4fe939c8643c0595b2ea82da1e815cede2b68d7e5da | Customer 9091 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-caec04d1bed2c54e092d0fe4c78914dfd2c00d291c7f7d983869375c2687b968 | OPP-9bd581837cc3bb059af06f48bbc1d763b51ec94daabea2657b67dcd0a5e0d1a8 | SER-56f2b95951cec24c836888eaed45c981d61db3a583eaa65bdbc9498341e86d32 | Not selected for publication; targeted context validation is still required. | **** | Meridian Medical Center, LLC | 9097 | HQ | FL | Overdue Reorder | Low | 56.37 | 260 | 183 | Beckman Access / DxI | 37200 — 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | 27 completed purchases over 1044 days; median interval 21.5 days; expected reorder 2026-09-03; Due Soon in 24 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-caec04d1bed2c54e092d0fe4c78914dfd2c00d291c7f7d983869375c2687b968 | Customer 9097 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6228f84a42d79219ec2cbb7bab6092348fab51a4eca6ff263facf9bec47ccca2 | OPP-c012b7cf55bb2a42096cd3aa7ea29f82b5389c78424350ff3b728421de5b642e | SER-aab44543d4cb5b566a4af2faba69b8d3f9532ccbb211439bc7447199952e8bf6 | Not selected for publication; targeted context validation is still required. | **** | Riverside Health Collective, PLLC | 8651 | Vendor | FL | Overdue Reorder | Low | 56.17 | 318 | 73.76 | MicroGenics | T-100240 — Thermo Kit Buprenorphine MCC, 65ml | 15 completed purchases over 756 days; median interval 31.0 days; expected reorder 2026-08-29; Due Soon in 19 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-6228f84a42d79219ec2cbb7bab6092348fab51a4eca6ff263facf9bec47ccca2 | Customer 8651 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a35bdb4b025ea8328e07ed276541eb3a1478568a6cefe565db6a7b80c6292967 | OPP-790dc1db4d61f5cb82434713db9bdb8ac701b1fb409a80df3f4373e25d4d3332 | SER-a2258e39bb3be3e944c82a78d6a1256f277309cf0db521ab19ffd3b08881ba72 | Not selected for publication; targeted context validation is still required. | **** | Riverside Health Collective, PLLC | 8651 | Vendor | FL | Overdue Reorder | Low | 52.28 | 309 | 57 | MicroGenics | T-1797 — Thermo Kit Creat-Detect 500mL | 3 completed purchases over 167 days; median interval 83.5 days; expected reorder 2026-07-27; Overdue by 14 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-a35bdb4b025ea8328e07ed276541eb3a1478568a6cefe565db6a7b80c6292967 | Customer 8651 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7eab51d1081fe029fe36cc3bf7b33af888e81dbc4c1a960e7877c661020dd4fe | OPP-cc86c23e1fb65c7340de8979ab6e25050fb4db310c67520350d3d9fd01f3b2f9 | SER-60b8b41f16dffd3e8c0ebbbfa7e3b2efad9d4fddee3b81cdb1d037c15f4a87f8 | Not selected for publication; targeted context validation is still required. | **** | Foothill Care Partners, Inc. | 9091 | Vendor | MS | Overdue Reorder | Low | 46.97 | 238.5 | 81.8 | MicroGenics | 981712 — 981712 Indiko Tube Maintenance Solution | 3 completed purchases over 672 days; median interval 336.0 days; expected reorder 2026-08-11; Due Soon in 1 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-7eab51d1081fe029fe36cc3bf7b33af888e81dbc4c1a960e7877c661020dd4fe | Customer 9091 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7ca6a75b1669c79dfcc67736112dbca17bf90f7069ad8e07bbace38fb1eb49af | OPP-8dc25f82f0c321ae873715b7f5c9e8211c87b632f3122501bc5a09dd956e7a16 | SER-c7668a230f1a5aa1f6d420dbd56b5e2286e36b62592c9573852403208fd6dd2e | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Health System, Corp. | 7771 | HQ | NY | Overdue Reorder | Needs Validation | 80.44 | 2500 | 1287 | Beckman Access / DxI | A98856 — A98856 Beckman 25(OH) Vitamin D Reagent (for use on UniCel DxI Immunoassay Systems), 100 Determinations, 2 x 50 Tests | 13 completed purchases over 360 days; median interval 27.5 days; expected reorder 2026-08-12; Due Soon in 2 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Rosa Bishop (Practice Admin, Usman says she is a good resource if Usman not available) | CONFIRM_ACCOUNT | Candidate CAND-7ca6a75b1669c79dfcc67736112dbca17bf90f7069ad8e07bbace38fb1eb49af | Customer 7771 | Order 53003 | Item 10892 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dac4c81edd510fa8555088922fded3ecdae42cb08bba1422d2639eedd19ce004 | OPP-ee182c343081b8dbddd6ed4bfca74aa0af02faf9453011e4d477275cf425474b | SER-04547c58ac2072f0c6a323de30a10bec79f73c14559a417c03dc6b959c02d87a | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Medical Center, Corp. | 605 | HQ | NY | Overdue Reorder | Needs Validation | 77.3 | 1164 | 622 | Olympus / Beckman AU | OSR6279 — OSR6279 Olympus CK-NAC Reagent 4 x 490 Tests | 8 completed purchases over 747 days; median interval 103.0 days; expected reorder 2026-02-01; High Risk by 190 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ezra Kilbride | CONFIRM_ACCOUNT | Candidate CAND-dac4c81edd510fa8555088922fded3ecdae42cb08bba1422d2639eedd19ce004 | Customer 605 | Order 48652 | Item 12340 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c2d81115f995a2953466368b05f1ca5af808035915e92d71086372ef941ddb73 | OPP-2f47cfc0b9bc142edaedf1d43a480a085adc03fe3592e9e8ed9597aaad15b9a3 | SER-f7d3577e50733e94681cc6a26f2b453cabadca4ddf46509360e596445124446f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Reference Labs, Inc. | 8324 | HQ | NJ | Overdue Reorder | Needs Validation | 77.28 | 1444.12 | 611.82 | Bio-Rad | 592 — Bio-Rad 592 Immunology 2 Liq 6 x 1mL | 7 completed purchases over 662 days; median interval 123.0 days; expected reorder 2026-01-09; High Risk by 213 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 7 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Nadia Lofgren | CONFIRM_ACCOUNT | Candidate CAND-c2d81115f995a2953466368b05f1ca5af808035915e92d71086372ef941ddb73 | Customer 8324 | Order 47771 | Item 13496 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ab0162930b931f5e618a012b67f76fb1bce144d1ddb5f9b174e425d4dfb23ae9 | OPP-9a6cba1325d493816b8db517ec7d2769a062ae7992a3d960eb7faccb13a94ea9 | SER-3cb773ce15cb6fa745d22140e9d2e6af3f872366eea6d82756b569c007e28997 | Not selected for publication; targeted context validation is still required. | **** | Silverline Clinical Group, Inc. | 8342 | HQ | NJ | Overdue Reorder | Low | 76.61 | 1575 | 483 | Beckman Access / DxI | 37200 — 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | 13 completed purchases over 846 days; median interval 28.5 days; expected reorder 2026-05-13; High Risk by 89 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ab0162930b931f5e618a012b67f76fb1bce144d1ddb5f9b174e425d4dfb23ae9 | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5420f08a87459a0dcc84e00b5fb21d87aaefd31a761c8a685f3d7c6bbe084841 | OPP-908764a3aceccc85a502ee54d3a5e71b822786f9f022abdfdbc4727ce1f55d33 | SER-87ebaab884cab98705fd8ed887bdc13407523e0881b28ce67602273baf8719e0 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Reference Labs, Inc. | 8324 | HQ | NJ | Overdue Reorder | Needs Validation | 76.51 | 1328.28 | 774.83 | Bio-Rad | 593 — Bio-Rad 593 Immunology 3 Liq 6 x 1mL | 7 completed purchases over 662 days; median interval 123.0 days; expected reorder 2025-12-12; High Risk by 241 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 7 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Nadia Lofgren | CONFIRM_ACCOUNT | Candidate CAND-5420f08a87459a0dcc84e00b5fb21d87aaefd31a761c8a685f3d7c6bbe084841 | Customer 8324 | Order 47771 | Item 13497 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ecb41642ba8fa5feab34d556536cbfb26c6a2daa9f7bd09f0036db7cb8cf7e8b | OPP-635652c4e7e1e4f9c361c8626499b45c0c63a9bc12442474e19256516a0f877f | SER-6f2540ca87f82088979a6f7d40d06b18ab72866b9b6acb17788cc2e8912bb50e | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Reference Labs, Inc. | 8324 | HQ | NJ | Overdue Reorder | Needs Validation | 76.51 | 1328.28 | 774.83 | Bio-Rad | 591 — Bio-Rad 591 Immunology 1 Liq 6 x 1mL | 7 completed purchases over 662 days; median interval 123.0 days; expected reorder 2025-12-12; High Risk by 241 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 7 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Nadia Lofgren | CONFIRM_ACCOUNT | Candidate CAND-ecb41642ba8fa5feab34d556536cbfb26c6a2daa9f7bd09f0036db7cb8cf7e8b | Customer 8324 | Order 47771 | Item 13495 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-446902eda0f2998554dbe8ffe8bedf4baa3651a632879c8b473a56dc58408a47 | OPP-e2b301d912ac21234743876122d72da1f984ccfb1fd04c9e54e724c038d55fcc | SER-e7653b221da911be98dc5b98ef5151f26b27a51e08550c77d5272e31d32ee543 | Not selected for publication; targeted context validation is still required. | **** | Silverline Clinical Group, Inc. | 8342 | HQ | NJ | Overdue Reorder | Low | 75.8 | 910 | 420 | Beckman Access / DxI | A13422 — A13422 T3 FREE RGT 100/BX | 14 completed purchases over 987 days; median interval 28.0 days; expected reorder 2026-06-03; High Risk by 68 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-446902eda0f2998554dbe8ffe8bedf4baa3651a632879c8b473a56dc58408a47 | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78f7b8e331ee42ff2eb35a12d1efd5d795d9709754785468d63d4103b532e4fe | OPP-59e6c767078aab7deea30f881131b2101df4d1ebad613f37bacd41d41bc56851 | SER-5cc62d6ead5e5b949bb2a36bd220090a044a9e983e7e676ac7626fe8ddd85f71 | Not selected for publication; targeted context validation is still required. | **** | Silverline Clinical Group, Inc. | 8342 | HQ | NJ | Overdue Reorder | Low | 74.56 | 966.67 | 238.25 | Beckman Access / DxI | A12985 — A12985 TPO Antibody, Access, 2 x 50 tests - MUST ALL BE SAME LOT | 12 completed purchases over 759 days; median interval 35.0 days; expected reorder 2026-06-15; High Risk by 56 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-78f7b8e331ee42ff2eb35a12d1efd5d795d9709754785468d63d4103b532e4fe | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-89ef99c63f82dbb31a8bc3c53284e5e2adc613c83f9d260f0868df7d626c8d10 | OPP-3ae57ae2d5485de4a54b3b4de61388e38ebc51dec0a83e7b97b657adc9ac4428 | SER-a98867883d609569a0563e09edf65e6acb4bd685270e1b774466c407996fd5c8 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Health System, Corp. | 7771 | HQ | NY | Overdue Reorder | Needs Validation | 73.06 | 525 | 224 | Olympus / Beckman AU | OSR61205 — OSR61205 UIBC (Unsaturated Iron Binding Capacity) Reagent, 4 x 240 Tests | 10 completed purchases over 303 days; median interval 30.0 days; expected reorder 2026-06-27; High Risk by 44 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Rosa Bishop (Practice Admin, Usman says she is a good resource if Usman not available) | CONFIRM_ACCOUNT | Candidate CAND-89ef99c63f82dbb31a8bc3c53284e5e2adc613c83f9d260f0868df7d626c8d10 | Customer 7771 | Order 52077 | Item 11805 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4051d8fb44a0663af05acfcaef46f3e7448036525f64c16678dc09cc3e4bd6ee | OPP-3a17740af407eb6a39c603d91c9f92a5f972cd71b203b5398c638b32306e1356 | SER-692c6133e3f06d96d1751b26e2081a613e5ef4f11bf9096bd0d29d79786a580c | Not selected for publication; targeted context validation is still required. | **** | Silverline Clinical Group, Inc. | 8342 | HQ | NJ | Overdue Reorder | Low | 70.87 | 491.67 | 185 | Beckman Access / DxI | 33560 — 33560 Beckman Access Testosterone (REF) | 11 completed purchases over 861 days; median interval 27.5 days; expected reorder 2026-05-19; High Risk by 83 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-4051d8fb44a0663af05acfcaef46f3e7448036525f64c16678dc09cc3e4bd6ee | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1d6c7b8658651726ea4a2e0050c1a297ac1e63e004d6c61c1de6c875938eeb3f | OPP-9e9fd2ad49c12e68a0578e779292aac6d3af6ebcc3c3506424fc24ced6336e65 | SER-158f6d9661c5226cce9bf13cd0e8340a1b895b7f8bde834cee1721a1ee6c6528 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Crestview Health Collective, PLLC | 10326 | HQ | PA | Overdue Reorder | Needs Validation | 70.41 | 4500 | 479.8 | bioMerieux VIDAS | 30409 — 30409 VIDAS PROGESTERONE, 60 Tests | 13 completed purchases over 466 days; median interval 32.5 days; expected reorder 2026-09-01; Due Soon in 22 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Rosa Rowntree | CONFIRM_ACCOUNT | Candidate CAND-1d6c7b8658651726ea4a2e0050c1a297ac1e63e004d6c61c1de6c875938eeb3f | Customer 10326 | Order 53307 | Item 10368 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5dd886625e34c6bf2fe6e410198360e93485d74efdae096dc28cc3862f578074 | OPP-20c4de9b02891c890e592075c2f4e3d9cd713f424daa2ef7b8cf1bdc6482f62a | SER-f72c9389477d079b70007c37bf6e432bd1ad49dfeddb88a33996a0464450432a | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Health System, Corp. | 7771 | HQ | NY | Overdue Reorder | Needs Validation | 70.12 | 1200 | 965.65 | Olympus / Beckman AU | OSR6199 — OSR6199 C-Reactive Protein - Latex (Normal CRP) - Latex (High Sensitivity CRP) 4 x 30 mL R1 4 x 30 mL R2 | 6 completed purchases over 321 days; median interval 44.0 days; expected reorder 2026-08-02; Overdue by 8 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Rosa Bishop (Practice Admin, Usman says she is a good resource if Usman not available) | CONFIRM_ACCOUNT | Candidate CAND-5dd886625e34c6bf2fe6e410198360e93485d74efdae096dc28cc3862f578074 | Customer 7771 | Order 52690 | Item 11366 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-04e60a3dec4aa80f3775649e5f025d4b8dba88f889ef01b93230dffe604fcf14 | OPP-ee72342d9beb498b65f4e8fa3b71d65d23ba3745ddf691ac4266b5d986cffced | SER-3d1329f620add08b01548fa8ef7d768f20795dd4803a9a88e8703fb15c1ca389 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Medical Center, Corp. | 605 | HQ | NY | Overdue Reorder | Needs Validation | 69.3 | 377.57 | 143.9 | Olympus / Beckman AU | OSR6137 — OSR6137 Olympus CO2 Reagent (4x580 tests) | 13 completed purchases over 929 days; median interval 76.0 days; expected reorder 2026-06-26; High Risk by 45 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ezra Kilbride | CONFIRM_ACCOUNT | Candidate CAND-04e60a3dec4aa80f3775649e5f025d4b8dba88f889ef01b93230dffe604fcf14 | Customer 605 | Order 51579 | Item 11335 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-46bdf564796d0e55ac7272224ad3fbe9badef98ca6d2bd73556c42d96c744d97 | OPP-c6291e6d8c9ba40a69cd558bf0c0bacde844a9924f5b588576644996f9f26ae2 | SER-651e1fecb5a95533b1f9fc1613d3faf4fd984c02599d110a6438f0925b2885e9 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Health System, Corp. | 7771 | HQ | NY | Overdue Reorder | Needs Validation | 68.82 | 1491.67 | 565 | Olympus / Beckman AU | OSR61105 — OSR61105 Olympus RF Reagent(4x250 tests) | 6 completed purchases over 281 days; median interval 75.0 days; expected reorder 2026-07-25; Overdue by 16 days. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Rosa Bishop (Practice Admin, Usman says she is a good resource if Usman not available) | CONFIRM_ACCOUNT | Candidate CAND-46bdf564796d0e55ac7272224ad3fbe9badef98ca6d2bd73556c42d96c744d97 | Customer 7771 | Order 52077 | Item 11367 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c4c32338d94063c00a806eef465416700d32271b3708eaef008ee48a86937ba9 | OPP-c93ebc84defb6e742d13d13e1b9bd0fda1f0051bb9f5c1482f40ee5678af4544 | SER-6f189bddd9e79c4cdecfc387703226223d7df09144612eb75df594c2d4eb2347 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Reference Labs, Inc. | 7376 | HQ | MA | Overdue Reorder | Needs Validation | 68.77 | 894 | 452.61 | Olympus / Beckman AU | ODR2000 — ODR2000 Olympus Wash Solution, 4 x 5 L, AU 2700/ 5400 Series, DxC 700 | 40 completed purchases over 1071 days; median interval 30.5 days; expected reorder 2026-09-02; Due Soon in 23 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ian Jennerman (Primary, Lab Mgr) | CONFIRM_ACCOUNT | Candidate CAND-c4c32338d94063c00a806eef465416700d32271b3708eaef008ee48a86937ba9 | Customer 7376 | Order 53272 | Item 12246 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e4012a1d1232a894556742afc1c30d37eb5704e6e67cd6f80c1605170e1e69ed | OPP-f6fec8938adb634f23e68313fa31ecd8a758b478d13d30c8eb342f289f3ee9e5 | SER-95153d113e73a650c1ff40f3b3b6f3785ac748b07e367282373bc19f50a429a1 | Not selected for publication; targeted context validation is still required. | **** | Summit Health Collective, PLLC | 9210 | HQ | NY | Overdue Reorder | Low | 67.19 | 2732.93 | 920.22 | Parts Group | 10736515 — 10736515 Siemens EPOC BGEM BUN Test Cards (Detectable Analytes - pH, pO2, pCO2, Na+, K+, Ca++, Cl-, Glucose, Lactate, Creatinine, Hct, TCO2, BUN), PKG/25 Tests | 3 completed purchases over 524 days; median interval 262.0 days; expected reorder 2026-02-25; High Risk by 166 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e4012a1d1232a894556742afc1c30d37eb5704e6e67cd6f80c1605170e1e69ed | Customer 9210 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9471c3849747a12f725558bf70609cab8b1f5874f15fefa00f47289360a3575e | OPP-5025167553f82b8ce1ebcbbd60e9b1d17171ca5e02bda47fee14dfdd3848816c | SER-7ee7168f47bcc2fe049141054897b95375c2757050492b2b0bd5a6e962f47349 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Low | 65.89 | 881.67 | 682.35 | Beckman Access / DxI | 37200 — 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | 3 completed purchases over 22 days; median interval 11.0 days; expected reorder 2026-04-03; High Risk by 129 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-9471c3849747a12f725558bf70609cab8b1f5874f15fefa00f47289360a3575e | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8a05a8dc8f7b4395c7dfa224b02169731aef90b7112ebb5bfbb9118536d0f117 | OPP-2a0e8f07ab6cb8b88cb949a01f13511c7292ea3389eb75dcaa1427baa2ca82c1 | SER-786bd99bf6b225b9a5e04950bbde1db3eabb2a2660fed74f9a0b780aedc9ac22 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bridgeport Diagnostics, Corp. | 5592 | HQ | NY | Overdue Reorder | Needs Validation | 64.34 | 399.05 | 552.08 | Beckman Access / DxI | 33510 — 33510 BECKMAN ACCESS hLH, 100/BX | 20 completed purchases over 1015 days; median interval 45.0 days; expected reorder 2026-09-03; Due Soon in 24 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Aaron Garrow | CONFIRM_ACCOUNT | Candidate CAND-8a05a8dc8f7b4395c7dfa224b02169731aef90b7112ebb5bfbb9118536d0f117 | Customer 5592 | Order 52670 | Item 4954 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b22bbff6a9935ea4842b2571373d19c7b0fd4fd96fe7238c35eb38d27b39ce91 | OPP-4478ef97cd63aadb3f12500019ed93e44272fcaf248ce41f24938ff558f305fc | SER-2a8adfc76f78b1c6482c9a7abce9d6bb7e1673bc01d69e85a725a1b7f612d68b | Not selected for publication; targeted context validation is still required. | **** | Silverline Clinical Group, Inc. | 8342 | HQ | NJ | Overdue Reorder | Low | 63.62 | 158 | 25 | Olympus / Beckman AU | OSR60118 — OSR60118 Triglycerides reagent 4x20/4x5mL 4/Kt | 7 completed purchases over 876 days; median interval 59.5 days; expected reorder 2026-05-11; High Risk by 91 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b22bbff6a9935ea4842b2571373d19c7b0fd4fd96fe7238c35eb38d27b39ce91 | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3918fcef18e2203f8a4d6b5e513255c26b5077858b6004ea80e7697d0a47273a | OPP-60a94a62714a0fc311e8b442c0fb47639eb6d4b2b19dcd8ec1307ad5265c2d9a | SER-b09f1c6bd36e2a0f123dd2b67fee589dec3af9583993967cb8fbac2cc7caa53a | Not selected for publication; targeted context validation is still required. | **** | Silverline Clinical Group, Inc. | 8342 | HQ | NJ | Overdue Reorder | Low | 63.57 | 1277 | 178.13 | Beckman Access / DxI | 33020 — 33020 BECKMAN ACCESS FERRITIN RGT 100/BX | 12 completed purchases over 1067 days; median interval 44.0 days; expected reorder 2026-09-06; Due Soon in 27 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-3918fcef18e2203f8a4d6b5e513255c26b5077858b6004ea80e7697d0a47273a | Customer 8342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-824e8c31ea414077130a44507f97c43fd1f908933c54bbf7bdf62eb5f340a3c0 | OPP-97b583718374466965382b3c6fe4b90ee31b0ea4de713ef0b69c074d852e21fd | SER-27d76d725e3fc5ad4ff508f2a43c56f3bafbc4d5011da00a84f82128e9ef6d82 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Medium | 62.59 | 315.56 | 67.62 | Beckman Access / DxI | 386167 — Beckman 386167 Reaction Vessels, UniCel DxI 800, 1000/bag, 10 bags/box | 7 completed purchases over 156 days; median interval 14.5 days; expected reorder 2026-07-14; Overdue by 27 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-824e8c31ea414077130a44507f97c43fd1f908933c54bbf7bdf62eb5f340a3c0 | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ce41b57097b8cebc01447307ff23a258d9ad6471a75470177f490f437d806022 | OPP-d01362591f790061d2473550b833b2a969cb51033f92fad07856d09fdcb81f54 | SER-72f13443989687b0807dceaeb6de91bdd2a117d14cde98d12ed11ef6baa714e4 | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 62.59 | 189 | 140 | Olympus / Beckman AU | OSR6132 — OSR6132 Olympus TP Reagent (4x750 tests) | 9 completed purchases over 860 days; median interval 104.5 days; expected reorder 2026-06-05; High Risk by 66 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ce41b57097b8cebc01447307ff23a258d9ad6471a75470177f490f437d806022 | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-832dc80e1ddeb7b50e34c5cf0965a893abc78381872d047209a20b3f20a35b87 | OPP-43da0357bc451b92f2d3a94adc7de2718860ca0414926dddf1a2abb7bf5d657e | SER-e7ddca0bf3dc1a2a23ba09455f75c8603a2e3d3f607d8f8a0659b012e789ed5f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Medical Center, Corp. | 605 | HQ | NY | Overdue Reorder | Needs Validation | 62.38 | 212 | 134 | Olympus / Beckman AU | OSR6189 — Olympus OSR6189 MAGNESIUM REAGENT (4x250 tests) | 18 completed purchases over 993 days; median interval 48.0 days; expected reorder 2026-08-16; Due Soon in 6 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ezra Kilbride | CONFIRM_ACCOUNT | Candidate CAND-832dc80e1ddeb7b50e34c5cf0965a893abc78381872d047209a20b3f20a35b87 | Customer 605 | Order 52625 | Item 10575 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-098666957f0ea0bf7fd4df2feed03c74b03c4261db5ecfb4f97fcbb5d3f98da6 | OPP-a21e7721efae8e327c02ed55669676f4bc25d47fcfa0a11879956924bc2ebf70 | SER-aaf9756c8fe0d6b588b9942b2c4aeecc898cd5d276443ee19a9297c609a71be2 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Clinical Partners, PLLC | 9506 | HQ | MA | Overdue Reorder | Low | 62.34 | 152 | 76.08 | Beckman Access / DxI | A16792 — A16792 Beckman Access Wash Buffer, Pkg/4 bottles, 1.9 L/bottle | 7 completed purchases over 764 days; median interval 64.0 days; expected reorder 2026-06-06; High Risk by 65 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-098666957f0ea0bf7fd4df2feed03c74b03c4261db5ecfb4f97fcbb5d3f98da6 | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-0f92b0a74302053febc8f051da880abbf3955213dcb746870832f12f4e44e0f0 | OPP-576884b0739d4d29cc8de68fa2fc544c20681f52d8c464afc25b2867e4961bd4 | SER-45112e9fad88f833ee552a09ee7c237d09c4955c01aabad6b60f7df046efd87e | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 62.06 | 225 | 112 | Olympus / Beckman AU | OSR61205 — OSR61205 UIBC (Unsaturated Iron Binding Capacity) Reagent, 4 x 240 Tests | 8 completed purchases over 819 days; median interval 76.0 days; expected reorder 2026-06-16; High Risk by 55 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-0f92b0a74302053febc8f051da880abbf3955213dcb746870832f12f4e44e0f0 | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c501f07a7285e6da0198c3e2fc0d44ab06f8985961b59c640c2b7cdb6effd222 | OPP-12d64fe0ce2cfb160cdd17405fd4d6afdc417fed07384e5442af916b1b4eb17a | SER-57c17259276e4432a568083a52137a7ee214923da86f69f98f5d12e13241edfb | Not selected for publication; targeted context validation is still required. | **** | Bellwood Medical Group, Inc. | 7389 | HQ | NY | Overdue Reorder | Medium | 61.98 | 521 | 109.11 | Olympus / Beckman AU | MU919600 — MU919600 Beckman CL Electrode | 5 completed purchases over 742 days; median interval 188.5 days; expected reorder 2026-02-26; High Risk by 165 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-c501f07a7285e6da0198c3e2fc0d44ab06f8985961b59c640c2b7cdb6effd222 | Customer 7389 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ef3975523eb49942bf49499b79304838bcfc6e25c9202dad4eec1faa1d912c4d | OPP-42a3622d5ab3347e0619b4e83b24615917094101c13d11c90fbaa60a7365f523 | SER-74ffefcf3af57d04d0d6303563057c89545606418a49a120c3cc394c34b4aa7f | Not selected for publication; targeted context validation is still required. | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | NY | Overdue Reorder | Medium | 61.86 | 293.18 | 268.18 | Olympus / Beckman AU | OSR6189 — Olympus OSR6189 MAGNESIUM REAGENT (4x250 tests) | 12 completed purchases over 523 days; median interval 33.0 days; expected reorder 2026-08-26; Due Soon in 16 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ef3975523eb49942bf49499b79304838bcfc6e25c9202dad4eec1faa1d912c4d | Customer 44663 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5d8af44b9cef425f487c037beeeef4aa2028d74b5aeff92d32303d7ac4d9e011 | OPP-da57a80f17545d838d5617b47580f2e501784ab36177fd91c66b8fad8eae59a6 | SER-c2178115927010a953a209aa15d4ce302c4dc15d92920c74643bd61229fba82c | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 61.7 | 503.47 | 413.4 | Beckman Access / DxI | 33000 — 33000 Beckman Access B12 Reagent 100/BX | 28 completed purchases over 1029 days; median interval 28.0 days; expected reorder 2026-08-17; Due Soon in 7 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-5d8af44b9cef425f487c037beeeef4aa2028d74b5aeff92d32303d7ac4d9e011 | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3412ab771b695520754dec2671e28f179c22e92159e012a0af86bbd74f640919 | OPP-865217f28393b3a765d22f305f3da13724e4073ab639aa76aa4aceaf51b20515 | SER-177bcb7532adf2799f47141677cec2e06c2646acef7aa614be8a8f243f830f54 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Low | 61.68 | 360 | 191.25 | Beckman Access / DxI | A98032 — A98032 Beckman Access Folate Reagent | 3 completed purchases over 16 days; median interval 8.0 days; expected reorder 2026-04-16; High Risk by 116 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-3412ab771b695520754dec2671e28f179c22e92159e012a0af86bbd74f640919 | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-511da45fc0934d4b00f46ddfc661b899d81f35c6006569952c0e433c14755e9b | OPP-8c47e0f374f5833cc62d18c81ffa53e5ec2f5c1dcd184914490d52475fb7a4bd | SER-c8c7634fa52392e37c52621c2185770f5cce9a02bdf98e9345a139b49e2908b5 | Not selected for publication; targeted context validation is still required. | **** | Northgate Analytical Labs, LLC | 4329 | HQ | PA | Overdue Reorder | Medium | 61.51 | 247 | 138 | bioMerieux VIDAS | 30706 — 30706 BioMerieux VIDAS System Quality Control QCV Strips, Pkg/60 | 6 completed purchases over 797 days; median interval 168.0 days; expected reorder 2026-06-08; Overdue by 63 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-511da45fc0934d4b00f46ddfc661b899d81f35c6006569952c0e433c14755e9b | Customer 4329 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5c4f9d99c21092ad2151d1c96a61351ef929c2f50758d4163aecb2c56b699ff6 | OPP-f6c330c1bcf265b6565eaede3d6d25154b770e3a4eb26a79d32bba35490f4efe | SER-1bdc7a03e4dc801b535523808f3e7d7b7b364ec674ef0442d7cef162b1403fcc | Conflicting cost evidence produced a negative and reversed GP range. Margin is unknown until cost and pricing are validated. | **** | Sequoia Clinical Partners, PLLC | 9506 | HQ | MA | Overdue Reorder | Needs Validation | 61.42 | 422.23 | — | MicroGenics | T-10016154 — Thermo Kit EtG Rgt DRI CJF | 11 completed purchases over 407 days; median interval 47.5 days; expected reorder 2026-08-18; Due Soon in 8 days. | Classification: End-User Laboratory (High). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Default vendor lead time: 1 days. Activity review: 20 most recent deduplicated meaningful CRM/email logs were reviewed; latest 2026-05-06. 35 logs matched the SKU, product, platform, quote, or relevant commercial/technical terms. Examples: 2025-06-23 — f | 2025-06-18 — au point reagents | 2025-06-09 — f. Customer record is active. Current vendor lead time: 1 days. | Conflicting cost evidence produced a negative and reversed GP range. Margin is unknown until cost and pricing are validated. | Piper Halbrook (Operations Manager) OM | MANAGER_REVIEW | Candidate CAND-5c4f9d99c21092ad2151d1c96a61351ef929c2f50758d4163aecb2c56b699ff6 | Customer 9506 | Order 52723 | Item 11553 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-93aaba3634cef0bda34234973cbf63396911375b76ee40164acd90a2cac8589f | OPP-4f7e5e0d57151fbd79185fdee9d321dd35b47a9a7dd671fa03eb0dbcc46eea7c | SER-819a5ec21f78eb2735fd4eec3c252ab403650f239f6b0da1f71f67419883134c | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Low | 61.42 | 227.33 | 108.23 | Beckman Access / DxI | 33880 — 33880 BECKMAN ACCESS FREE T4 RGT 100/BX | 6 completed purchases over 66 days; median interval 8.0 days; expected reorder 2026-04-19; High Risk by 113 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-93aaba3634cef0bda34234973cbf63396911375b76ee40164acd90a2cac8589f | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ed0844834f309364d2b5cb8535fa9855343ab781c1f00ca56858c9f8121280c1 | OPP-c54891d29b951a89b19dc0d7174f674f11b6723a092e07bbeae02287e71f7f4a | SER-2ccbceeeb69f3f0a602d7fd4b35906ca7d519b4a032040a7b11032fa344d887a | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Medium | 61.24 | 474.67 | 95.45 | Beckman Access / DxI | 33830 — 33830 BECKMAN ACCESS TOTAL T3 RGT 100/BX | 8 completed purchases over 176 days; median interval 22.0 days; expected reorder 2026-08-10; Due Soon by 0 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ed0844834f309364d2b5cb8535fa9855343ab781c1f00ca56858c9f8121280c1 | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e620ad76bf0e10a6dd8bd765d2de15c48498ebdf79d8c96d870d8c73b9b29b54 | OPP-6dd65d6cd64f081ba2b91b7b49854ba2174f73bd4ac39a5882cbc7a65bacf944 | SER-946802e6678014b20d7498250e12d948d37007a8803cf724905c4a11925d120c | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 60.98 | 875 | 743 | Beckman Access / DxI | 37200 — 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | 10 completed purchases over 935 days; median interval 99.0 days; expected reorder 2026-08-31; Due Soon in 21 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e620ad76bf0e10a6dd8bd765d2de15c48498ebdf79d8c96d870d8c73b9b29b54 | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7164a618f767fc7dc721e82bfe4dc1fca0d438dfb73fa764821d58a99ef2df3e | OPP-dd9fa88f953bad9ed70d83dd77dc4b88330db1977225e6ef60b82ba39e8146d9 | SER-d317c15736aad59476cc58e43e4c1163a5372c63c47c166942eb0d4f1c021e27 | Not selected for publication; targeted context validation is still required. | **** | Alderbrook Clinical Partners, PLLC | 44961 | HQ | WA | Overdue Reorder | Medium | 60.91 | 370.64 | -115.54 | MicroGenics | T-10014585 — Thermo Kit Amphetamine Rgt DRI | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-7164a618f767fc7dc721e82bfe4dc1fca0d438dfb73fa764821d58a99ef2df3e | Customer 44961 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ce6328d5dc5aa0de3ecc3d1a644cde76cbc32e71a21b1115a4008427ebbab518 | OPP-1e7988326812eea3c56931816fe5f7625e166b47138b061d4d34d8a42978bc22 | SER-a6227042a1aeb2694bd7eecc190a5f82e48d0829397cd0332ddce6dd1b0ad616 | Not selected for publication; targeted context validation is still required. | **** | Alderbrook Clinical Partners, PLLC | 44961 | HQ | WA | Overdue Reorder | Medium | 60.91 | 370.64 | -122.44 | MicroGenics | T-10014601 — Thermo Kit Opiate Rgt DRI | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ce6328d5dc5aa0de3ecc3d1a644cde76cbc32e71a21b1115a4008427ebbab518 | Customer 44961 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a60064f0beb8aa6d8b8dfc812b3f4fc109c00ebbd3d7baa59ac9518f74cc7e1a | OPP-35a47c37bed7a0107a0c232b70a98e949953f6961dcbe44f61fc5588f4e484f2 | SER-adafe9c7defec708734ab1596c1416deb7e6b702c2c3050ee870e3c661f47fa5 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Low | 60.84 | 413.33 | 88.16 | Beckman Access / DxI | A48617 — A48617 Beckman Access SHBG RGT 2x50T | 3 completed purchases over 16 days; median interval 8.0 days; expected reorder 2026-04-16; High Risk by 116 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-a60064f0beb8aa6d8b8dfc812b3f4fc109c00ebbd3d7baa59ac9518f74cc7e1a | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a9784c8aa908b6bc2c936a03405ce0ea6d0630ae4e73855400a9f540b455c6e3 | OPP-86b65d158ead18bf7240e49a62ac653028a2391497b5ec6af7a66c2873ec2493 | SER-b24f35038a43f5f65f6daa822100a5747aa203ec5e32e7097b5bb48ad21bf47d | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Medium | 60.76 | 425 | 186.5 | Beckman Access / DxI | 33560 — 33560 Beckman Access Testosterone | 4 completed purchases over 51 days; median interval 8.0 days; expected reorder 2026-04-13; High Risk by 119 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-a9784c8aa908b6bc2c936a03405ce0ea6d0630ae4e73855400a9f540b455c6e3 | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-aec160f274b014085a8e6e5203781b14c68f9fd3b167cfc8d7f0e2faec5e9f6d | OPP-99ae757543ff34529386b8e1a6d14a4e3d943a76b9f4c706f8dc5aa37bcbba37 | SER-9fb263c5a8f20775c76539919ebcd537b30de8cadee635434d15c6dc23ca2453 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | Vendor | NJ | Overdue Reorder | Medium | 60.47 | 250 | 70.9 | Globe Scientific | 3469 — ESR: Sedi-Rate Westergren System, Pipettes and Citrate Vials, 100 Tests | 4 completed purchases over 100 days; median interval 34.0 days; expected reorder 2026-07-06; High Risk by 35 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-aec160f274b014085a8e6e5203781b14c68f9fd3b167cfc8d7f0e2faec5e9f6d | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5dfb0d93d2a1d165a881465893a95a06e900b3200f3902aba306bbcfae67cecb | OPP-da8279c6f4773748cabe08765f943697ad3f1ac3ab33163e76f1ca547e5b51cf | SER-caa7a5ae71fd27878ce8460ce669f515b685b4bb1bfcb43d89b8bc42a3bf810b | Not selected for publication; targeted context validation is still required. | **** | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | WA | Overdue Reorder | Low | 60.21 | 184.08 | 23.01 | MicroGenics | 980929 — 980929 Indiko Wash Solution, 4.5% | 3 completed purchases over 203 days; median interval 101.5 days; expected reorder 2026-02-15; High Risk by 176 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-5dfb0d93d2a1d165a881465893a95a06e900b3200f3902aba306bbcfae67cecb | Customer 44961 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dcaf625b90e05f9d767f0e8a3ca0d4903bbc3b8b3c331f785c93b6ad9158a18c | OPP-df4aa375c50be6bcf2d75c098db96f32a0bf9ef3f40e9c2ae93b9f32565ef9f7 | SER-7e7cfe189b68a9072cc00308b1ba65a542e77e29961f4a0d30767077e01a68f0 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | MA | Overdue Reorder | Medium | 60.01 | 165.2 | 36.97 | Horiba | 5390013099 — Calcium (CPC) Reagent - AU | 8 completed purchases over 378 days; median interval 51.0 days; expected reorder 2026-08-18; Due Soon in 8 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-dcaf625b90e05f9d767f0e8a3ca0d4903bbc3b8b3c331f785c93b6ad9158a18c | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c03666a6567f7b805642df4b1d91550d4c6c28a8ce1de4a474fba28c6ecec67f | OPP-520529266b99de1e12aa8e184c9c0523533d1e4257be01c58eddc7b1d02dc4f5 | SER-718908b917f2c070825d34d0e80d91b2a46d68ab5922e427842fa02fc1b76610 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cascade Clinical Group, Inc. | 44841 | HQ | NJ | Overdue Reorder | Needs Validation | 59.99 | 1480 | 675.96 | bioMerieux VIDAS | 30409 — 30409 VIDAS PROGESTERONE, 60 Tests | 5 completed purchases over 298 days; median interval 71.0 days; expected reorder 2026-08-23; Due Soon in 13 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Wade Draycott | CONFIRM_ACCOUNT | Candidate CAND-c03666a6567f7b805642df4b1d91550d4c6c28a8ce1de4a474fba28c6ecec67f | Customer 44841 | Order 52314 | Item 10368 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-aaa8dccbaf2e992bb4650ff201d1249e30bd4483f9dc9cdd7632aeff14a06b3d | OPP-c0a85ea36f942d57b4886f75e1d13078659e7276267450d6b19687b84fb565ad | SER-00e96bcce44237c59cb42f2ec50194fa73cd2ab830331f4c065dde6337b3f3f9 | Not selected for publication; targeted context validation is still required. | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | NY | Overdue Reorder | Medium | 59.25 | 153.78 | 111.58 | Beckman Access / DxI | 33885 — 33885 Beckman Access FREE T4 CAL | 4 completed purchases over 249 days; median interval 81.0 days; expected reorder 2026-03-27; High Risk by 136 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-aaa8dccbaf2e992bb4650ff201d1249e30bd4483f9dc9cdd7632aeff14a06b3d | Customer 44663 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c1db28474fbcb5a9dfbb32574b325953b5fcd49c099355743267073ade74ea0f | OPP-68a6b356e8b1e91f7d93e0ee5039dc0956f0ffa49a33f6fd972a920b1b9e08df | SER-19fe3fe8c57c498a2c017656a2d740610b1d9277c7bd6e3408b66aad6e805869 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | MA | Overdue Reorder | Medium | 59.18 | 315 | 63 | MicroGenics | T-1797 — Thermo Kit Creat-Detect 500mL | 8 completed purchases over 365 days; median interval 57.0 days; expected reorder 2026-08-31; Due Soon in 21 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-c1db28474fbcb5a9dfbb32574b325953b5fcd49c099355743267073ade74ea0f | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5e6d408f0b542a207e34ef3c07ad258515f516d68af80fd02ad505ba49bffcfc | OPP-bde98fe574d0e0b227282a02ee4ddafc65f39f596642ff15640c4b39c8adc45f | SER-aa566ff58196f262aa87e2384d43afa61c831778236a01c071b6dd8c2d7428e5 | Not selected for publication; targeted context validation is still required. | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | NY | Overdue Reorder | Low | 57.94 | 296.27 | 228.42 | Olympus / Beckman AU | OSR6178 — Olympus OSR6178 CREATININE Reagent (4x990 tests) | 11 completed purchases over 523 days; median interval 29.5 days; expected reorder 2026-08-24; Due Soon in 14 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-5e6d408f0b542a207e34ef3c07ad258515f516d68af80fd02ad505ba49bffcfc | Customer 44663 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-83eb40f9ba59a597d5efb86800a15904ab2ebbaea44ea5f646fe51052b8f992b | OPP-93586c26e5329503328b309e155dd7e23691333416067de7ba595218eaa63b5d | SER-3fc44652ad0c52c67eb8aa017e80434cbce4b0f43b4f38970be65cd5cd2139ba | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Low | 57.89 | 966.67 | 949.3 | Olympus / Beckman AU | OSR6199 — OSR6199 C-Reactive Protein - Latex (Normal CRP) - Latex (High Sensitivity CRP) 4 x 30 mL R1 4 x 30 mL R2 | 3 completed purchases over 129 days; median interval 64.5 days; expected reorder 2026-09-04; Due Soon in 25 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-83eb40f9ba59a597d5efb86800a15904ab2ebbaea44ea5f646fe51052b8f992b | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-abc80fbd26bae2d8c096528850c6e461770a12e8e4a0b2d3645d7b77b5448761 | OPP-1249e12044db170db94d1cbd063865afcf0392c8698bea21af44554fd757e3b3 | SER-d86a821a952bcbfb6662468d3d2da86d4157307301c7b0f06c2407d044cfc3ac | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 57.69 | 1911 | 517.85 | Beckman Access / DxI | 98200 — 98200 Quidel Triage BNP Reagents for Access 2 | 4 completed purchases over 630 days; median interval 253.0 days; expected reorder 2026-07-29; Overdue by 12 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-abc80fbd26bae2d8c096528850c6e461770a12e8e4a0b2d3645d7b77b5448761 | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2446d81c0fcdcd04bc5b291c9f8caef76354f7cb64e1e37cdff8affdd090fc45 | OPP-c3e7fd5a65fc4382836b136dc8a3306644ae2bc3b5a26692fe2833bec0c20e84 | SER-3208d44d9962f9a6226644f1a450f3fcdc28fd445551a77074ee154f73b60407 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | MA | Overdue Reorder | Medium | 57.5 | 153.92 | 26.96 | Horiba | 5390013098 — Carbon Dioxide Reagent - AU | 13 completed purchases over 404 days; median interval 32.5 days; expected reorder 2026-09-03; Due Soon in 24 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-2446d81c0fcdcd04bc5b291c9f8caef76354f7cb64e1e37cdff8affdd090fc45 | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b69f53c1da6348c322c7830eee9cd2d2b9ac8a7c7572afdc4098a7775508b68a | OPP-15c9f2b0900fcf28bbc646872ef31aa8f3cdcf76c5ad0368199d256b80368a5d | SER-ce906ef9f743b35b168309d70e00018153b7d0a668cc677820278808f15aa147 | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 56.92 | 296.27 | 249.39 | Olympus / Beckman AU | OSR6178 — Olympus OSR6178 CREATININE Reagent (4x990 tests) | 13 completed purchases over 1027 days; median interval 68.0 days; expected reorder 2026-08-15; Due Soon in 5 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-b69f53c1da6348c322c7830eee9cd2d2b9ac8a7c7572afdc4098a7775508b68a | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7bea7d4079aeaaabdfbd3f2f7dd7aa96f69f2f1b64277318f244ac646b28910b | OPP-61ad1a648010572ae00e92579e789cd5c71bb82430b3291c35759550c34aa655 | SER-496787aa378e3db729deae7fc10eee0284855212d5cb1fee6deb1ffdd127ac0b | Not selected for publication; targeted context validation is still required. | **** | Bellwood Medical Group, Inc. | 7389 | HQ | NY | Overdue Reorder | Medium | 56.88 | 214.14 | 165.14 | Olympus / Beckman AU | OSR6132 — OSR6132 Olympus TP Reagent (4x750 tests) | 8 completed purchases over 966 days; median interval 122.0 days; expected reorder 2026-08-25; Due Soon in 15 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-7bea7d4079aeaaabdfbd3f2f7dd7aa96f69f2f1b64277318f244ac646b28910b | Customer 7389 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-1f121bf719a0cabdcc4a088b8eb888a4b17aa933f046f052ddb1d89cf9fa95a3 | OPP-5f90cd9f7c4f474d9698ae8913cd85f024475d70b9d00f0a3c4d0cee5c0b6001 | SER-61666cab66890272798471ccc0832da274002c1c416fff4d67d6d1b05a06febc | Not selected for publication; targeted context validation is still required. | **** | Bellwood Medical Group, Inc. | 7389 | HQ | NY | Overdue Reorder | Medium | 56.69 | 694.67 | 165.06 | Olympus / Beckman AU | MU919400 — MU919400 Beckman Na Electrode | 4 completed purchases over 742 days; median interval 273.0 days; expected reorder 2026-05-26; Overdue by 76 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-1f121bf719a0cabdcc4a088b8eb888a4b17aa933f046f052ddb1d89cf9fa95a3 | Customer 7389 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4f0ebd4f9885cbf4d14a86ee56ca7ab977ce3e5eb2399f461490a8c6a0367b0c | OPP-653c0717b5c2f78e88dd7376b72d42b9ec7370210f3d53a7e76ed441f637a918 | SER-0b632423317f472167eb42c48e61d271e2b434642ff5e5d0de5e0396124a46b9 | Not selected for publication; targeted context validation is still required. | **** | Northgate Health System, PLLC | 10250 | Vendor | NJ | Overdue Reorder | Medium | 56.56 | 309 | 57 | MicroGenics | T-1797 — Thermo Kit Creat-Detect 500mL | 7 completed purchases over 307 days; median interval 51.0 days; expected reorder 2026-09-05; Due Soon in 26 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-4f0ebd4f9885cbf4d14a86ee56ca7ab977ce3e5eb2399f461490a8c6a0367b0c | Customer 10250 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-69b5e6f620f0af35bcf23f927ca80b30aaf9c1ed64947871b14deb81f5d9d4a6 | OPP-e979ddff463cdbcccd1566745026835521279ff2bb0082e1063303eb5008fbda | SER-e3e1a66ea801d0ce70136a45d71c8ad2c209fa9911f612df0bd82fb1d595faae | Not selected for publication; targeted context validation is still required. | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | MA | Overdue Reorder | Low | 55.78 | 248.25 | 82.75 | MicroGenics | T-10009958 — Thermo Kit Gen Oxidant | 3 completed purchases over 182 days; median interval 91.0 days; expected reorder 2026-06-28; Overdue by 43 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-69b5e6f620f0af35bcf23f927ca80b30aaf9c1ed64947871b14deb81f5d9d4a6 | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c9addcd48778b1ee99a7fb76b2efa5ad95bd581f43b29d538ccb87e8eb0ef6a6 | OPP-7600dc623b17b6c4b94951f111f8fb05aee8b292ed9ffacc2f82148d5bf43c6a | SER-4226f1321281b926921bf753bdb53faf54fc121c4378d870eee7f18a25812ec8 | Not selected for publication; targeted context validation is still required. | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | NY | Overdue Reorder | Low | 55.6 | 176 | 91 | Beckman Access / DxI | B24839 — B24839 Access 25(OH) Vitamin D Calibrators (for use on Access 2 Immunoassay Systems) (S0-S5) | 3 completed purchases over 221 days; median interval 110.5 days; expected reorder 2026-05-17; High Risk by 85 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-c9addcd48778b1ee99a7fb76b2efa5ad95bd581f43b29d538ccb87e8eb0ef6a6 | Customer 44663 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dbc18fd189b9e4711d5605addbc76bc4a29ca7ddfe34507fb8b2df780fb9b974 | OPP-618b7b3280ee1897c5a3bfd8bd1064cd9f3e6c45a8ca159a338d45760311bf39 | SER-4a23e8d2de229367ff81555601a5383d4638201ec285f1caaccc182db0e1dee5 | Not selected for publication; targeted context validation is still required. | **** | Brightwater Health Alliance, LLC | 8501 | Vendor | CT | Overdue Reorder | Medium | 55.33 | 252.6 | 52.81 | Medica EasyLyte | 2121 — [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | 4 completed purchases over 242 days; median interval 109.0 days; expected reorder 2026-05-19; High Risk by 83 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-dbc18fd189b9e4711d5605addbc76bc4a29ca7ddfe34507fb8b2df780fb9b974 | Customer 8501 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2d87b178c020c3802caba753bbca364dc5a97248964819518cf099622993ddd4 | OPP-81e7b890513390b0cd0352b298208f18b9c60aabee0a20656b87795fd765291a | SER-27309c4661815aa44a50457e8be104556d128c38ac74cb56d10e8a23d5ac813d | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 55.17 | 207.78 | 108.78 | Beckman Access / DxI | A16792 — A16792 Beckman Access Wash Buffer, Pkg/4 bottles, 1.9 L/bottle | 24 completed purchases over 1062 days; median interval 42.0 days; expected reorder 2026-08-26; Due Soon in 16 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-2d87b178c020c3802caba753bbca364dc5a97248964819518cf099622993ddd4 | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e998f0077ed74b2db7c101c7f1c919e2329de1e659e7ad645fea40769eb35897 | OPP-9e2fd8fd14d48a03a2ea0e429a46b7742866a9bb1c150f433d87a9f7dbf3ebfc | SER-a6996cb8ae688e3f8a838a7894855112c2c7e4be053046460b362c01c36e1ba7 | Not selected for publication; targeted context validation is still required. | **** | Cedar Lab Services, LLC | 6977 | Vendor | NJ | Overdue Reorder | Medium | 52.91 | 152.53 | 38.72 | MicroGenics | T-100282 — Thermo Kit pH Detect Ctrl 3.6 | 7 completed purchases over 924 days; median interval 161.5 days; expected reorder 2026-09-09; Due Soon in 30 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e998f0077ed74b2db7c101c7f1c919e2329de1e659e7ad645fea40769eb35897 | Customer 6977 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ace98cd08b184e9ee4cd3709329a3df36d02c54ba1b81fd025894a6a450f7902 | OPP-cab62467ddaa8d4b6318d180b0192789e788ce853e7bc84ea47fe282988ad0dc | SER-12cabf3782dabd780b513ac110d6b1319fb34131f7646091935df22d0f62aa73 | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Medium | 52.53 | 243.2 | 113.2 | Beckman Access / DxI | 33800 — 33800 BECKMAN ACCESS TOTAL T4 RGT 100/BX - Lot 439961 | 17 completed purchases over 1001 days; median interval 61.5 days; expected reorder 2026-09-07; Due Soon in 28 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ace98cd08b184e9ee4cd3709329a3df36d02c54ba1b81fd025894a6a450f7902 | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5da0a3279e43039e6ff81244160a701c7158fe702f904b0ec6b623307f1567ff | OPP-31eac9393c4310f087145e1f4445d02de35ba0179705d4518a05773e8964057d | SER-d4c567c636550c25961a5d336646ff9ebf27041946c66c9ddbc5ff38cb4c03ba | Not selected for publication; targeted context validation is still required. | **** | Sequoia Clinical Partners, PLLC | 9506 | Vendor | MA | Overdue Reorder | Medium | 52.41 | 264.49 | 53.49 | MicroGenics | T-100054 — Thermo Kit pH-Detect 500mL | 4 completed purchases over 304 days; median interval 87.0 days; expected reorder 2026-08-14; Due Soon in 4 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-5da0a3279e43039e6ff81244160a701c7158fe702f904b0ec6b623307f1567ff | Customer 9506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-aa72f10198b4ab9ea9d864090eaab08a3593abd9fe432ce34bd0d33a16ecb68a | OPP-817307557d1555555d4e5f3372f0b3e70a115ea245e4a1aa9a59dff0bf34fb31 | SER-ec081605347293dc342ebc168c1ff188dba039b2fc78f0be8522ba1c0dfc124f | Not selected for publication; targeted context validation is still required. | **** | Summit Analytical Labs, Inc. | 2550 | HQ | NY | Overdue Reorder | Low | 52.17 | 207 | 148 | Olympus / Beckman AU | OSR6112 — OSR6112 Olympus Total Bilirubin 4 x590 tests | 6 completed purchases over 602 days; median interval 76.0 days; expected reorder 2026-07-27; Overdue by 14 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-aa72f10198b4ab9ea9d864090eaab08a3593abd9fe432ce34bd0d33a16ecb68a | Customer 2550 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-353d6df8208aaf3acffdb2fab8f690bdb7d7196a57c1e9b924aed261b5d56c09 | OPP-cea5b243216c2b543f8ba62adf06294c4f45c0ac2ac03b9bb131ba3da3bb3dd6 | SER-2c96947ff24e58732f432df6cd62e910e373e6853d0fdf0950ce023782ffe0eb | Not selected for publication; targeted context validation is still required. | **** | Copperfield Laboratory Partners, Corp. | 44663 | HQ | NY | Overdue Reorder | Medium | 51.81 | 195 | 136.95 | Olympus / Beckman AU | OSR60118 — OSR60118 Triglycerides reagent 4x20/4x5mL 4/Kt | 6 completed purchases over 409 days; median interval 67.0 days; expected reorder 2026-09-09; Due Soon in 30 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-353d6df8208aaf3acffdb2fab8f690bdb7d7196a57c1e9b924aed261b5d56c09 | Customer 44663 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-76c07b56e7f2b20e5699d4f9beb38546e0242ea156ddfb26d9036bf0136ad613 | OPP-2c4fc0704c23447039035c631e0fe9c8dabc62c000f13aa8f09b38f0af1b60d4 | SER-7e0061a3f539b30b683921c2829784ca6fc227191589e336f2fc6f5fc6ae0bd4 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Low | 49.46 | 205.51 | 50.51 | Olympus / Beckman AU | OSR6179 — OSR6179 Olympus CK Reagent (4x230 tests) | 3 completed purchases over 124 days; median interval 62.0 days; expected reorder 2026-08-16; Due Soon in 6 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-76c07b56e7f2b20e5699d4f9beb38546e0242ea156ddfb26d9036bf0136ad613 | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-202e94a7daae9f5de98704ceca2a3c4d15f8eaf1868090fa2048a078734560d6 | OPP-04fdf87a77646830eac1a19d573b05b7d903849ea4dda10a4c196620923963bb | SER-bfdbc68ff8a84c43a28d8d43df3a4dcd9616ca7b3ca987fc16a6c2ad9cb50448 | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | HQ | NJ | Overdue Reorder | Low | 44.69 | 166.67 | 36.27 | Beckman Access / DxI | A16953 — A16953 Beckman Access Intact PTH Calibrators (S0-S5, RB), 1 set, S0-S5 - 1.0 mL, RB - 2 x 4.0 mL | 3 completed purchases over 126 days; median interval 63.0 days; expected reorder 2026-08-25; Due Soon in 15 days. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-202e94a7daae9f5de98704ceca2a3c4d15f8eaf1868090fa2048a078734560d6 | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4220d6e437aea24efb83d5d6faa5d881df1200a1d00c246de3eb618c460a226f | OPP-b35981debcff937acbca818a580770ce89d846c1ba3695cb8dd6089aa33cdcea | SER-007d751795f5c77c440e9f5d3ffc084459953d0f7db798c5f0d3d6a13ffbae2e | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | Unassigned / Needs Mapping | Bellwood Medical Center, PLLC | 3280 | HQ | — | Overdue Reorder | Needs Validation | 55.32 | 4228.77 | 1318 | Medica EasyLyte | 2108 — MEDICA EASYLYTE SOLUTIONS VALVE | 3 completed purchases over 547 days; median interval 273.5 days; expected reorder 2026-08-13; Due Soon in 3 days. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-4220d6e437aea24efb83d5d6faa5d881df1200a1d00c246de3eb618c460a226f | Customer 3280 | Order 49057 | Item 516 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-041598262f2c9362ce44d7e6eaf7166dbf9ed63ff941d1ad1a4acfaf88539e68 | OPP-cbf63370336fe0112afb2f39c9f20a63670f1ea7bf6a7fa53c1ae3a91a2a3098 | SER-a8eab42e9d94bf6765e86bdcb32b6b8d7cc79161d4cffb2d8ddffd786fd976b3 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Health Partners, LLC | 8145 | — | NC | Quote Leakage | Needs Validation | 87.75 | 37000 | 8060.5 | — | Quote 32065 | High-Margin Open Quote Without Activity on quote 32065; quote age 25 days; last modified 14 days ago; quoted value $74000.00; converted line value $0.00; unconverted line value $74000.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 32065: 50%/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Xander Xiong | CONFIRM_ACCOUNT | Candidate CAND-041598262f2c9362ce44d7e6eaf7166dbf9ed63ff941d1ad1a4acfaf88539e68 | Customer 8145 | Quote 32065 | Item 10617 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e80eae32fee4dc69aa212140bab3a3d926bec7d314337703222472d083f6fcd4 | OPP-9193380900be27b86b6b0075ced6d210a10d0c75a66725d60a7d74457fa4b0ea | SER-391a4cd42811333147a680a51bdfb20083e908f76cee704c08016e052d263207 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Lakeside Diagnostics, LLC | 9305 | — | MD | Quote Leakage | Needs Validation | 87.16 | 11264.6 | 5038.5 | — | Quote 28614 | Stale Open Quote on quote 28614; quote age 250 days; last modified 249 days ago; quoted value $56323.00; converted line value $0.00; unconverted line value $56323.00. | Classification: Unknown (Low). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 28614: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ezra Ulster | CONFIRM_ACCOUNT | Candidate CAND-e80eae32fee4dc69aa212140bab3a3d926bec7d314337703222472d083f6fcd4 | Customer 9305 | Quote 28614 | Item 10716 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b6b334aa6379b1777b66d8fe9514d5bc45752e2adb960794975474ee318f4f9f | OPP-b4e39246b1b633db583a571f7a20e6c286c10704bc4bdb952568865339ecbf2d | SER-9fb4fc323ff51a0bc1c4fe1b5959ea21af7cec6e51b074d8d2ea11578e267291 | Inactive Beckman AU480-R item 15527; verify actual unit availability. | **** | Summit Clinical Partners, LLC | 44635 | — | KY | Quote Leakage | Needs Validation | 83.98 | 7310 | 2438.7 | — | Quote 27124 | Stale Open Quote on quote 27124; quote age 357 days; last modified 341 days ago; quoted value $36550.00; converted line value $0.00; unconverted line value $36550.00. | Classification: Physician-Office Laboratory (High). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 27124: Processing/Open. Vendor lead time unavailable or not relevant. Activity review: all 5 available deduplicated meaningful CRM/email logs were reviewed; latest 2026-06-02. 3 logs matched the SKU, product, platform, quote, or relevant commercial/technical terms. Examples: 2026-06-02 — f | 2025-02-19 — Service | 2025-02-12 — Intro. Website reviewed: https://www.blockscientific.com/. Customer record is active. Target item is inactive; publication requires explicit validation. | Inactive Beckman AU480-R item 15527; verify actual unit availability. | Cole Isakov | VERIFY_INVENTORY | Candidate CAND-b6b334aa6379b1777b66d8fe9514d5bc45752e2adb960794975474ee318f4f9f | Customer 44635 | Quote 27124 | Item 15527 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b8f2a4c8bed4d27ccc4a727286b33e62788a6a44058812c3a61c99e8c16185bb | OPP-890ec71123745d2d1961b46056827b7fc2c96cee17dd80612f6f6813213026eb | SER-a3f17026bf2286385943fdd6d667747ae5bd1364dfdb0e50741db04122af1490 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Physician Group, PLLC | 8457 | — | TN | Quote Leakage | Needs Validation | 78.59 | 15400 | — | — | Quote 26865 | Stale Open Quote on quote 26865; quote age 378 days; last modified 335 days ago; quoted value $77000.00; converted line value $0.00; unconverted line value $77000.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 26865: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jenna Zellner | CONFIRM_ACCOUNT | Candidate CAND-b8f2a4c8bed4d27ccc4a727286b33e62788a6a44058812c3a61c99e8c16185bb | Customer 8457 | Quote 26865 | Item 13377 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7c89c2c05276719425472276ef1f01be6dbc81dbcd3fb01fe81a6afecc23f117 | OPP-636c2a2b3854aeb58fce49cbae98277756a8bddc484c8aef855a2a4747c27410 | SER-be53aa44673f3b272f46957bc7a6f79a53e8e6bfb44f32374bc02ab36cb33812 | Inactive Beckman AU480-R item 15527; verify actual unit availability. | **** | Summit Medical Partners, LLC | 9966 | — | NC | Quote Leakage | Needs Validation | 78.29 | 8030 | 3658.7 | — | Quote 26939 | Stale Open Quote on quote 26939; quote age 372 days; last modified 371 days ago; quoted value $40150.00; converted line value $0.00; unconverted line value $40150.00. | Classification: End-User Laboratory (High). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 26939: Processing/Open. Vendor lead time unavailable or not relevant. Activity review: 20 most recent deduplicated meaningful CRM/email logs were reviewed; latest 2026-01-07. 20 logs matched the SKU, product, platform, quote, or relevant commercial/technical terms. Examples: 2025-02-14 — Service Call | 2024-09-03 — Update | 2024-09-03 — UPDATED PRICE COMPARE. Customer record is active. Target item is inactive; publication requires explicit validation. | Inactive Beckman AU480-R item 15527; verify actual unit availability. | Xander Halbrook | VERIFY_INVENTORY | Candidate CAND-7c89c2c05276719425472276ef1f01be6dbc81dbcd3fb01fe81a6afecc23f117 | Customer 9966 | Quote 26939 | Item 15527 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-54f89cc507f838990d8e8f2c66d5cc5f8ba28fc1e47dd3ac1828f97c39034c2a | OPP-ebcd05162d1c8684b77c2d9dfab034be8a9bf76f424b3bfce796fdb7584f7ae6 | SER-66c92fd516785e2818681dea8b4963239eb92ed901fa21fb689b688d54961cd9 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Diagnostic Labs, Inc. | 5778 | — | — | Quote Leakage | Needs Validation | 77.03 | 5591.25 | 908.25 | — | Quote 24805 | Stale Open Quote on quote 24805; quote age 539 days; last modified 538 days ago; quoted value $27956.25; converted line value $0.00; unconverted line value $27956.25. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 24805: Processing/Open. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Fiona Draycott | CONFIRM_ACCOUNT | Candidate CAND-54f89cc507f838990d8e8f2c66d5cc5f8ba28fc1e47dd3ac1828f97c39034c2a | Customer 5778 | Quote 24805 | Item 10846 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7b9f9416b68ea33479b708e070ea84187bdb4ae66e2c714b3825a63104167694 | OPP-7c0798794419eb1a29c94468fb7ca0a1f79c147a042ec9089600aa39ad83d78e | SER-02ad732f326372f8be4a71f250c21b68178102a6c2a77b1f55f0212f7aceea7f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Foothill Medical Group, Inc. | 8441 | — | — | Quote Leakage | Needs Validation | 76.55 | 16490 | 9961.43 | — | Quote 26901 | Stale Open Quote on quote 26901; quote age 376 days; last modified 371 days ago; quoted value $82450.00; converted line value $0.00; unconverted line value $82450.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 26901: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Rosa Carrow | CONFIRM_ACCOUNT | Candidate CAND-7b9f9416b68ea33479b708e070ea84187bdb4ae66e2c714b3825a63104167694 | Customer 8441 | Quote 26901 | Item 10617 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c5f329a6c206ec94cd7768107ec6fdf03c290a32b3c4ffbe39242959a351e9b0 | OPP-f72ad815a710bb2ee99a302e5e6ca2748c8636afeec401e22912f87a9e02b714 | SER-85be55d71246613ef97d0e42c07272d8eb3b3b552aac2d5d45e7f9b23073dc88 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Physician Group, PLLC | 8457 | — | TN | Quote Leakage | Needs Validation | 75.45 | 10440 | 8415 | — | Quote 27202 | High-Value Lost Quote Recovery on quote 27202; quote age 354 days; last modified 349 days ago; quoted value $52200.00; converted line value $0.00; unconverted line value $52200.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27202: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Item appears inactive; validate replacement or supersession before quoting. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Jenna Zellner | CONFIRM_ACCOUNT | Candidate CAND-c5f329a6c206ec94cd7768107ec6fdf03c290a32b3c4ffbe39242959a351e9b0 | Customer 8457 | Quote 27202 | Item 6962 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8ea46246306f929396da19c3558bef53efb7e2f6d14536be12052f1d03d771f1 | OPP-eb6cb236776d1483b7c99e7dfdd5adf453b4e89122136b6a0d6592ccff84a08b | SER-aab345e414ca93b7f3dadc3312592c7d70f0ab743dad8ea26ad5fa577dc42afe | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Health Partners, LLC | 8145 | — | NC | Quote Leakage | Needs Validation | 72.27 | 27587.25 | — | — | Quote 31952 | Repeated Unconverted Quote on quote 31952; quote age 29 days; last modified 27 days ago; quoted value $110349.00; converted line value $0.00; unconverted line value $110349.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 31952: 25%/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Xander Xiong | CONFIRM_ACCOUNT | Candidate CAND-8ea46246306f929396da19c3558bef53efb7e2f6d14536be12052f1d03d771f1 | Customer 8145 | Quote 31952 | Item 17704 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-22ca9eef4a4a6a611d25500337246c6f9223ad607d8096c332472b355416e028 | OPP-27947dabc1939d4947769c4191fd8dfc871fe5702062ac141e757662bc91678e | SER-51aa19cea4adf2402707f61b5e545a2e8c32afcbaf0aa6a272c34de10a8fdbb8 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Health System, LLC | 7777 | — | ON | Quote Leakage | Needs Validation | 72.03 | 4762.8 | 1112.84 | — | Quote 31814 | Stale Open Quote on quote 31814; quote age 36 days; last modified 35 days ago; quoted value $23814.00; converted line value $0.00; unconverted line value $23814.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 31814: Processing/Open. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Aaron Quezada | CONFIRM_ACCOUNT | Candidate CAND-22ca9eef4a4a6a611d25500337246c6f9223ad607d8096c332472b355416e028 | Customer 7777 | Quote 31814 | Item 13498 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4d479f85b4dd5de102d25f08df4b958fa53886d2f6a59774dd81ea4e0a54b52d | OPP-86d75ba084dc818df148b99ff0b1e19f56976ef0e2aae76dccf56a8852660089 | SER-0d67db6ba31cb99c49b2749892f80a52f820fdf142b45666768583858b9da51e | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Sequoia Medical Partners, PLLC | 53594 | — | KY | Quote Leakage | Needs Validation | 71.06 | 1386.13 | 378.8 | — | Quote 29058 | Stale Open Quote on quote 29058; quote age 209 days; last modified 207 days ago; quoted value $6930.63; converted line value $0.00; unconverted line value $6930.63. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29058: Processing/Open. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Quinn Ibsen | CONFIRM_ACCOUNT | Candidate CAND-4d479f85b4dd5de102d25f08df4b958fa53886d2f6a59774dd81ea4e0a54b52d | Customer 53594 | Quote 29058 | Item 11567 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-83708aad99c534002fc2ffcaa1425aa7305e669e720fb541b88ccb3608ac76c3 | OPP-d9ddb9974d5cb51b92a9fd2b707b9ac0b9e14ff693abd3965ff292ca45c1935f | SER-67c7c12e846aa5a0321e42da9d4560cf4593be6a528683eaa0de71641b579736 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Health Collective, LLC | 9768 | — | KY | Quote Leakage | Needs Validation | 70.99 | 3140.56 | 434.88 | — | Quote 29873 | Stale Open Quote on quote 29873; quote age 147 days; last modified 146 days ago; quoted value $15702.81; converted line value $0.00; unconverted line value $15702.81. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29873: Processing/Open. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jenna Bishop | CONFIRM_ACCOUNT | Candidate CAND-83708aad99c534002fc2ffcaa1425aa7305e669e720fb541b88ccb3608ac76c3 | Customer 9768 | Quote 29873 | Item 11537 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7c161c4e512f07c37c18f57e8e7cd3f00d1e6b0df6ab2b4e75ab8eb147705305 | OPP-72676a0657ad417be4cf9e9d6fbc337095e7db82ee5b45c4f6738de29cd6334a | SER-0d2649d306e75a8d3001d69f5f6e58278e5a4ebbef63cb9d67a982644f481bb6 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Medical Partners, Corp. | 47700 | — | VA | Quote Leakage | Needs Validation | 68.76 | 1657.82 | 211.69 | — | Quote 28245 | Stale Open Quote on quote 28245; quote age 279 days; last modified 277 days ago; quoted value $8289.08; converted line value $0.00; unconverted line value $8289.08. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 28245: Processing/Open. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Cole Isakov | CONFIRM_ACCOUNT | Candidate CAND-7c161c4e512f07c37c18f57e8e7cd3f00d1e6b0df6ab2b4e75ab8eb147705305 | Customer 47700 | Quote 28245 | Item 11433 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-afd074bf840870d3d75c7a6701b2b4e11461470a3cade9ccedd904ce6cb81db3 | OPP-6e551a7748a259927df5b2f081f7ab0b89aa25efeb4a6bc5b7cb8cfbca9abc70 | SER-24754555f69bd3a9572fd518e324c874970ae512e05aa6b1abb7d9336aa1f50d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Analytical Labs, Inc. | 8673 | — | NC | Quote Leakage | Needs Validation | 66.36 | 6284 | — | — | Quote 25183 | Stale Open Quote on quote 25183; quote age 510 days; last modified 507 days ago; quoted value $31420.00; converted line value $0.00; unconverted line value $31420.00. | Classification: Unknown (Low). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 25183: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Hana Ulster | CONFIRM_ACCOUNT | Candidate CAND-afd074bf840870d3d75c7a6701b2b4e11461470a3cade9ccedd904ce6cb81db3 | Customer 8673 | Quote 25183 | Item 15789 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cec4d7014a1911139bf7133432936fb0dd55ccd3cc5fc056cf3b3cb507d45f2c | OPP-2dffcfac2dab5cb02221a4dac0fc12e5c5d135485dbbee879ed52026693e26ca | SER-d4b077a5146ef9eec9691c1437a98f5dcb9d872d11c7b7acfdd0822308886be6 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Pathology Associates, Corp. | 7815 | — | DHAKA | Quote Leakage | Needs Validation | 64.83 | 5830 | — | — | Quote 25446 | Stale Open Quote on quote 25446; quote age 489 days; last modified 488 days ago; quoted value $29150.00; converted line value $0.00; unconverted line value $29150.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 25446: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Sam Carrow | CONFIRM_ACCOUNT | Candidate CAND-cec4d7014a1911139bf7133432936fb0dd55ccd3cc5fc056cf3b3cb507d45f2c | Customer 7815 | Quote 25446 | Item 12017 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-726ea0cc198baf71e01d17b193c16bf42549ae63b0d94ed3d0c40bc4da0bc29c | OPP-695aa6d171a33667de746e71a4eba592a554ddbb14be3506e02bcd64da9ba443 | SER-486c838d5ef979c938bc1e8efbe01c358df8b6b92fc18e8afdfd49d9195d5a77 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bellwood Lab Services, Inc. | 42719 | — | — | Quote Leakage | Needs Validation | 62.15 | 6204.8 | — | — | Quote 22549 | Stale Open Quote on quote 22549; quote age 726 days; last modified 725 days ago; quoted value $31024.00; converted line value $0.00; unconverted line value $31024.00. | Classification: Unknown (Low). Customer active: false. No material CRM note was found in customer_detail. Quote context reviewed for quote 22549: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Miles Marrow | CONFIRM_ACCOUNT | Candidate CAND-726ea0cc198baf71e01d17b193c16bf42549ae63b0d94ed3d0c40bc4da0bc29c | Customer 42719 | Quote 22549 | Item 1653 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-df6bb0e8d8bafaa13116edf1dbbfb65fcbecdc6c27fb6526d9d764fcf860c7e3 | OPP-f576e6aff778578852f47e4ff69eef612ea252b70a714da7b83aa506f2813b8f | SER-038de47e754310d926af155057aa95b6cccca1c17eb554052ec63728328b03f5 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Health System, PLLC | 9403 | — | KY | Quote Leakage | Needs Validation | 60.45 | 5460 | 1461.49 | — | Quote 29109 | High-Value Lost Quote Recovery on quote 29109; quote age 204 days; last modified 124 days ago; quoted value $27300.00; converted line value $0.00; unconverted line value $27300.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29109: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Ian Ibsen | CONFIRM_ACCOUNT | Candidate CAND-df6bb0e8d8bafaa13116edf1dbbfb65fcbecdc6c27fb6526d9d764fcf860c7e3 | Customer 9403 | Quote 29109 | Item 10716 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8cf266ddb7801d3fc8957fa2cdb7dd57b92fc993361c6bb0fc49375139ebd217 | OPP-1c518435e348fb3795a9523bbe2ed9138a46fed8d6b0f0373e301adc174458d6 | SER-c824bb0c352331a82cf049fd0f6462bfd704458eb9061a72c65097bde394457f | Not selected for publication; targeted context validation is still required. | **** | Brightwater Health System, Inc. | 9289 | — | MD | Quote Leakage | Low | 60.38 | 2237.2 | — | — | Thermo-Indiko-Plus Proactive Plan — Plan includes unlimited technical support, one preventative maintenance visit per year, inclusive of parts, labor and travel related to the standard preventative maintenance service; unlimited repair calls per year; and a 24 hour onsite response time. Refer to plan service agreement for limitations, terms and conditions. | Stale Open Quote on quote 29712; quote age 159 days; last modified 157 days ago; quoted value $11186.00; converted line value $0.00; unconverted line value $11186.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-8cf266ddb7801d3fc8957fa2cdb7dd57b92fc993361c6bb0fc49375139ebd217 | Customer 9289 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-931d61e7626f20f5a4aefbdd8e2e104af86ab0dbac7c285ba25cd668e76d62dc | OPP-006f3488e181da9d9315e96cd6ea589164ed10aa649c89c88b2a5adf2ede1b4d | SER-d014189f54bc64e9d5e9df13fb7cec277746c21ef7d3f53d472fdcc6453e68b2 | Inactive Beckman AU480-R item 15527; verify actual unit availability. | **** | Copperfield Diagnostics, PLLC | 9363 | — | OH | Quote Leakage | Needs Validation | 89.19 | 10584.4 | 5513.1 | — | Quote 26324 | Stale Open Quote on quote 26324; quote age 420 days; last modified 419 days ago; quoted value $52922.00; converted line value $0.00; unconverted line value $52922.00. | Classification: End-User Laboratory (High). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 26324: Processing/Open. Vendor lead time unavailable or not relevant. Activity review: 20 most recent deduplicated meaningful CRM/email logs were reviewed; latest 2026-05-07. 10 logs matched the SKU, product, platform, quote, or relevant commercial/technical terms. Examples: 2025-12-18 — Approved by Jennifer | 2025-06-17 — service | 2025-06-16 — service. Customer record is active. Target item is inactive; publication requires explicit validation. | Inactive Beckman AU480-R item 15527; verify actual unit availability. | Ezra Palladino (Sindhu) | VERIFY_INVENTORY | Candidate CAND-931d61e7626f20f5a4aefbdd8e2e104af86ab0dbac7c285ba25cd668e76d62dc | Customer 9363 | Quote 26324 | Item 15527 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4f85a6bc5b3ae01088351f88b1937b455752affe93e862ef7766e33bf5a220ad | OPP-8ed26a323c6fad044e1c2768731f4aa632053bfe24261134aafd33d2247e6947 | SER-966c6db719bb1168b1ce2371786aff0320877b24bfeaaaf4497dd3b7428e7f8c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Wrenfield Diagnostic Labs, Corp. | 46937 | — | WI | Quote Leakage | Needs Validation | 84.55 | 11920.07 | 7151.09 | — | Quote 26492 | Stale Open Quote on quote 26492; quote age 406 days; last modified 355 days ago; quoted value $59600.36; converted line value $0.00; unconverted line value $59600.36. | Classification: Unknown (Medium). Customer active: false. No material CRM note was found in customer_detail. Quote context reviewed for quote 26492: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Wade Emberton | CONFIRM_ACCOUNT | Candidate CAND-4f85a6bc5b3ae01088351f88b1937b455752affe93e862ef7766e33bf5a220ad | Customer 46937 | Quote 26492 | Item 5086 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-cb0965307e24ee22e98a0d7e467754aaac125424fe346e8e758351d5f9729219 | OPP-af25af49aadb5cc85ced8c1033d58219ed72dfbb0be1ccce49f33aae2ccd732b | SER-b34a7f9cf3c869bf68051b7a93a7df34bb3eece4c88a691219e3173311ad05e7 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Health Partners, LLC | 8950 | — | MN | Quote Leakage | Needs Validation | 79.51 | 3630 | 2930 | — | Quote 29874 | Stale Open Quote on quote 29874; quote age 147 days; last modified 146 days ago; quoted value $18150.00; converted line value $0.00; unconverted line value $18150.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29874: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Zoe Rowntree | CONFIRM_ACCOUNT | Candidate CAND-cb0965307e24ee22e98a0d7e467754aaac125424fe346e8e758351d5f9729219 | Customer 8950 | Quote 29874 | Item 12671 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3d2a6aef51e8ceada3478910be269362603614f1bc1f7c1c12dccdca76faee39 | OPP-f71fb99ceb28f3de9ecffeb594ec1f7fcf811e3f01f4d4e5ecb143c5bf35aad1 | SER-e06ac48d769cdbd27376c985fa698e9f79f189b907630f4e8cecf575e896637d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Physician Group, LLC | 8228 | — | OH | Quote Leakage | Needs Validation | 79 | 7520 | 3691.67 | — | Quote 29688 | Stale Open Quote on quote 29688; quote age 161 days; last modified 160 days ago; quoted value $37600.00; converted line value $0.00; unconverted line value $37600.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29688: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-3d2a6aef51e8ceada3478910be269362603614f1bc1f7c1c12dccdca76faee39 | Customer 8228 | Quote 29688 | Item 11345 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-30e7ac357d9f01b0ef45901d65d588cb79e0ff41b1546bd7c94e189ec4f5ccba | OPP-49bbf31aa98ea03c76b08ab93b87d7edc87608cb655121ef997612ac1c1a1847 | SER-af771eb7f4ca4156a9cb77593b47228ade1169d79bdac30c239b3c9a1122dc20 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Reference Labs, Inc. | 8159 | — | IN | Quote Leakage | Needs Validation | 78.97 | 4074 | 2407.4 | — | Quote 27615 | Stale Open Quote on quote 27615; quote age 321 days; last modified 320 days ago; quoted value $20370.00; converted line value $0.00; unconverted line value $20370.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27615: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ezra Halbrook | CONFIRM_ACCOUNT | Candidate CAND-30e7ac357d9f01b0ef45901d65d588cb79e0ff41b1546bd7c94e189ec4f5ccba | Customer 8159 | Quote 27615 | Item 1653 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2f6c82234da25ac5dd666c6edfd96f358ace44cf19157b630f9d7bec93d381a1 | OPP-72648c8627c4e4438adce5590d30611824a741b51c1eb9c26a5f0a61a8746618 | SER-91debee2155336f0ab1399dfb4511ce7307922e336fd0b056cd079b3fdc9f26f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Medical Partners, LLC | 9018 | — | OH | Quote Leakage | Needs Validation | 77.95 | 6860 | 633.9 | — | Quote 29787 | Stale Open Quote on quote 29787; quote age 152 days; last modified 151 days ago; quoted value $34300.00; converted line value $0.00; unconverted line value $34300.00. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 29787: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Xander Feldstein | CONFIRM_ACCOUNT | Candidate CAND-2f6c82234da25ac5dd666c6edfd96f358ace44cf19157b630f9d7bec93d381a1 | Customer 9018 | Quote 29787 | Item 10716 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-68f5fc9c5dee463697e3464108c71251b6e7a00890fb9c32bfab6a94c6b0296b | OPP-0a7b0a458d2d001e3a8681f28e80fedd55e6117ad0554d60ed32dfa5375d6f99 | SER-52db32c9e08bc8541b95c85cd1cb94befae2792e8da9055b1225663be8032be2 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Analytical Labs, PLLC | 41506 | — | IL | Quote Leakage | Needs Validation | 70.78 | 19875 | — | — | Quote 31938 | Repeated Unconverted Quote on quote 31938; quote age 29 days; last modified 27 days ago; quoted value $79500.01; converted line value $0.00; unconverted line value $79500.01. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 31938: 25%/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Kyle Kessler | CONFIRM_ACCOUNT | Candidate CAND-68f5fc9c5dee463697e3464108c71251b6e7a00890fb9c32bfab6a94c6b0296b | Customer 41506 | Quote 31938 | Item 14235 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-b666254f0b7e99fc2790e995a256c111a8bcfcf1b36f0a2d5dab7781de458e36 | OPP-5d7ebc90a7fd75579b5c10c208934da87392739c8f21721c2f45ac1bad5029f6 | SER-9f41f26600d5037139565778e7ce81a43551c05d04c272c2f135beae54094481 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Clinical Labs, PLLC | 43919 | — | LAVENTILLE | Quote Leakage | Needs Validation | 70.5 | 33042 | 12292.5 | — | Quote 28363 | High-Value Lost Quote Recovery on quote 28363; quote age 272 days; last modified 243 days ago; quoted value $165210.00; converted line value $0.00; unconverted line value $165210.00. | Classification: Unknown (Low). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 28363: Closed Lost/Lost. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Felix Nakamura | CONFIRM_ACCOUNT | Candidate CAND-b666254f0b7e99fc2790e995a256c111a8bcfcf1b36f0a2d5dab7781de458e36 | Customer 43919 | Quote 28363 | Item 10667 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-dc05ae4dbda0727dac59475260a074f4fd9a4b47c123cc41d484287c35fb9db2 | OPP-53c3f7a7863597f80290f1a3a34355be10fcdc5d72d2c26a4439dbe375e4fa0f | SER-847c7412276d13581c897dd24f168591fa8cd493788e33f7cf8bdab911fdfab5 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Elmhurst Health Alliance, LLC | 7676 | — | IL | Quote Leakage | Needs Validation | 70.05 | 10934 | 1726 | — | Quote 28668 | High-Value Lost Quote Recovery on quote 28668; quote age 246 days; last modified 66 days ago; quoted value $54670.00; converted line value $0.00; unconverted line value $54670.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 28668: Closed Lost/Lost. Default vendor lead time: 7 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Blake Rowntree ("Key-You") Li (Primary, Lab Director) | CONFIRM_ACCOUNT | Candidate CAND-dc05ae4dbda0727dac59475260a074f4fd9a4b47c123cc41d484287c35fb9db2 | Customer 7676 | Quote 28668 | Item 15076 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6e90fcaa5da9c71b026d6cff127ff696f10b11fe401ec595ca8e38c5f7b0b56c | OPP-61994262e67a93c33f5c7cd1a3f360e48486485506914e03573f7949681ca92e | SER-c4b444a88f9eb27548195570b9b0a291120b5410e41d4a66d83030f1da39b7ad | Not selected for publication; targeted context validation is still required. | **** | Northgate Clinical Partners, LLC | 35691 | — | IL | Quote Leakage | Low | 69.15 | 2114.41 | 652.82 | — | OSR6295 — OSR6295 Olympus HDL Reagent (4x250 tests) | Stale Open Quote on quote 30257; quote age 125 days; last modified 124 days ago; quoted value $10572.04; converted line value $0.00; unconverted line value $10572.04. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-6e90fcaa5da9c71b026d6cff127ff696f10b11fe401ec595ca8e38c5f7b0b56c | Customer 35691 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a15cc1bb558fd22c73ae33d290392046270bdc7fd91eed70ce7344895a954da6 | OPP-c42a6baeb471ef2f5849bb4d5fd2aae7ecc41bc9e4a80e1b5c0b78dca89c802f | SER-1517030899c517ed1c10025d992cd2627f37cd88a2054aefbd40e81ff731b548 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Fairmont Health Alliance, LLC | 52751 | — | NB | Quote Leakage | Needs Validation | 68.33 | 10532.61 | 2430.6 | — | Quote 28762 | High-Value Lost Quote Recovery on quote 28762; quote age 242 days; last modified 210 days ago; quoted value $52663.07; converted line value $0.00; unconverted line value $52663.07. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 28762: Closed Lost/Lost. Default vendor lead time: 7 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Laura Lindqvist | CONFIRM_ACCOUNT | Candidate CAND-a15cc1bb558fd22c73ae33d290392046270bdc7fd91eed70ce7344895a954da6 | Customer 52751 | Quote 28762 | Item 15575 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-443297f198cfbe4e13c3a27f19d8a681881a3e72a76cb9e44447dec4980bf904 | OPP-2a6fbf3030be567426d2b967de4f476406bcb1ec3f994f284b1a53306a3e5f49 | SER-2ff1dbeb80f043100671d5b22440794e14ef91c6f557cf4488c3fb252f3b33a0 | Not selected for publication; targeted context validation is still required. | **** | Bellwood Laboratory Partners, LLC | 41633 | — | IL | Quote Leakage | Low | 67.41 | 2043.68 | 592.72 | — | OSR6196 — OSR6196 Olympus LDL-C (LDL Cholesterol) Reagent, 4x30 mL & 4x10 mL | Stale Open Quote on quote 30785; quote age 97 days; last modified 96 days ago; quoted value $10218.41; converted line value $0.00; unconverted line value $10218.41. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-443297f198cfbe4e13c3a27f19d8a681881a3e72a76cb9e44447dec4980bf904 | Customer 41633 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e3a1c45ba01c96aaf167dbe990b306c3f5669520fc23ce3fa5c66e0796a8eb1f | OPP-bc059208f28779356de58f3ba7af9b446fb87bfd818cbbd0a6a9edb4cc6c346b | SER-6c28934296317bbff8e7e4bc797d317b6310c91d6b123d5d4a8dae5cb535ab90 | Not selected for publication; targeted context validation is still required. | **** | Fairmont Health System, Inc. | 5465 | — | NE | Quote Leakage | Low | 63.59 | 1020.88 | 267.1 | — | IST-03P9225 — IST-03P9225 Abbott I-Stat CKMB CARTRIDGE | Stale Open Quote on quote 31112; quote age 76 days; last modified 75 days ago; quoted value $5104.42; converted line value $0.00; unconverted line value $5104.42. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e3a1c45ba01c96aaf167dbe990b306c3f5669520fc23ce3fa5c66e0796a8eb1f | Customer 5465 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-236bb8470bc55c96d69893261c2d12385d3c66f59fa3d6cd83fab35900ecba04 | OPP-c670fdc148acdb23be62ce4f2c77e6bd51382d99cf61015dd0b7f54da375df7d | SER-2b32d024729bdbf3d1a2203744dd8105dd242d95c99ba2078cc483586d8e247c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Foothill Lab Services, Corp. | 8168 | — | OH | Quote Leakage | Needs Validation | 62.98 | 1200 | 342 | — | Quote 31217 | Stale Open Quote on quote 31217; quote age 70 days; last modified 69 days ago; quoted value $6000.00; converted line value $0.00; unconverted line value $6000.00. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 31217: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ezra Ellery | CONFIRM_ACCOUNT | Candidate CAND-236bb8470bc55c96d69893261c2d12385d3c66f59fa3d6cd83fab35900ecba04 | Customer 8168 | Quote 31217 | Item 1688 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-191307c051fbe23cbe16dbc24a1c531915f491cb2682a0f2cf422d69f7a42091 | OPP-634cf79c2073db4073952f4f3c422da5fd99a94b6f44e71d0bcf5c48e48317ad | SER-613b7a534566bfb6e56a5e806a91494ff2e51d6ed56433fd077eaa4db537f418 | Not selected for publication; targeted context validation is still required. | **** | Elmhurst Medical Associates, LLC | 9915 | — | IA | Quote Leakage | Low | 52.66 | 1418 | — | — | BIO-MERIEUX-MINI-VIDAS-R — Bio Merieux Mini VIDAS Immunoassay Analyzer, Refurbished | Stale Open Quote on quote 31349; quote age 63 days; last modified 62 days ago; quoted value $7090.00; converted line value $0.00; unconverted line value $7090.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-191307c051fbe23cbe16dbc24a1c531915f491cb2682a0f2cf422d69f7a42091 | Customer 9915 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-38de06bd5c4f49f5dd555ed5ab7ea2e97a1008b830b66901f7821a4734fe56d6 | OPP-56471e557600a269741d28c7ca394f4a19d212fa2929f28e232af5436cd542d8 | SER-0bb6017c52582a18860dce043b26cb7daee68a2b6e9eff9891b55424966afa4f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Pathology Associates, Corp. | 26531 | — | MN | Quote Leakage | Needs Validation | 49.71 | 6217.97 | — | — | Quote 27904 | High-Value Lost Quote Recovery on quote 27904; quote age 301 days; last modified 283 days ago; quoted value $31089.86; converted line value $0.00; unconverted line value $31089.86. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27904: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Felix Lofgren | CONFIRM_ACCOUNT | Candidate CAND-38de06bd5c4f49f5dd555ed5ab7ea2e97a1008b830b66901f7821a4734fe56d6 | Customer 26531 | Quote 27904 | Item 17133 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-86e672ece2d51e0abc073ad767852cbf186b129ff5969d7217fc8fb8ee4d10a7 | OPP-32bf19e9726a9379521dad1101d40659864b427c8a98747eb00111c9dc814e90 | SER-9bdac15bc6d0d5ef90bba107a46355f8695c1fdd6442b353c70617141e52ef74 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Alderbrook Clinical Labs, PLLC | 6703 | — | OH | Quote Leakage | Needs Validation | 49.61 | 5635 | — | — | Quote 28003 | High-Value Lost Quote Recovery on quote 28003; quote age 294 days; last modified 217 days ago; quoted value $28175.00; converted line value $0.00; unconverted line value $28175.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 28003: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-86e672ece2d51e0abc073ad767852cbf186b129ff5969d7217fc8fb8ee4d10a7 | Customer 6703 | Quote 28003 | Item 1653 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-74bffb36113b22e6e2525c7c20668d46e0c11c0258d3aa2b9a1c12a1bd5af765 | OPP-a7147d7d5e6af1e093e3ea63ace66075b0af77cbb68166fdce994faeb569345b | SER-3ee06288d6fa03c39dcc3a29ac71e7df49f3e427b1450b9612363f4a4693e65d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Medical Partners, PLLC | 41412 | — | TX | Quote Leakage | Needs Validation | 89.05 | 30125 | 21375 | — | Quote 32001 | High-Margin Open Quote Without Activity on quote 32001; quote age 27 days; last modified 26 days ago; quoted value $120500.00; converted line value $0.00; unconverted line value $120500.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 32001: 25%/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Vera Merriweather | CONFIRM_ACCOUNT | Candidate CAND-74bffb36113b22e6e2525c7c20668d46e0c11c0258d3aa2b9a1c12a1bd5af765 | Customer 41412 | Quote 32001 | Item 14429 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4ba56f9aeb01c3fa6215b45ae2571b14b24a0683bce991be18e682d00401cc83 | OPP-48940f0fca14f9b452a7ce6213c7f21ffe5e7f1a4c9dd020c3d6484ce36e685a | SER-d69601bd7c29deabd93dc5ffea7b1afda1adc69ec748494fee6df59aaba694b8 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Foothill Medical Group, PLLC | 44814 | — | CA | Quote Leakage | Needs Validation | 86.6 | 11757.67 | 5040.39 | — | Quote 25094 | Stale Open Quote on quote 25094; quote age 517 days; last modified 465 days ago; quoted value $58788.35; converted line value $0.00; unconverted line value $58788.35. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 25094: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Zoe Zellner | CONFIRM_ACCOUNT | Candidate CAND-4ba56f9aeb01c3fa6215b45ae2571b14b24a0683bce991be18e682d00401cc83 | Customer 44814 | Quote 25094 | Item 10464 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-233f3b19a418fe50316f2bb08c86bd93e7a202899fac97d1752dab712dac7fe2 | OPP-1da01892ae67bb2883a18fede5127f73f714e5e8f166d55e4c7280a9414ba949 | SER-13ceb01897969ee548c1b3acf31e81cf317f36bcf26a3c577f11b3d8e0f6654c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Health Collective, LLC | 47319 | — | TX | Quote Leakage | Needs Validation | 82.89 | 9852.2 | 5304.2 | — | Quote 26738 | Stale Open Quote on quote 26738; quote age 389 days; last modified 388 days ago; quoted value $49261.00; converted line value $0.00; unconverted line value $49261.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 26738: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Item appears inactive; validate replacement or supersession before quoting. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jenna Sutcliffe | CONFIRM_ACCOUNT | Candidate CAND-233f3b19a418fe50316f2bb08c86bd93e7a202899fac97d1752dab712dac7fe2 | Customer 47319 | Quote 26738 | Item 15527 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6d32cff03bf37a06872b9070dd762f4941839e5fe2289970679ca5a0b1d12c56 | OPP-ccdef656afc048eeda2007477906d5625d4ab2496a04e0bbae335170547c631b | SER-347718fd7fa09e7661c42b35254abb84fef5bb25747a343949139018c8beee32 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cedar Medical Group, Inc. | 56305 | — | TX | Quote Leakage | Needs Validation | 78.33 | 9524.08 | 4122.02 | — | Quote 31526 | Repeated Unconverted Quote on quote 31526; quote age 43 days; last modified 26 days ago; quoted value $19048.17; converted line value $0.00; unconverted line value $19048.17. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 31526: 50%/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-6d32cff03bf37a06872b9070dd762f4941839e5fe2289970679ca5a0b1d12c56 | Customer 56305 | Quote 31526 | Item 13383 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8d9fd59f0397dc26f56841314ad4db4f05288bc6ba6b6daf7df01c21fa9c30cc | OPP-50159ce9fc3f470bb068f83d7af1708820521146514e8ef6d49e3e9edb6a763e | SER-eb0d01d743a7ed688953d015dce4a8cbbb949b1506c9fbe27e55e283740cfb5b | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Maple Medical Partners, PLLC | 41412 | — | TX | Quote Leakage | Needs Validation | 73.28 | 6300 | 600 | — | Quote 31279 | Stale Open Quote on quote 31279; quote age 68 days; last modified 67 days ago; quoted value $31500.00; converted line value $0.00; unconverted line value $31500.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 31279: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Vera Merriweather | CONFIRM_ACCOUNT | Candidate CAND-8d9fd59f0397dc26f56841314ad4db4f05288bc6ba6b6daf7df01c21fa9c30cc | Customer 41412 | Quote 31279 | Item 17127 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a2755d1e5750ea303295d16a4034f245ee75fe491687bb7aa775334c23725b73 | OPP-89bd5536828de721c0d2e45f5538e17b45b32103c29be74cc71d68f4d595e0b7 | SER-70d74991bfc31f797caebf91f9262b62c45849f97def41315df52623478648b1 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Wrenfield Diagnostic Group, Corp. | 9912 | — | TX | Quote Leakage | Needs Validation | 73.09 | 8160 | — | — | Quote 23721 | Stale Open Quote on quote 23721; quote age 637 days; last modified 636 days ago; quoted value $40800.00; converted line value $0.00; unconverted line value $40800.00. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 23721: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Umar Marrow | CONFIRM_ACCOUNT | Candidate CAND-a2755d1e5750ea303295d16a4034f245ee75fe491687bb7aa775334c23725b73 | Customer 9912 | Quote 23721 | Item 13377 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a2809dda2ebedf7ed63c52d12a8abe3db2fb9c23fb71b9a43bf9077d0435bbb3 | OPP-e92c7b32a3d8c19158360eee30a52d6133f3a7ca7139d8c74425e6c83c2216d2 | SER-8a3f2e66d742e4a160d6e4837d2f4747092efcf506465623e84a69899303a56c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Health Collective, LLC | 9212 | — | CO | Quote Leakage | Needs Validation | 69.62 | 3121.08 | 1345.65 | — | Quote 31784 | Repeated Unconverted Quote on quote 31784; quote age 40 days; last modified 18 days ago; quoted value $15605.42; converted line value $0.00; unconverted line value $15605.42. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 31784: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Derek Jennerman | CONFIRM_ACCOUNT | Candidate CAND-a2809dda2ebedf7ed63c52d12a8abe3db2fb9c23fb71b9a43bf9077d0435bbb3 | Customer 9212 | Quote 31784 | Item 14096 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-89806a41dc042794ad71d97a961f03c0d7be94b48c7fcb21dd4c0de8c3f7aaef | OPP-79e3651957f17dcf3cda3de3bf80f8134523edea1c6796f21da232fec8580282 | SER-0624eadae137d360e1ac54670f0f7a66bd6fc0c85a84301ffe27b1ed56ae68c8 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Medical Group, Inc. | 1330 | — | CA | Quote Leakage | Needs Validation | 68.8 | 1996.37 | 831.72 | — | Quote 27876 | Stale Open Quote on quote 27876; quote age 305 days; last modified 67 days ago; quoted value $9981.84; converted line value $0.00; unconverted line value $9981.84. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27876: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Opal Emberton | CONFIRM_ACCOUNT | Candidate CAND-89806a41dc042794ad71d97a961f03c0d7be94b48c7fcb21dd4c0de8c3f7aaef | Customer 1330 | Quote 27876 | Item 13200 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-85d6a88726ceb7bd08cdd3a5a14bb62cc5937da1a623fa73c7f2f0c54d729c01 | OPP-99028803e19eaea824117e678e98fab11dcd58176fdfbb8c6015eeaabb552789 | SER-ff2b7f33b243df9e33a5474be6082783abc66952535810b76b3b7e02a95c4da0 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Alderbrook Medical Associates, PLLC | 48112 | — | CA | Quote Leakage | Needs Validation | 67.11 | 8462.18 | 2440.88 | — | Quote 27235 | High-Value Lost Quote Recovery on quote 27235; quote age 350 days; last modified 332 days ago; quoted value $42310.88; converted line value $0.00; unconverted line value $42310.88. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27235: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Jenna Isakov | CONFIRM_ACCOUNT | Candidate CAND-85d6a88726ceb7bd08cdd3a5a14bb62cc5937da1a623fa73c7f2f0c54d729c01 | Customer 48112 | Quote 27235 | Item 10716 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ffaf7c8ab62c842d9f98321969ad91ea01be4564fa004b91a03538c5aecfccc0 | OPP-92b52d00d04a7d428b36cf0128f15694bdafac79b5020f912468d9d25d9ca7d0 | SER-f7478e89040de8d8733b107310417b1e014ca6175df85b09908bd12599bf5f03 | Not selected for publication; targeted context validation is still required. | **** | Cedar Lab Services, Corp. | 9376 | — | CA | Quote Leakage | Low | 66.4 | 1462.5 | 276.44 | — | DZ888A-K — EZ Vitamin D Assay, Liquid Stable (R1: 1x40mL, R2: 1x10mL) | Stale Open Quote on quote 29604; quote age 168 days; last modified 67 days ago; quoted value $5850.00; converted line value $0.00; unconverted line value $5850.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-ffaf7c8ab62c842d9f98321969ad91ea01be4564fa004b91a03538c5aecfccc0 | Customer 9376 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-549eea6c62670c9fcc6938390229783823d9463c9fbce83dcebd35c6dc20e025 | OPP-1cec3561d1b5fe2fdda86d7ff4d2211e10c5a60f2b8c807ff650d5faace1ada0 | SER-2a7a47de166bc5c92a606bb66c29d0c5c98bb43e0d081c00d11e9a9af478e9af | Not selected for publication; targeted context validation is still required. | **** | Highmark Clinical Labs, LLC | 10126 | — | CA | Quote Leakage | Low | 63.64 | 1729.91 | 704.32 | — | LS120-4 — ACETONITRILE WITH 0.1% FORMIC ACID (V/V), OPTIMA LC/MS, SOLVENT BLENDS, Fisher Chemical, Case of 4 x 4L | Stale Open Quote on quote 27984; quote age 295 days; last modified 67 days ago; quoted value $6919.65; converted line value $0.00; unconverted line value $6919.65. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-549eea6c62670c9fcc6938390229783823d9463c9fbce83dcebd35c6dc20e025 | Customer 10126 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6368bfe06f622e1f011872e7a7072dda8bab0f24e543918e1f0a80e516d3dec8 | OPP-f8bbd6a4118e5a2e74d28d638e7e7e10dc01c9ea600eb56c1ac68f4361ba8f5d | SER-88da6ab64fb3aca4345d79ed230c4ceef9c80f22e88c9d3b09c71f89ac6c2940 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Silverline Diagnostic Group, Corp. | 57339 | — | CA | Quote Leakage | Needs Validation | 63.15 | 6645 | — | — | Quote 31252 | Repeated Unconverted Quote on quote 31252; quote age 69 days; last modified 4 days ago; quoted value $33225.00; converted line value $0.00; unconverted line value $33225.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 31252: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Leo Lindqvist | CONFIRM_ACCOUNT | Candidate CAND-6368bfe06f622e1f011872e7a7072dda8bab0f24e543918e1f0a80e516d3dec8 | Customer 57339 | Quote 31252 | Item 12342 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-de6e73a5cbbb30e57f9f854cd89e7b390a2664bb6924583cf109f68f51bb2fe5 | OPP-d654e7c51f5263faf4aff3bebc0a9bc7a7ac6cb46950814619e7ebf22a1502d3 | SER-8d03bdd59bbf2da8deab5c19ac7e8a4e556e08035d64fc85dc143212227216ed | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Northgate Clinical Labs, LLC | 7605 | — | CA | Quote Leakage | Needs Validation | 62.47 | 7370 | 2895 | — | Quote 28244 | High-Value Lost Quote Recovery on quote 28244; quote age 279 days; last modified 208 days ago; quoted value $36850.00; converted line value $0.00; unconverted line value $36850.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 28244: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Noah Fenwick | CONFIRM_ACCOUNT | Candidate CAND-de6e73a5cbbb30e57f9f854cd89e7b390a2664bb6924583cf109f68f51bb2fe5 | Customer 7605 | Quote 28244 | Item 13377 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-383b7c8aa3c0ecde914bb9a3eaa2c7d65962fcb309ef5a7bda91091c82d60c61 | OPP-77841e61f33bb40a9fd74bd7a811525ee05efeb8f0a600c08dfb7adb5f7a8278 | SER-9252082cb6e09f70b0d2d2fa920c08e95621ca5d9f7d3f31a861a2ee9b3220d7 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Brightwater Health Partners, Corp. | 21153 | — | ON | Quote Leakage | Needs Validation | 62.08 | 7545 | 1318.9 | — | Quote 29264 | High-Value Lost Quote Recovery on quote 29264; quote age 194 days; last modified 66 days ago; quoted value $37725.00; converted line value $0.00; unconverted line value $37725.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29264: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Oscar Vance | CONFIRM_ACCOUNT | Candidate CAND-383b7c8aa3c0ecde914bb9a3eaa2c7d65962fcb309ef5a7bda91091c82d60c61 | Customer 21153 | Quote 29264 | Item 10716 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c23389e40b575bfbda58ae4137e0f085e3f994019a4c5d20e6966a41494a1b83 | OPP-72ec188c891c0a4c01059ebac266baf3b2371ce8b6dff30fac8c1338a140d1cb | SER-baa0c1bbd95e0e1c6d76d0e1723e54025076ded610fd7d11270dcb3f88cda122 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Brightwater Medical Associates, LLC | 6750 | — | CA | Quote Leakage | Needs Validation | 61.65 | 6025.17 | 1792.91 | — | Quote 30539 | High-Value Lost Quote Recovery on quote 30539; quote age 111 days; last modified 59 days ago; quoted value $30125.84; converted line value $0.00; unconverted line value $30125.84. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 30539: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Xander Ulster | CONFIRM_ACCOUNT | Candidate CAND-c23389e40b575bfbda58ae4137e0f085e3f994019a4c5d20e6966a41494a1b83 | Customer 6750 | Quote 30539 | Item 15033 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-406dbee284771cbd73de84a53fb50b719effdf4f5ef2754dc7a64104f4794a65 | OPP-8949a72c79adac90962fd0fc6da058a80058aa750d8aa1cc076917826b4bc248 | SER-4a57dff70e6b7b6ab7dcb3b9b17b480756d22e6f0b1d468f07ddeba1b2704f0e | Not selected for publication; targeted context validation is still required. | **** | Cascade Medical Center, Corp. | 14093 | — | CA | Quote Leakage | Low | 57.63 | 1800 | — | — | Beckman-AU480 Protected Plan — Plan includes unlimited technical support, one preventative maintenance visit per year, and up to two repair calls per year, inclusive of parts, labor, and travel expenses related to both the preventative maintenance and repair services. The plan also guarantees a 48-hour onsite response time. Please refer to the service agreement for limitations, terms, and conditions. | Stale Open Quote on quote 27158; quote age 356 days; last modified 355 days ago; quoted value $9000.00; converted line value $0.00; unconverted line value $9000.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-406dbee284771cbd73de84a53fb50b719effdf4f5ef2754dc7a64104f4794a65 | Customer 14093 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-05d4fce29de484db2bba40fbfea560dcc2963f3d66bde97f08481b3f7e3a2d42 | OPP-1174588a3af856938507ec2265c7987f46fa709b6c6afd0a687fcbb784041a40 | SER-e5d389aa9e80ba9662cd4f3efb58119a62ecdc1b95381af3e5e7ae2933806ddc | Not selected for publication; targeted context validation is still required. | **** | Bellwood Care Partners, Inc. | 39506 | — | CA | Quote Leakage | Medium | 56.45 | 5800 | — | — | Misc Equipment Used — Roche e801 Analyzer used. | High-Value Lost Quote Recovery on quote 28242; quote age 280 days; last modified 276 days ago; quoted value $29000.00; converted line value $0.00; unconverted line value $29000.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-05d4fce29de484db2bba40fbfea560dcc2963f3d66bde97f08481b3f7e3a2d42 | Customer 39506 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-56e6eec30ea9c0cd3e38d4c3ca94443cfbff927da18c49457e1e7458d78ed1f7 | OPP-e4be3887988a98ac4cfe96c6a2358fa731800f1fc987e40cc51a6799646997e9 | SER-0b10bcda6bead979b960ecfab0a90f3dd60b4e078727648fffa32951776034a6 | Not selected for publication; targeted context validation is still required. | **** | Highmark Clinical Partners, PLLC | 40839 | — | CA | Quote Leakage | Medium | 55.67 | 2556.27 | — | — | Freight — Freight | Stale Open Quote on quote 29762; quote age 154 days; last modified 31 days ago; quoted value $12781.35; converted line value $0.00; unconverted line value $12781.35. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-56e6eec30ea9c0cd3e38d4c3ca94443cfbff927da18c49457e1e7458d78ed1f7 | Customer 40839 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-92facf103e47784b10ba635757e30ae5177f97f2f3998dbce7de53f4d552f13d | OPP-a18f076334f646cc8d1929449a3f95bd03744a2a86eb313d4b75d061f076fdce | SER-3c15289afea5b6a7f5b663a86528f240090db627e31c91c75710bb1f4b00f971 | Not selected for publication; targeted context validation is still required. | **** | Silverline Lab Services, Corp. | 10574 | — | CA | Quote Leakage | Medium | 54.54 | 5400 | — | — | Thermo Q Exactive-U — Thermo Q Exactive SN02948L with Vanquish, roughing pump, and UPS | High-Value Lost Quote Recovery on quote 29548; quote age 174 days; last modified 145 days ago; quoted value $27000.00; converted line value $0.00; unconverted line value $27000.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-92facf103e47784b10ba635757e30ae5177f97f2f3998dbce7de53f4d552f13d | Customer 10574 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-15cabf17d9336665a8a6c0a759dd25bb69054075b6362a86fb56f718345c0c5a | OPP-1360631cf495f60f34ac6c5a4a1de6a7158b33ca87151d7eeb72d4cfe7a5fbe3 | SER-b96960f25358b11b85abf4b6274b6281cb5844f2421d4aaaa405aa4943c0f65c | Not selected for publication; targeted context validation is still required. | **** | Alderbrook Analytical Labs, LLC | 33576 | — | CA | Quote Leakage | Medium | 53.06 | 5756 | — | — | Thermo Fisher Quantstudio 12k Flex-U — Thermo Fisher Quantstudio 12k Flex with open array well block Refurbished with 90 day parts warranty | High-Value Lost Quote Recovery on quote 28582; quote age 252 days; last modified 207 days ago; quoted value $28780.00; converted line value $0.00; unconverted line value $28780.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-15cabf17d9336665a8a6c0a759dd25bb69054075b6362a86fb56f718345c0c5a | Customer 33576 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3932abde312e69d4c75f2a354003e7ed90085e6f1debcc048f93e78c91fe9dd5 | OPP-f844641cbd3274fd4a9e5e1ae1ebd34ab71ee9af1ef2d0dcf2bc70d752fa0411 | SER-e30027833ab914d6ad251aa87c1cf148d85075833c4bb15bdbfa45f67eab401c | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Diagnostic Labs, Inc. | 1022 | — | TX | Quote Leakage | Needs Validation | 51.68 | 13000 | — | — | Quote 27974 | High-Value Lost Quote Recovery on quote 27974; quote age 298 days; last modified 245 days ago; quoted value $65000.00; converted line value $0.00; unconverted line value $65000.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27974: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Contact Enrichment Required | CONFIRM_ACCOUNT | Candidate CAND-3932abde312e69d4c75f2a354003e7ed90085e6f1debcc048f93e78c91fe9dd5 | Customer 1022 | Quote 27974 | Item 14816 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c93a5d2e04a1451ffd2300636f7fef2a27c3e549d432f350b1dfcac6e5719874 | OPP-747eddb5bf16918c9ded8094004a4183c7a7ef1b80b04426a59be3400c27a9bf | SER-171a59f81bbe7f213877a3c19e12ae5e580a81213ac37cfcb53c01dcfb78f05c | Not selected for publication; targeted context validation is still required. | **** | Whitmore Lab Services, Corp. | 10237 | — | CA | Quote Leakage | Medium | 51.32 | 5175 | — | — | ABBOTT-I-STAT-1-R — Abbott i-STAT 1 Analyzer, Refurbished, including Downloader, Electronic Simulator, and Printer | High-Value Lost Quote Recovery on quote 31439; quote age 60 days; last modified 18 days ago; quoted value $25875.00; converted line value $0.00; unconverted line value $25875.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-c93a5d2e04a1451ffd2300636f7fef2a27c3e549d432f350b1dfcac6e5719874 | Customer 10237 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5bc46bca548398c3894e2fedeaa379e31c15c1e98efd254cec59bcf565664733 | OPP-94ca5929ab80c84a73887210c74c1df022ea3cfbd5aea33dec6fdea08cdc1fd4 | SER-19ba664c919bd5f26e6a8249ec534915492076ac43ea82a57ffd438b3909c760 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Fairmont Analytical Labs, LLC | 41687 | — | FL | Quote Leakage | Needs Validation | 82.68 | 9724.37 | 5125.95 | — | Quote 23364 | Stale Open Quote on quote 23364; quote age 664 days; last modified 662 days ago; quoted value $48621.83; converted line value $0.00; unconverted line value $48621.83. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 23364: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Fiona Fenwick | CONFIRM_ACCOUNT | Candidate CAND-5bc46bca548398c3894e2fedeaa379e31c15c1e98efd254cec59bcf565664733 | Customer 41687 | Quote 23364 | Item 7085 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9f498fc4dc791b941fa6d0265e19508956b764d55a312e2b09e9a0bceaa6e372 | OPP-ff0269217583e139aabbc7e8c3339bba90d908fb19d8dba105020a1fa2c89e1b | SER-ec3cb302fad43b6cf61e2faa6f21bd879d567b91a758e3566d7f78a8ba6b9403 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Lakeside Laboratory Partners, Corp. | 9666 | — | FL | Quote Leakage | Needs Validation | 80.97 | 33056.8 | — | — | Quote 22536 | Stale Open Quote on quote 22536; quote age 727 days; last modified 630 days ago; quoted value $165284.00; converted line value $0.00; unconverted line value $165284.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 22536: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Item appears inactive; validate replacement or supersession before quoting. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Zoe Kessler | CONFIRM_ACCOUNT | Candidate CAND-9f498fc4dc791b941fa6d0265e19508956b764d55a312e2b09e9a0bceaa6e372 | Customer 9666 | Quote 22536 | Item 12316 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f2af7f0e791cb4375a08f17a1c97fe0a1d0ed0591a5fe2709e532163c1fdf202 | OPP-1ed28d2f109a3030b3b08af4012bdd8bfaeba802ce10db1c8f022ed07f7f818c | SER-779cd2b21a49a5c9e0ecaeb01efc66845b3d47b31ab45b9a47d7fd7f73f0dd61 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Clinical Labs, Corp. | 9122 | — | FL | Quote Leakage | Needs Validation | 79.71 | 7360.43 | 1264.09 | — | Quote 23373 | Stale Open Quote on quote 23373; quote age 210 days; last modified 209 days ago; quoted value $36802.16; converted line value $0.00; unconverted line value $36802.16. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 23373: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Kyle Ashcombe | CONFIRM_ACCOUNT | Candidate CAND-f2af7f0e791cb4375a08f17a1c97fe0a1d0ed0591a5fe2709e532163c1fdf202 | Customer 9122 | Quote 23373 | Item 14438 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-6678c4a04052bfad9597ff3af54186995531a6a136385bb82ad2b39738222e1f | OPP-390c1abbb63c863750e2ac2562d68ff6b07b19c2306af5750a3a9b9e77df1820 | SER-aaf70b18e5626990dcbacd5501648f6a58cc99a939a6d6de9656c5b6c842f05b | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Clinical Partners, LLC | 41977 | — | FL | Quote Leakage | Needs Validation | 72.57 | 3069 | 2072 | — | Quote 30957 | Stale Open Quote on quote 30957; quote age 88 days; last modified 87 days ago; quoted value $15345.00; converted line value $0.00; unconverted line value $15345.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 30957: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Ezra Marrow | CONFIRM_ACCOUNT | Candidate CAND-6678c4a04052bfad9597ff3af54186995531a6a136385bb82ad2b39738222e1f | Customer 41977 | Quote 30957 | Item 4099 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-f0f05c2621a9e2146a91e3f3e56cc0af963ca43600a2c22a947d6567ac7278ac | OPP-800916022621b7ea35aa7e80486c3a0147f1a8717a7920fb4e2edc38ca7c5b6c | SER-0307445696fae138ebb434f248a57c4c179e967ba98883ce56ceadacfcb64a6d | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Health System, LLC | 28789 | — | NV | Quote Leakage | Needs Validation | 69.59 | 9503.6 | 6655.6 | — | Quote 27929 | High-Value Lost Quote Recovery on quote 27929; quote age 300 days; last modified 195 days ago; quoted value $47518.00; converted line value $0.00; unconverted line value $47518.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27929: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Vera Whitfield | CONFIRM_ACCOUNT | Candidate CAND-f0f05c2621a9e2146a91e3f3e56cc0af963ca43600a2c22a947d6567ac7278ac | Customer 28789 | Quote 27929 | Item 14302 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7927abe101597fee4e0e3c940a7e14682b4577946affea5b97e30bae5d6e9687 | OPP-4ecf999b922210984d9a47a4898ba09ec7fb48cd5d31fba859d1523fbeedfc78 | SER-294e0370410eb8450485e3cea373881810ef2b59334cf5b71566a891fc69d5ab | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Whitmore Diagnostic Labs, LLC | 10321 | — | NV | Quote Leakage | Needs Validation | 68.88 | 1637.5 | 399.15 | — | Quote 30786 | Stale Open Quote on quote 30786; quote age 97 days; last modified 96 days ago; quoted value $6550.00; converted line value $0.00; unconverted line value $6550.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 30786: 25%/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Wade Grissom | CONFIRM_ACCOUNT | Candidate CAND-7927abe101597fee4e0e3c940a7e14682b4577946affea5b97e30bae5d6e9687 | Customer 10321 | Quote 30786 | Item 12163 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c3fc9edf764683bab7805ed77b6e530aee74ad6baaff7844a8de56c9aa791bf4 | OPP-c53b97a1f16867d6f5b1482c38e8c09748e9499c9b998ee6c5c80165c17c5dac | SER-268f366e8e7a9b7b2730fc920663805bffcc7fb937cc8be90e79d3067dc428e2 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ironwood Medical Center, Corp. | 9695 | — | FL | Quote Leakage | Needs Validation | 68.29 | 8400 | — | — | Quote 24338 | Stale Open Quote on quote 24338; quote age 575 days; last modified 574 days ago; quoted value $42000.00; converted line value $0.00; unconverted line value $42000.00. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 24338: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Elena Ulster | CONFIRM_ACCOUNT | Candidate CAND-c3fc9edf764683bab7805ed77b6e530aee74ad6baaff7844a8de56c9aa791bf4 | Customer 9695 | Quote 24338 | Item 14586 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d8320bcb26deb9a68314cdc88278c79cbe4e694ade161d06716644522a3fbfa5 | OPP-5755fb84e322082f4b4aa50876be06d570cfb5278aece6b42b23557536841ce7 | SER-189197ff3195873a27ecf5a73dd94f2dab8c4ad6b09a8188482d4a8cf095572e | Not selected for publication; targeted context validation is still required. | **** | Whitmore Lab Services, PLLC | 57074 | — | AZ | Quote Leakage | Low | 67.96 | 1887.02 | 389.42 | — | ABBOTT-I-STAT-1-R — Abbott i-STAT 1 Analyzer, Refurbished, including Downloader, Electronic Simulator, and Printer | Stale Open Quote on quote 29197; quote age 200 days; last modified 67 days ago; quoted value $7548.07; converted line value $0.00; unconverted line value $7548.07. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-d8320bcb26deb9a68314cdc88278c79cbe4e694ade161d06716644522a3fbfa5 | Customer 57074 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-a5ffcde47a662a543defdc9417e11b05be0574cb51d972672dc6d74a5fdc56a9 | OPP-a987837a47fd75a70526b560e6949332d67a5b71cd8a9a30a0db139d6ff80ac3 | SER-238a13aa4f3780fbe25f4e209e8c4f5869f1ba58a5fad83180e24ea9a00536e4 | Not selected for publication; targeted context validation is still required. | **** | Riverside Health Collective, PLLC | 8651 | — | FL | Quote Leakage | Low | 67.26 | 2306.03 | 508.72 | — | T-100249 — Thermo Kit Oxycodone 500mL | Stale Open Quote on quote 30907; quote age 91 days; last modified 90 days ago; quoted value $11530.13; converted line value $0.00; unconverted line value $11530.13. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-a5ffcde47a662a543defdc9417e11b05be0574cb51d972672dc6d74a5fdc56a9 | Customer 8651 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e0c275930a8650af3a2fd06391cfb0aff7a1b49834c8553cd75744b19d87421a | OPP-6f86ca24da89c8657e86f1fa395575164e52bb1e8e77ecedf8f1b3877680cc51 | SER-9b8b32f18cbc535bb71564e9d672ffaf6151d2ec52fd644dcc8423ed7a5b2640 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Cascade Medical Center, Inc. | 41477 | — | AZ | Quote Leakage | Needs Validation | 66.6 | 2859.33 | 528.31 | — | Quote 32051 | Repeated Unconverted Quote on quote 32051; quote age 26 days; last modified 24 days ago; quoted value $14296.64; converted line value $0.00; unconverted line value $14296.64. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 32051: Processing/Open. Default vendor lead time: 1 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Jasper Holcomb | CONFIRM_ACCOUNT | Candidate CAND-e0c275930a8650af3a2fd06391cfb0aff7a1b49834c8553cd75744b19d87421a | Customer 41477 | Quote 32051 | Item 11537 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-429117bed345b4721cebfee57f833f8e1db4e3955285eff7f1a1ba29388c24ff | OPP-fb98677d49a6d127368d69858962f54079d2334eb7033aef4950e9afb4be4539 | SER-c0438fc22f799b2f3abb522ca6076477766d7a003a883981809120c3830467e3 | Not selected for publication; targeted context validation is still required. | **** | Brightwater Medical Partners, LLC | 44268 | — | FL | Quote Leakage | Low | 66.58 | 1835.4 | 275.4 | — | Water System - Olympus AU 400. AU 480 — AQUA SOLUTIONS RODI-T2 TYPE 2 REAGENT GRADE 4-5 LPM DI SYST WITH BUILT-IN 60-LPH RO PRETREAT AND 200-L TANK - Waiting for final quote | Stale Open Quote on quote 27659; quote age 319 days; last modified 318 days ago; quoted value $9177.00; converted line value $0.00; unconverted line value $9177.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-429117bed345b4721cebfee57f833f8e1db4e3955285eff7f1a1ba29388c24ff | Customer 44268 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-e630635f2c884e4f72183306ddc549bf91f97b4f85edf507ca77298df5c6a3ed | OPP-e03d4eddf0a2c6b8f0be4fa2e03da2edd7b492dc73caec26c8126f587f65c4cb | SER-a0b3495ee5874c33d31ced82de19c8154b8dbda6d4155b64d34ebd6af0ca0ca5 | Not selected for publication; targeted context validation is still required. | **** | Bridgeport Care Partners, Corp. | 41006 | — | LA | Quote Leakage | Low | 63.77 | 1275.31 | — | — | L2KCO6 — L2KCO6 (10381480) Immulite 2000 Cortisol, 600 Tests | Stale Open Quote on quote 30346; quote age 120 days; last modified 119 days ago; quoted value $6376.53; converted line value $0.00; unconverted line value $6376.53. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-e630635f2c884e4f72183306ddc549bf91f97b4f85edf507ca77298df5c6a3ed | Customer 41006 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-61cec998c63d3b09669998c4dc85a2b8e8a69f99ce7f3b1e607ac3265d43f39f | OPP-412deaeed6c796283c3b56260dbd879c602223f8e928b80c1284b91ab5824d1a | SER-ce449a006ea92fec564994e0fbde3eb34ab5ce84672cca5eb1787cec4d9fa7de | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Collective, LLC | 55981 | — | LA | Quote Leakage | Low | 62.47 | 1222.28 | 705.25 | — | B24838 — B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests | Stale Open Quote on quote 30942; quote age 89 days; last modified 60 days ago; quoted value $6111.42; converted line value $0.00; unconverted line value $6111.42. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-61cec998c63d3b09669998c4dc85a2b8e8a69f99ce7f3b1e607ac3265d43f39f | Customer 55981 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-d36ceca32f47cdc19ec95b9bf6cb1d79a8343bffbdb9881d20fee653bf2168b8 | OPP-0fce06184e06144d9f70ee714f559aa02fc62d7a433b96eabd7a7449b63072b9 | SER-45dadd06084c913c94cae6e1a1f21d319fb81722ada7b19d43a82417be4bedf3 | Not selected for publication; targeted context validation is still required. | **** | Elmhurst Clinical Partners, LLC | 43074 | — | UT | Quote Leakage | Low | 59.27 | 2375 | — | — | Siemens-Sysmex-CA-620-R — Siemens Sysmex CA-620 Coagulation Analyzer, Refurbished | Stale Open Quote on quote 31459; quote age 57 days; last modified 55 days ago; quoted value $9500.00; converted line value $0.00; unconverted line value $9500.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-d36ceca32f47cdc19ec95b9bf6cb1d79a8343bffbdb9881d20fee653bf2168b8 | Customer 43074 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-851f2a6e7565075351877f16bbadec6569115def517691ba23415a5a416be8db | OPP-5f79654958b35b803038f1e545474f80ce5676d9e1935f2d2d5115f36a1484c8 | SER-1c7da58a5a0b625cfc0e358adf38907c2f6702db9e550c4d70c509fedbcf36e8 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Care Partners, Inc. | 8023 | — | PA | Quote Leakage | Needs Validation | 84.63 | 14376.97 | 8834.25 | — | Quote 29700 | Stale Open Quote on quote 29700; quote age 160 days; last modified 159 days ago; quoted value $28753.93; converted line value $0.00; unconverted line value $28753.93. | Classification: Unknown (Low). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 29700: 50%/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Grant Whitfield | CONFIRM_ACCOUNT | Candidate CAND-851f2a6e7565075351877f16bbadec6569115def517691ba23415a5a416be8db | Customer 8023 | Quote 29700 | Item 2116 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5289b2abfa9ee8cd82670fcd4a9b127d00cf7503bac92cd269b49518d1dc9f68 | OPP-94cb2dd6ebf6389929e6201fcb0a1aa0a78b80703a79ae21212f9ee386b11e58 | SER-2bdfdbc9a3020a0e01cfb4a7be123af5661e103431100e46d85993746aae33eb | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Fairmont Health Alliance, Corp. | 4581 | — | NY | Quote Leakage | Needs Validation | 82.47 | 8480 | 2253.9 | — | Quote 28667 | Stale Open Quote on quote 28667; quote age 246 days; last modified 245 days ago; quoted value $42400.00; converted line value $0.00; unconverted line value $42400.00. | Classification: Unknown (Low). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 28667: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Quinn Quezada | CONFIRM_ACCOUNT | Candidate CAND-5289b2abfa9ee8cd82670fcd4a9b127d00cf7503bac92cd269b49518d1dc9f68 | Customer 4581 | Quote 28667 | Item 10716 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c373cc8bd843558bb9b88033bfd8eafa687c39f38ce871678ed3f195b657fa53 | OPP-e96c70d251a24dda28d19ec4bdc25b8aaa9283fa3f467d58266a1f4d2c37207e | SER-2692ac5b7f7e2e84438906dc4b38f0139244adf5258b999a8f2131ba3f34dab3 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Whitmore Laboratory Partners, Inc. | 7879 | — | NY | Quote Leakage | Needs Validation | 80.87 | 7447.2 | 941.31 | — | Quote 25365 | Stale Open Quote on quote 25365; quote age 495 days; last modified 494 days ago; quoted value $37236.01; converted line value $0.00; unconverted line value $37236.01. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 25365: Processing/Open. Default vendor lead time: 7 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Oscar Nakamura | CONFIRM_ACCOUNT | Candidate CAND-c373cc8bd843558bb9b88033bfd8eafa687c39f38ce871678ed3f195b657fa53 | Customer 7879 | Quote 25365 | Item 14098 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-32ecebc454f68578150d0f1ba2ef9d9397e7cfbf9f7375d9ac9b10187b931ee2 | OPP-d413274c03e09b9cf9f7adc7a56e2fe43ff98a77756f6e7140666aabf8a86271 | SER-42553be7824a9c6ff2c9332f59409658997d10adc9876c22dcd7f85c57429cae | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Harbor Health Alliance, LLC | 8271 | — | NY | Quote Leakage | Needs Validation | 79.74 | 5895.6 | 2417.11 | — | Quote 29237 | Stale Open Quote on quote 29237; quote age 167 days; last modified 166 days ago; quoted value $29478.02; converted line value $0.00; unconverted line value $29478.02. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29237: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Cole Rowntree | CONFIRM_ACCOUNT | Candidate CAND-32ecebc454f68578150d0f1ba2ef9d9397e7cfbf9f7375d9ac9b10187b931ee2 | Customer 8271 | Quote 29237 | Item 12162 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-afa2ae43c7098b97609bbf0167e57d359e9a50637c1d6a976dcaca325fffe591 | OPP-d32381f339e0cc5a6ff92edc027072cbb51acf965cfda9276b8b6dc679ee000c | SER-4ab684cf4cc462d2513c9e6758ac2725054dc7c4639ab6beb5e7edf2d9071530 | Not selected for publication; targeted context validation is still required. | **** | Meridian Reference Labs, Corp. | 52352 | — | NJ | Quote Leakage | Low | 72.4 | 2319.5 | 799.84 | — | T-10028872 — Thermo DRI Fentanyl II 115mL | Stale Open Quote on quote 29115; quote age 204 days; last modified 203 days ago; quoted value $11597.51; converted line value $0.00; unconverted line value $11597.51. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-afa2ae43c7098b97609bbf0167e57d359e9a50637c1d6a976dcaca325fffe591 | Customer 52352 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-197b83f583df4623a0991a24956edd6dfe1cd85dfd58342dcb0a7da6c5c84358 | OPP-9a41a7293258ba89f127ce6d3ec2e729956012420eaaefba15bbb750cb1c4450 | SER-a59c283d950e31e1f82ced5eaa3604cfe72b1b8ea562d32df2aceacfde4ded8a | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Meridian Reference Labs, Inc. | 8324 | — | NJ | Quote Leakage | Needs Validation | 71.52 | 6050 | — | — | Quote 28912 | Stale Open Quote on quote 28912; quote age 218 days; last modified 217 days ago; quoted value $30250.00; converted line value $0.00; unconverted line value $30250.00. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 28912: Ready for Review/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Nadia Lofgren | CONFIRM_ACCOUNT | Candidate CAND-197b83f583df4623a0991a24956edd6dfe1cd85dfd58342dcb0a7da6c5c84358 | Customer 8324 | Quote 28912 | Item 10716 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-3eca0e3d31d9f8fb3dedf7d99211b52d99feb368eef118a60198625eab2d1e06 | OPP-0b5401dbcd506f1e64dc8bbae2128b705c1a3254fa490e75ea5cb51c3cac9c71 | SER-96df83a96db2be4e7eafe63ef02bbe9a04e5ee177b06a3215b60770517061c16 | Not selected for publication; targeted context validation is still required. | **** | Summit Health System, Inc. | 5175 | — | NY | Quote Leakage | Low | 67.72 | 1996.91 | 399.38 | — | Misc Reagent — 43-873-91 Applied Biosystems AgPath-ID One-Step RT-PCR Reagents, 1,000 Reactions | Stale Open Quote on quote 31041; quote age 82 days; last modified 81 days ago; quoted value $9984.53; converted line value $0.00; unconverted line value $9984.53. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-3eca0e3d31d9f8fb3dedf7d99211b52d99feb368eef118a60198625eab2d1e06 | Customer 5175 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-097246218893257e2669dce1cf5d482fb4f8091bbf506b1eaae7d1f86e21160a | OPP-45fb424343809ab3dfe30f0fb91e0f23c7a771c734c90f977a33646c024ddd41 | SER-f55b6820b3ee3dfa108850a7116893f2bc7f244b393cdf1709abd1b27731302f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Summit Analytical Labs, PLLC | 8970 | — | NY | Quote Leakage | Needs Validation | 67.31 | 1820.36 | 932.67 | — | Quote 27716 | Stale Open Quote on quote 27716; quote age 314 days; last modified 313 days ago; quoted value $9101.78; converted line value $0.00; unconverted line value $9101.78. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 27716: Processing/Open. Default vendor lead time: 30 days. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Sam Sutcliffe | CONFIRM_ACCOUNT | Candidate CAND-097246218893257e2669dce1cf5d482fb4f8091bbf506b1eaae7d1f86e21160a | Customer 8970 | Quote 27716 | Item 12034 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-66613b3829aa1f9f9b6671103f596971bc9945137e616066d22143dd6bacc412 | OPP-29f45a4da2ff54319107274a85d998b869628253e90af87f7ebd1f0c1fdd8bb7 | SER-66bb0f482345403aeb0cfbcbece83ce84ad0e9a118098cb47c52e3046609dc0f | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Alderbrook Analytical Labs, PLLC | 48042 | — | NJ | Quote Leakage | Needs Validation | 65.65 | 43000 | — | — | Quote 27103 | High-Value Lost Quote Recovery on quote 27103; quote age 361 days; last modified 285 days ago; quoted value $215000.00; converted line value $0.00; unconverted line value $215000.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 27103: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Jarrett | CONFIRM_ACCOUNT | Candidate CAND-66613b3829aa1f9f9b6671103f596971bc9945137e616066d22143dd6bacc412 | Customer 48042 | Quote 27103 | Item 15074 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-126b435f9d02bcbc5a9f103f36e05ff8bd2f2f7f5e07f664cfdc38eb42b8f418 | OPP-eed3ebcc5794aab4e75dd2bae05d55ec46c01d14489168e3b37b28bab15e33f0 | SER-38739006d98d69f127c82aaa40179cdfe9e01f3f308e9f819726c8d305b832e4 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Ashcroft Laboratory Partners, LLC | 10185 | — | OR | Quote Leakage | Needs Validation | 64.86 | 5060 | — | — | Quote 24062 | Stale Open Quote on quote 24062; quote age 609 days; last modified 608 days ago; quoted value $25300.00; converted line value $0.00; unconverted line value $25300.00. | Classification: Unknown (Low). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 24062: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Carly Ashcombe | CONFIRM_ACCOUNT | Candidate CAND-126b435f9d02bcbc5a9f103f36e05ff8bd2f2f7f5e07f664cfdc38eb42b8f418 | Customer 10185 | Quote 24062 | Item 1653 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-96987923501f4ef4dce77ea0888d99f64faefdbe8fef1c2762db5ec16bdf8e49 | OPP-7c3b94a57241cfb7e7449cbcb6b33c773572baa3403dc1f457b9c35d301903f8 | SER-10ff26d4bbd852f11e37f1ff072dd7da92afbfc6a19ff8b463df882e7d2afbc2 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Crestview Health Collective, PLLC | 10326 | — | PA | Quote Leakage | Needs Validation | 64.69 | 1000 | 350 | — | Quote 30452 | Stale Open Quote on quote 30452; quote age 116 days; last modified 115 days ago; quoted value $5000.00; converted line value $0.00; unconverted line value $5000.00. | Classification: Unknown (Medium). Customer active: true. CRM notes reviewed; verify exact note details before outreach. Quote context reviewed for quote 30452: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Rosa Rowntree | CONFIRM_ACCOUNT | Candidate CAND-96987923501f4ef4dce77ea0888d99f64faefdbe8fef1c2762db5ec16bdf8e49 | Customer 10326 | Quote 30452 | Item 1688 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-8ec273ceb442301020fbf5d53a71ac9f5321df8a822d5690d1b37e13d8ed19a4 | OPP-1c60e6fff3ad3ccaa47003ea12b209f6465e84a9cead87f0babcb26bbe24b8f6 | SER-7b6188c0607a7aad845913d70292c46b402dd12211180cf32cdc08469678fd5b | Not selected for publication; targeted context validation is still required. | **** | Sequoia Health Alliance, LLC | 7690 | — | NJ | Quote Leakage | Low | 62.22 | 1700 | — | — | Siemens-Sysmex-CA-620-R — Siemens Sysmex CA-620 Coagulation Analyzer, Refurbished | Stale Open Quote on quote 31299; quote age 67 days; last modified 66 days ago; quoted value $8500.00; converted line value $0.00; unconverted line value $8500.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-8ec273ceb442301020fbf5d53a71ac9f5321df8a822d5690d1b37e13d8ed19a4 | Customer 7690 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-9962c321c205ab5d97649959601df295e00bda9d96b54144d84fa29ada165a4a | OPP-5cf6f911eab5aa1fc888507ac4d59a3ce20defacaf11bd7fe097a2820e574114 | SER-454ccccb76399b97b40f3ebbb22ed3d1e2f89332e5f80071644aecb15403c4b2 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Bridgeport Diagnostics, Corp. | 5592 | — | NY | Quote Leakage | Needs Validation | 60.17 | 4460 | — | — | Quote 28949 | Stale Open Quote on quote 28949; quote age 48 days; last modified 47 days ago; quoted value $22300.00; converted line value $0.00; unconverted line value $22300.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 28949: Processing/Open. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. An open quote exists; use quote follow-up or verify the quote is still active. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. An open quote exists and is treated as the quote-follow-up action, subject to line/order coverage. | Aaron Garrow | CONFIRM_ACCOUNT | Candidate CAND-9962c321c205ab5d97649959601df295e00bda9d96b54144d84fa29ada165a4a | Customer 5592 | Quote 28949 | Item 1653 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-c44967287116ebaeca00645b28aab40f3fc87b28eedbc8abbc14b231b1816d3d | OPP-f3feac27c81fcb3797650f81af8c66ebc1975fa831a6721dcb39ea4d3bf6f158 | SER-480201b006c7d3b0d29e9e5142a44b9f83ff4f3aa638da39cf9bf7931214e518 | Context reviewed; one or more account, site, contact, product, or commercial checks remain unresolved. | **** | Alderbrook Analytical Labs, PLLC | 48042 | — | NJ | Quote Leakage | Needs Validation | 58.58 | 12540 | — | — | Quote 29514 | High-Value Lost Quote Recovery on quote 29514; quote age 175 days; last modified 154 days ago; quoted value $62700.00; converted line value $0.00; unconverted line value $62700.00. | Classification: Unknown (Medium). Customer active: true. No material CRM note was found in customer_detail. Quote context reviewed for quote 29514: Closed Lost/Lost. Vendor lead time unavailable or not relevant. No relevant email or CRM log was found. Customer record is active. | Checked candidate suppression state, approved/processing order flag, open-quote flag, customer active status, item active status, vendor lead-time availability, and territory/source-rep mapping. No disqualifying approved or processing order was found in the candidate signal. No active quote conflict was identified by the candidate signal. Current Pass 2 recheck: customer/site, territory assignment, account classification, open-order flag, quote/order linkage, item status, contact status, and source-snapshot change window were checked. No relevant open order flag remains. No active replacement quote flag was found. | Cole Jarrett | CONFIRM_ACCOUNT | Candidate CAND-c44967287116ebaeca00645b28aab40f3fc87b28eedbc8abbc14b231b1816d3d | Customer 48042 | Quote 29514 | Item 14451 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-26eb733d175d2bedc3399e08a588a771b6bba12a6870e776ec73b257b1a17532 | OPP-cd3b71af1999da3c8217060be3eb81bcffe52c1618e3557d4bc733a439729c0b | SER-5bbe1d128379d0b729d8fd74374786e99d084e0913c516bcf99971736b6dfc19 | Not selected for publication; targeted context validation is still required. | **** | Cedar Reference Labs, Corp. | 7235 | — | NJ | Quote Leakage | Medium | 58.17 | 5485 | — | — | BECKMAN-ACCESS-II-R — Beckman Access II Immunoassay Analyzer, Refurbished | High-Value Lost Quote Recovery on quote 29430; quote age 181 days; last modified 144 days ago; quoted value $27425.00; converted line value $0.00; unconverted line value $27425.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-26eb733d175d2bedc3399e08a588a771b6bba12a6870e776ec73b257b1a17532 | Customer 7235 |
| 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-54beb4e9e464e65f035d4f26892f43b9ef3d48f86bf63fac1a2d60ca022a767d | OPP-2e954fe839bd809d5acbb0f854619c55ac1fee38f362b1949fc4509cb3db6e28 | SER-fa6656a12c98539db1883b4efdb31291d4cf4c1c99a73fcf1f74a4d83dd55b8b | Not selected for publication; targeted context validation is still required. | **** | Brightwater Health System, PLLC | 143 | — | NY | Quote Leakage | Medium | 55.65 | 5356 | — | — | Pentra-C400-R — Horiba ABX Pentra C400 Chemistry Analyzer, Refurbished | High-Value Lost Quote Recovery on quote 28936; quote age 217 days; last modified 192 days ago; quoted value $26780.00; converted line value $0.00; unconverted line value $26780.00. | Targeted CRM context review not completed. | Counter-evidence review required. | Contact Enrichment Required | MANAGER_REVIEW | Candidate CAND-54beb4e9e464e65f035d4f26892f43b9ef3d48f86bf63fac1a2d60ca022a767d | Customer 143 |